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Abstract 
LEWIS PREECE, DOCTOR OF PHILOSOPHY 
UNIVERSITY OF SUSSEX 
STUDIES TOWARD A TOTAL SYNTHESIS OF LACTONAMYCIN 
 
SUMMARY 
Work was undertaken towards the synthesis of the promising antibiotic lactonamycin 
(iii). Following the work of Parsons et al. it was proposed that cyclisation of the ene-
diyne (i) would give access to advanced pentacyclic intermediate (ii) and that from this 
a total synthesis of lactonamycin would be achieved (scheme I).  
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Scheme I : Proposed Parsons, Board, Waters cyclisation to form the pentacycle (iii) 
A synthesis towards the cyclisation precursor (i) was carried out and a route to the key 
tetrasubstituted phthalide (v) established. Further chemistry was proposed to complete 
the synthesis of lactonamycin (scheme II). 
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Scheme II : Formation of a fully substituted benzolactone.  
During attempts to introduce the β-bromoallyl group of key intermediate (v) using a 
high temperature Claisen rearrangement it was established that the benzodioxin (vii) 
underwent thermolysis to generate the reactive quinone methide intermediate (viii) and 
that in the presence of a nucleophilic solvent the adduct (ix) was formed (scheme III). 
Model studies showed the reaction to be both general and high-yielding. 
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Scheme III : Novel quinone methide methodology. 
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1. Introduction 
 
 
“Lord, I fall upon my knees 
And pray that all my syntheses 
May no longer be inferior, 
     To those conducted by bacteria.” 1 
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1.1 The Need for New Antibiotics. 
1.1.1 The Rise of Antibiotic Resistance. 
Antimicrobial compounds have been one of the key medical developments of the past 
century. The introduction of the penicillins2 and sulfonamides3 (figure 1.1) of the 
1930’s and 40’s changed the way in which physicians tackled bacterial infections 
forever. Once fatal or debilitating illnesses could be cured in near miraculous fashion. In 
the intervening years antibiotics have saved the lives of millions of people and 
alleviated the suffering of many more. In that time many more efficacious compounds 
would be discovered, with a vast array of structures and modes of action, a great 
number are natural products, some entirely synthetic creations of man and many more 
are the semi-synthetic results of chemists adapting and improving upon nature’s good 
work. 
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Figure 1.1: The first commercial antimicrobials. 
So successful were these miracle drugs that their usage expanded rapidly and whilst a 
great deal of good has come of this (and continues to), humanity has often wielded these 
potent biological tools recklessly. Antibiotics have frequently been misused by 
physicians, patients and those in the agricultural sector. Doctors have and indeed still do 
prescribe them inappropriately, patients frequently disregard their instructions for use 
and it is common practice in the rearing of livestock to use them indiscriminately in 
prophylaxis. 
Antibiotic resistance arises as simple consequence of natural selection. When we apply 
a selection pressure in the form of antibiotics to a colony of bacteria we promote the 
survival of only those most able to tolerate that pressure. The sheer numbers 
(approximately 1014 bacterial cells in the human body)4 and rate of reproduction 
(generation times of the order of minutes and hours)5 of bacteria, mean that the 
evolution of resistance is a phenomenon we can observe over the course of months and 
years rather than millennia. Resistance is a natural consequence of antibiotic use, it 
would always occur. However our careless use can increase the rate at which resistance 
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develops substantially. 
There are a number of ways that bacteria have been shown to adapt to avoid the 
deleterious effects of antimicrobial compounds to which they’re exposed: 
• Drug inactivation, whereby the bacterium gains the ability to destroy or bind the 
drug molecule so as to render it inert. For example the very many examples of  
β-lactamases, which actively cleave the  β-lactam unit of the penicillins.6 
• Alteration of target site, whereby the bacterium gains an alteration to the 
chemical binding target of the active compound either steric or chemical that 
prevents the active compound binding to that site, or decreases the rate at which 
it does so.7 
• Alteration of metabolic pathway, whereby the bacterium gains the ability to 
circumvent the elements of a metabolic pathway that are targeted by the active 
compound.8 
• Reduced drug accumulation, whereby the bacterium gains the ability to lower 
the rate of influx (through a reduction in cell wall binding proteins for example)9 
and/or increase the rate of efflux (through active pumping proteins in the 
bacterial wall)10 thus resulting in a lower cytoplasmic concentration of the active 
compound. 
Of course the development of resistance by one strain of bacteria to a single antibiotic is 
of relatively little concern. Let us not forgot that bacteria tend to be immune to vast 
swathes of our antibacterial armoury entirely naturally. It is when through selection, we 
start to induce resistance to whole classes of antibiotics followed by multiple classes 
that we start to lack any effective means of fighting off such infections. Such multiply 
resistant strains, or ‘superbugs’ as they have become colloquially known are becoming 
more and more ubiquitous in both the healthcare and community environments. 
Methicillin Resistant Staphylococcus Aureus (MRSA) is one of the most frequently 
cited examples of such a multiply resistant organism, particularly in the popular press. It 
was first identified in the UK in 1961,11 approximately 2 years after the first clinical use 
of the newly developed penicillin derivative methicillin (figure 1.2). This resistance was 
notable at the time as methicillin itself had been introduced as an alternate treatment for 
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infections exhibiting resistance to penicillin G. MRSA is in fact resistant to not just the 
penicillins, but all other classes of β-lactam antibiotics including the cephalosporins, 
carbapenems, and penems.12 This resistance arises from a change in one of the bacterial 
cell wall proteins, to which β-lactam antibiotics bind, inhibiting growth.13 MRSA strains 
are also frequently resistant to erythromycin, fusidic acid, tetracycline, minocycline, 
streptomycin, spectinomycin, and the sulphonamides.12 In a distressing example of quite 
how rapidly such resistance can develop one study found that a single year after the 
introduction of ciprofloxacin (a fluoroquinolone antibiotic) incidences of resistance in 
MRSA increased from 5% to over 80%.14 Throughout the emergence of ever more 
resistant strains and over the course of almost 40 years the drug vancomycin (figure 1.2) 
persisted as the drug of choice for nearly all cases of MRSA,15 leading some to 
optimistically suggest that it may even be impossible for resistance to develop. In 2002 
the first case of Vancomycin Resistant S.Aureus (VRSA) was identified in a hospital in 
Michigan.16  
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Figure 1.2 : Methicillin and Vancomycin. 
Many commentators have noted that the continuing trend of ever greater numbers of 
multiply drug resistant organisms and ever decreasing supplies of novel drugs with 
which to fight them may well be leading us to disaster; the waning of an unheralded 
golden age, in which man’s mastery over the microbial was unquestioned. It is against 
this backdrop that we synthetic chemists are charged with both synthesising new 
antimicrobial compounds and completing artificial syntheses of natural products with 
the aim of developing methodology to allow the creation of efficacious analogues. 
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1.1.2 The Lactonamycins. 
Lactonamycin (1.1) (figure 1.3) was isolated in 1996 by Matsumoto et al.17 from a 
culture broth of the bacterium Streptomyces Rishiriensis which was in turn isolated 
from a soil sample (as more than half of all known antibiotics are)18 collected in 
Yokohama city within the Greater Tokyo Area. Isolated as part of a routine screening 
process attempting to identify new antibiotics, initial results suggested this compound 
showed potent activity against gram-positive bacteria. Significantly this included 
MRSA. The fully elucidated structure including stereochemistry was published in 
1999,19 an accompanying publication also contained further details of the biological 
activities observed.20 MIC’s of between 0.39-1.56 µg/mL were noted for MRSA strains 
and 0.20-0.78 µg/mL for various strains of Vancomycin Resistant Enterococcus (VRE). 
In addition inhibitory behaviour was observed against a number of human tumour cell 
lines. It was these results that fuelled the initial interest in lactonamycin as a molecule 
of potential pharmaceutical interest. 
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Figure 1.3 : Lactonamycin and its analogues. 
The first natural analogue of lactonamycin (1.2) was discovered in 2003, it was 
identified as a metabolite of another soil-borne bacterium Streptomyces Sanglieri, which 
was itself found in pine wood soil samples from County Durham, UK.21 This compound 
was found to be structurally very similar to lactonamycin and as such was dubbed 
lactonamycin Z by its discoverers. Biological screening of this new compound showed 
disappointing levels of efficacy with respect to gram-positive bacteria however the 
material did exhibit notable inhibition of human gastric adenocarcinoma cell lines (IC50: 
0.19 µg/mL).  
Lactonamycin and its analogue differ only by the sugar moiety linked through the O-
glycosidic bond, the core structure being coupled with α-rhodinose and α-2,6-
dideoxyribohexose saccharides respectively. The range of biological activities brought 
about by relatively minor structural changes suggests an interesting target for total 
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synthesis and synthetic analogue development. In addition it was noted by the 
discoverers of lactonamycin that the naptha[e]isoindole structure that comprises the 
DEF ring system is unique among natural products. In addition the chiral fused 
perhydrofuran-furanone structure of the AB ring system has been seen only in the 
natural products derived from Viburnum Wrightii,22 and in these systems (figure 1.4) the 
substituents differ significantly. 
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Figure 1.4 : Perhydrofuran-furanone containing compounds from V.Wrightii. 
1.1.3 Biosynthesis. 
The biosynthesis of the hexacyclic core of the Lactonamycins has been investigated by 
Parry et al.23 They initially noted the structural similarities between the aglycone 
lactonamycinone (1.3) and the napthacenequinone antibiotics Tetracenomycin C 
(TcmC) and Elloramycin (figure 1.5) and postulated that it too is a type II polyketide. 
Investigations into the biosynthesis of TcmC have previously revealed some novel 
chemistry involved in the formation of the cis-diol unit which it was thought may also 
result in the formation of the corresponding cis oxygen functionality in 
lactonamycinone.24 
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Figure 1.5 : Napthacenequinone Antiobiotics. 
It was proposed that lactonamycin was a decaketide formed by a similar pathway to 
TcmC, which is formed by the head to tail incorporation of ten acetate units to 
synthesise the polycyclic core. Parry conducted a number of labelling experiments to 
investigate this hypothesis (figure 1.6). 
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Figure 1.6 : Results of in vivo radiolabeled precursor incorporation in lactonamycin Z. 
Their results seemed to partly confirm the hypothesis with the labelling patterns 
consistent with the head to tail inclusion of 9 acetate units with a proposed oxidative 
cleavage of an initial linkage between C1 and C4. It was also noted that the presence of 
labelled acetate failed to produce any enrichment of C14 or C15. It was suggested that 
this may be due to the use of a nitrogen-containing starter unit for the polyketide chain. 
Experimentation with labelled glycine seemed to confirm that this was the source of 
both C14 and C15 as well as the nitrogen of the lactam. 
The results of the labelling experiments, especially when viewed with reference to the 
studies of TcmC biosynthesis,25 led them to propose the following biosynthetic pathway 
(scheme 1.1). Starting from 9 units of malonyl-CoA and 1 unit of glycinyl-CoA, it 
seemed reasonable to propose that this would follow an analogous route to the 
production of TcmD3 (1.7) as shown. From that structure it was proposed the AB ring 
system would be formed from the oxidative cleavage of the double bond indicated. 
Reduction of the resulting aldehyde (1.9) would allow a conjugate addition of the 
primary alcohol onto the adjacent double bond to form the tetrahydrofuran (1.11). 
Formation of the epoxide (1.12) would then allow either opening with a sulfur based 
enzyme followed by displacement with water26 or straight displacement with water 
followed by enzymatic epimerisation.24 Closing of the lactone and post facto installation 
of the lactam and the methoxy group would furnish a lactonamycinone type compound. 
Precursor Labelling pattern 
Sodium Acetate 
[1-13C] 
C1, C3, C5, C7, C9, C11, C13, C17, 
C19. 
Sodium Acetate 
[2-13C] 
C2, C4, C6, C8, C10, C12, C16, C18, 
C20. 
Sodium Acetate 
[1,2-13C2] 
C1, C2, C3, C4, C5, C6, C7, C8, C9, 
C10, C11, C12, C13, C16, C17, C18, 
C19, C20. 
Glycine 
[1,2-13C] C14, C15, C21, C22. 
Glycine 
[1-13C] C15. 
Glycine 
[2-13C, 15N] C14, C21, C22, N1. 
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Scheme 1.1 : Biosynthetic pathway proposed by Parry et al. 
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1.2 Previous Synthetic Approaches.  
The following is a concise analysis of the work published towards the synthesis of the 
Lactonamycins, in chronological order, with further detail following.   
Group Year Summary 
Danishefsky 2000 Model synthesis of the ABC system. 
Danishefsky 2001 Improved synthesis of the ABC system. 
Behar 2002 Model synthesis of CDEF system. 
Kelly 2002 Model synthesis of CDEF system. 
Danishefsky 2003 Total synthesis of racemic lactonamycinone. 
Kelly 2004 Asymmetric model synthesis of AB system. 
Barrett 2005 (L)-α-rhodinosylation methodology. 
Barrett 2006 Model synthesis of the ABC system. 
Barrett 2006 Model synthesis of the CDEF system. 
Barrett 2006 Failed attempts at the CDEF system. 
Nakata 2010 Model synthesis of the ABCD system. 
Tatsuta 2010 Total asymmetric synthesis of lactonamycin. 
 
Figure 1.7 : Summary of previous synthetic approaches to the Lactonamycins. 
It is readily apparent from these publications that lactonamycin can be thought of as a 3-
part challenge, with distinct strategies required for the synthesis of the asymmetric AB 
system, the planar fused CDEF system and the formation and attachment of the sugar 
residue. With this wide variety of synthetic challenges and as yet only one synthesis of 
lactonamycinone and one of lactonamycin it is clear that there is still a great deal to 
learn through the attempted synthesis of this molecule. No synthesis of lactonamycin Z 
has been reported at the time of publication. 
1.2.1 Danishefsky et al. 
Danishefsky was the first author to publish details of his synthetic attempts toward 
lactonamycin and his further contributions have been the most extensive of any author. 
His first publication in collaboration with Cox concerned his proposed synthesis of the 
ABC ring system.27 A Wessely oxidation28 would be utilised to trap a carboxylic acid29 
in an intramolecular fashion to form the A ring lactone (scheme 1.2). 
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Scheme 1.2 : Proposed Wessely oxidation route toward the AB ring system.  
Work on a model system however proved this route to be somewhat less simple than 
anticipated (scheme 1.3). Starting from lactone (1.17) introduction of the ester was 
accomplished simply enough with the addition of the enolate of tert-butyl acetate to 
give the hemiacetal (1.18), this in turn could be converted to the corresponding methyl 
acetal (1.19) by treatment with methanol over a catalytic acid resin. However what 
Danishefsky had not anticipated was how labile both the acetal and the hemiacetal 
would be in the presence of either acid or base, with elimination to form the              
α,β-unsaturated ester (1.21) occurring rapidly.  
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OBn
O
O
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O
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H
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(1.18) (1.23) (1.24)
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Scheme 1.3 : Reagents and Conditions: (a) LDA, tBuOAc then (1.17) (85%); (b) Amberlite IR 120+, 
MeOH (88%); (c) Triethylsilane, TFA, CH2Cl2 (95%); (d) H2, Pd/C, MeOH (99%); (e) Pb(OAc)4, CH2Cl2 
(20%). 
While attempts were made to allow cleavage of the ester without this undesired collapse 
of the acetal, ultimately none were successful. Danishefsky therefore elected to simply 
reduce out the acetal hoping that the required oxygen functionality could be installed 
later in the synthesis. Treatment of hemiacetal (1.18) with triethylsilane and TFA 
achieved both reduction of the acetal and cleavage of the ester in the same step. After 
standard hydrogenolytic cleavage of the benzyl protecting group, treatment of the 
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resulting phenol (1.23) with lead (IV) acetate led to the formation of desired tricycle 
(1.24). Sadly this product was only isolable in relatively low yield due to decomposition 
on silica, Florisil and alumina complicating its purification.  
Confident that their methodology was at least somewhat viable Danishefsky decided to 
proceed with a more complex synthesis  in the hope that the tetracyclic Wessely product 
(1.34) would display greater stability than model (1.24) (scheme 1.4). The synthesis 
began with the known phosphonate (1.25)30 which when deprotonated underwent a 
Michael addition with butenolide (1.26) the product of which cyclises to give 
hydroquinone (1.27). Standard protecting group chemistry was used to differentiate the 
phenols and the ester side chain was inserted by the established method to give Wessely 
precursor (1.33) in 7 steps. This compound underwent a clean and efficient cyclisation 
upon exposure to lead (IV) acetate to give lactone (1.34) with the additional ring 
appearing to confer the anticipated stability. Sadly when the epoxidation of this product 
was attempted with DMDO the undesired trans diastereoisomer of alcohol (1.35) was 
obtained in 95% d.e. Despite their best efforts to optimise the epoxidation it did not 
prove possible to achieve better than a diastereomeric ratio of 1:1 which itself came at 
the cost of a poor overall yield. 
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Scheme 1.4 : Reagents and Conditions: (a) LiOtBu, THF then (1.26) (80%); (b) Me2SO4, K2CO3, 
acetone, reflux (91%); (c) B-Iodo-9-BBN, CH2Cl2, reflux (79%); (d) BnBr, K2CO3, acetone, reflux (97%); (e) 
tBuOAc, LDA then (1.30); (f) Triethylsilane, TFA, CH2Cl2 (70% over 2 steps); (g) 1,4-Cyclohexadiene, 
Pd/C, EtOH (97%); (h) Pb(OAc)4, CH2Cl2 (74%); (i) DMDO, CH2Cl2 (80%). 
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It was decided that the best strategy would be to open the lactone ring and then use the 
exposed hydroxyl group to direct the epoxidation to the desired face. With the correct 
stereochemistry installed the lactone could then be closed again. This was a strategy that 
Danishefsky had used previously in his synthesis of Vernolepin.31 This approach proved 
to be successful with lactone (1.34) undergoing a methoxide mediated opening to give 
the alcohol (1.36) (scheme 1.5). After some optimisation it was possible to obtain the 
desired epoxidation product in 95% d.e. with the use of TFPAA. Exposure to catalytic 
acid reclosed the lactone and recrystallisation gave quinone (1.37) as a single 
diastereoisomer. 
a
O
OCH3
O
H
O
O
(1.34)
O
OCH3
O
H
OH
CO2Me O
O
O
H
O
O
OH
b, c
(1.36) (1.37)  
Scheme 1.5 : Reagents and Conditions: (a) LiHMDS, MeOH, CH2Cl2, -35 °C (91% based on recovered 
SM); (b) TFPAA, Na2CO3, CH2Cl2, 0 °C; (c) pTSA, benzene, reflux (51% over 2 steps). 
Whilst Danishefsky was disappointed that it had not been possible to integrate the 
desired methoxy unit at an earlier stage (and this would remain a long-term goal) it was 
felt that the strain of the lactone ring should allow addition of the required functionality 
in a Michael fashion (scheme 1.6).  
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Scheme 1.6 : Reagents and Conditions: (a) HMDS-H, imidazole, TMSCl, CH2Cl2 (84%); (b) TMSCl, THF 
then LiHMDS then NIS (86%); (c) DMDO, CH2Cl2 (88% based on recovered SM); (d) Tf2O, DIPEA, CH2Cl2 
(60%); (e) CSA, MeOH (88%); (f) LiI, THF, AcOH, reflux (55%). 
Initial attempts to enolise protected lactone (1.38) led only to β-elimination and opening 
of the hydrofuran ring. However when enolisation of unprotected lactone (1.37) was 
attempted in the presence of TMSCl the silyl ketene acetal (1.40) resulted and it proved 
possible to use this intermediate to form the α-iodolactone (1.41) through reaction with 
NIS. It was initially planned that the iodine be oxidised to an iodosyl intermediate 
which would then undergo elimination to give the necessary strained double bond.32 
Oxidation with DMDO however gave exclusively the α-ketolactone (1.42) through what 
Danishefsky suggested to be a Pummerer-like reaction. While this ketolactone was not 
the intended product it did enable the synthesis to be continued, trapping of the enolate 
of the newly formed ketone as the triflate (1.43) allowed Michael addition of methanol 
as predicted. Reductive removal of the triflate residue with lithium iodide gave target 
(1.45) with all of the ABC ring system functionality in place. 
Whilst this synthesis was a significant first step along the road towards a total synthesis, 
Danishefsky was disappointed. Despite the Wessely oxidation route working largely as 
planned there was substantial frustration that it had proved impossible to incorporate the 
angular methoxy group from an early stage, post facto installation of which greatly 
elongated the route. The epoxidation step was also felt to be somewhat inefficient.  The 
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main concern however was the apparent inability to utilise this route to install the 
absolute stereochemistry required. 
As a result of these problems Danishefsky opted to reevaluate his approach, hoping to 
circumvent some of the issues established in the earlier work. This re-evaluation led to 
the 2001 publication of an alternate route to the same ABC ring system (scheme 1.7).33 
The proposed route would involve the early installation of a quinone, with the key step 
a dihydroxylation, which would in theory allow access to an enantioselective synthesis 
in the future. Deprotection and cyclisation of the side chains would allow the 
completion of the model system. 
(1.46)
O
O
O
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O
O
CO2R
O
O
O
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O
O
O
OR
OH
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O
RO
OH
(1.47) (1.48)  
Scheme 1.7 : Proposed dihydroxylation route toward the AB ring system. 
Work began with known bromonapthalene (1.49)34 which was converted to 
napthaldehyde (1.51) through standard aromatic chemistry (scheme 1.8). Addition of 
the enolate of tert-butyl acetate to the aldehyde resulted in alcohol (1.52). The carbon of 
this alcohol corresponds to the carbon of the troublesome methoxy group in the final 
product, it was therefore considered desirable to attain the correct oxidation level at this 
early stage. However it was acknowledged that introducing a ketone alpha to the 
quinone double bond may inhibit the later dihydroxylation of that bond, as such both 
alcohol (1.52) and ketone (1.54) were synthesised. The oxidation to give the 
hydroxyquinone (1.53) proceeded in excellent yield, but the contrasting oxidation to the 
β-ketoquinone (1.55) was low-yielding as predicted. 
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Scheme 1.8 : Reagents and Conditions: (a) NBS, benzoyl peroxide, CCl4, reflux (quant.); (b) NaH, 
BnOH, TBAI, THF (81%); (c) nBuLi then EtOCHO, THF, -95 °C (80%); (d) LDA, tBuOAc, -78 °C, THF 
(quant.); (e) DMP, CH2Cl2 (76%); (f) CAN, MeCN, H2O (97%); (g) CAN, MeCN, H2O (20%). 
Sadly all efforts to dihydroxylate the electron deficient double bond of the α-
ketoquinone (1.55) proved ineffectual. Whilst this was disappointing, it was not 
unexpected. Thankfully dihydroxylation of the alcohol (1.53) proceeded smoothly to 
give the 1,2-diol (1.56) as a single diastereoisomer (scheme 1.9). Danishefsky felt it 
important to elaborate on the nature of the stereoselectivity in this transformation and 
was keen to cite work by Kishi et al.35 that explains that the allylic alcohol does not 
direct the osmium to the anti face of the alkene (examples of this seemingly reasonable 
hydrogen bonding effect are surprisingly rare)36 it merely sets up a steric environment in 
which attack is most favourable from the anti face. Work by Duthaler et al. led 
Danishefsky to believe that using an aldol reaction to form the equivalent of alcohol 
(1.53) in a future total synthesis could be conducted in a highly stereoselective 
manner,37 thus opening a route to an asymmetric synthesis.  
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Scheme 1.9 : Reagents and Conditions: (a) OsO4, NMO, acetone, H2O (71%); (b) TFA, H2O, CH2Cl2 
(83%); (c) BBr3, CH2Cl2, -78 °C (85%); (d) Acetone, AlCl3, Et2O, 0 °C (79%). 
With the triol (1.56) in hand Danishefsky imagined that the synthesis should be 
completed relatively simply by an intramolecular transesterification and exposure of the 
open chain ester to acidic conditions did indeed promote a rapid cyclisation to the β-
hydroxylactone (1.58). Further efforts were made to attain the correct oxidation state at 
the beta carbon but oxidation of the hydroxyl group (or its equivalents in (1.56) & 
(1.60)) proved to be extremely challenging and a working protocol could not be 
developed. Crystallography suggested this apparent inertness towards oxidation may be 
due to a surprisingly hindered environment around the geminal proton. 
Once again Danishefsky’s plans to install the methoxy group were foiled, this 
necessitated yet another awkward revision of route (scheme 1.10), utilising an 
intramolecular addition of the deprotected alcohol in (1.64) onto the electron poor 
double bond to give known α-iodolactone (1.41). Completion of the model system 
(1.45) then proceeded as demonstrated previously (vide supra, scheme 1.6). This 
completed the second synthesis of this system and with it Danishefsky managed to 
remedy the main problem of his initial Wessely oxidation route. The selectivity of the 
dihydroxylation and the potential to produce the precursor in enantiomerically pure 
form meant this route was far more suitable for a full asymmetric synthesis of 
lactonamycin. 
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Scheme 1.10 : Reagents and Conditions: (a) TMSCl, THF then LiHMDS then NIS, -78 °C (85%); (b) 
DBU, THF (82%); (c) BBr3, CH2Cl2, -78 °C; (d) SiO2, CHCl3 (84% over 2 steps). 
Details of the completed synthesis of lactonamycinone were published 2 years later in 
two communications.38 The first of these detailed the convergent synthesis of the CDEF 
ring system and the second the progression from this to the full hexacyclic construct. 
Danishefsky proposed to form the bulk of the structure by using his quinone 
dihydroxylation method of forming the ABC rings to give quinone (1.66) which would 
undergo a Tamura-Diels-Alder reaction with the enolate of a homophthalic anhydride 
(1.65) (scheme 1.11), the resulting advanced intermediate (1.67) would be converted to 
the target compound by the chemistry established in the model systems (vide supra, 
schemes 1.9 & 1.10). 
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Scheme 1.11 : Proposed Tamura-Diels-Alder route toward the CDEF ring system. 
Synthesis of the anhydride  began with lactam (1.68)39 which was converted to the diene 
(1.71) in two steps (scheme 1.12), it was Danishefsky’s intention to react this diene with 
an allene in order to form what would become the E ring of lactonamycinone. The 
Diels-Alder reaction with 1,3-dicarbobenzyloxyallene (1.72) gave the diester (1.73) in 
low, but viable yield. However whilst cleavage of the esters proceeded smoothly, 
attempts to dehydrate the resulting diacid proved unsuccessful, this was thought to be 
largely due to solubility issues with the extremely polar intermediate. 
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Scheme 1.12 : Reagents and Conditions: (a) I2, PIFA, pyridine, (51%); (b) (1.70), PdCl2(PPh3)2, toluene, 
reflux (83%); (c) (1.72), neat, 200 °C, (15 -25%); (d) H2, Pd/C (50%); (e) (Trimethylsilyl)ethoxyacetylene, 
MeCN, CH2Cl2 (trace). 
An alternate route was initiated (scheme 1.13), starting with known silyl enol ether 
(1.75)40 this underwent a similar cycloaddition reaction with allene (1.76) and the 
synthesis of the anhydride (1.80) proceeded without issue. The unusual choice of an 
octyloxymethyl protecting group was intended to counter the solubility issues 
experienced with the diacid in the previous synthesis and this appeared to work as 
intended with the dehydration proceeding in quantitative yield. 
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Scheme 1.13 : Reagents and Conditions: (a) (1.76), neat, 105 °C; (b) NH4F, MeOH, (75% over 2 steps); 
(c) CH3(CH2)7OCH2Cl, DIPEA, DMF (95%); (d) NBS, benzoyl peroxide, UV, benzene; (e) K2CO3, NH2Me, 
MeOH/MeCN (1:2), (30% based on recovered SM, over two steps); (f) KOH, MeOH (98%); (g) 
(Trimethysilyl)ethoxyacetylene, MeCN, CH2Cl2 (quant.). 
Synthesis of the Tamura-Diels-Alder coupling partner (1.84) was completed in 4 steps 
from known dithiane (1.81)41 using standard chemistry. The previous ambition33 of 
installing chirality at the secondary alcohol carbon was seemingly abandoned, there is 
no mention of any attempts to this end and one can only speculate that this proved 
substantially more challenging than originally anticipated. The racemic                         
β-hydroxyquinone (1.84) was therefore carried through. 
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Scheme 1.14 : Reagents and Conditions: (a) NaH, BnBr, TBAI, THF (86%); (b) PIFA, MeCN/H2O (1:1) 
(86%); (c) LDA, tBuOAc, -78 °C, THF (99%); (d) CAN, 0 °C, MeCN/H2O (9:1) (96%). 
No attempt was made to oxidise the secondary alcohol to the ketone as whilst this 
oxidation state may have still been desirable in terms of installing the methoxy group 
later in the synthesis, the β-hydroxyl group was now essential to the selectivity of the 
Tamura-Diels-Alder (scheme 1.15). Hydrogen bonding between the alcohol and the β-
carbonyl of the quinone activated it, making 1,4-addition to that carbonyl significantly 
more favourable than addition to the opposite end of the quinone system. 
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Scheme 1.15 : Reagents and Conditions: (a) NaH, THF, -78 °C to 0 °C (40%). 
The directing effect of the alcohol was further elaborated by the preparation of the TBS 
ether, when this was exposed to the Tamura-Diels-Alder conditions, no selectivity was 
observed, the product being a 1:1 ratio of the two possible stereoadducts. Preparation of 
a sodium chelate via pre-treatment of alcohol (1.84) with NaH demonstrated a similar 
mode of selectivity, yields were not improved however. 
Tetracyclic intermediate (1.89) was converted to the cis-diol (1.90) as expected with 
osmium tetroxide (scheme 1.16) and subsequent treatment with TFA allowed the 
formation of the lactone with concomitant deprotection of the octyloxymethyl ether 
giving spirocycle (1.91). Once again exhaustive efforts were made to oxidise the 
secondary alcohol to the desired ketone, but this target continued to prove elusive. This 
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resulted in a retreat to the previously described chemistry (vide supra, scheme 1.10) to 
integrate the angular methoxy group leading to iodolactone (1.94), this at least was a 
very encouraging development for Danishefsky as the analogous iodolactone (1.41) had 
been converted into the desired AB ring structure in both of the model studies of that 
system. In the case of the hexacyclic construct however it proved impossible to gain 
access to the required analog of vinyl triflate (1.43). It also proved impossible to close 
the B ring without the activating effect of iodine on the alkene. 
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Scheme 1.16 : Reagents and Conditions: (a) OsO4, pyridine, THF then NaHSO3 (90%); (b) TFA, 
CH2Cl2, H2O (97%); (c) TBSOTf, 2,6-lutidine (73%); (d) LDA, TMSCl, NIS, THF, -78 °C (61%); (e) Cs2CO3, 
THF (83%); (f) BBr3, CH2Cl2, -78 °C; (g) Al2O3, CHCl3, (65% over 2 steps). 
A different approach to the AB system was therefore required and so it was decided to 
attempt the oxidation of alcohol (1.89) (scheme 1.17). This was converted to ketone 
(1.95) with DMP. This ketone was not an ideal intermediate, as it would make the 
following dihydroxylation of the now deactivated alkene somewhat more complicated. 
It also ruled out the application of this route to a chiral synthesis, as the stereoselectivity 
imbued by the alcohol is removed. Whilst the conjugated ketoquinone did indeed prove 
resistant to dihydroxylation by OsO4, the use of a bidentate amine ligand (TMEDA) as 
described by Corey et al.42 increased the reactivity of the osmium significantly, 
allowing conversion to the diol (1.96) in surprisingly high yield. Treatment with acid 
once again allowed simultaneous deprotection of the octyloxymethyl group and 
formation of the spirolactone (1.97a), this reaction did however prove prone to 
decarboxylation, giving somewhat erratic yields. The ketolactone (or analogous 
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compounds) had been an elusive target for some time, unfortunately the deprotection of 
the O-benzyl group proved impossible without also causing significant decomposition 
of the labile ketolactone. Further triage of this route allowed conversion of the 
ketolactone into methyl tetronate (1.98), this proved sufficiently resilient for the benzyl 
ether to be cleaved. Work by Murphy et al.43 had shown how methyl tetronate had 
proved almost completely inert to Michael additions and the intramolecular closing of 
the primary alcohol proved to be just as resistant. 
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Scheme 1.17 : Reagents and Conditions: (a) DMP, CH2Cl2 (96%); (b) OsO4, TMEDA, CH2Cl2 then HCl, 
NaHSO3, THF (77%); (c) TFA, CH2Cl2, (20-55%); (d) TBSOTf, 2,6-lutidine, -78 °C, CH2Cl2; (e) TMSCHN2, 
DIPEA, MeCN, CH2Cl2, (22% over 2 steps); (f) BBr3, CH2Cl2, -78 °C (95%). 
This difficulty proved impossible to evade and this route too reached a dead end. It was 
felt however that a simple adjustment of the protecting group strategy (scheme 1.18), 
introducing a more labile protecting group instead of the benzyl ether would allow the 
route to proceed. Methoxymethyl-protected analog (1.97b) was prepared through the 
same methodology as the corresponding benzyl compound (1.97a).  
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Scheme 1.18 : Reagents and Conditions: (a) AcCl, MeOH, 65 °C (32%). 
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The protecting group in this compound was readily cleaved under acidic conditions 
without the decomposition previously observed, but these conditions also led to the 
methanolysis of the lactone, presumably leading to stereo randomisation of the 
hemiacetal centre in the ring open compound (1.99). No mention was made of attempts 
to reclose the lactone. The abandonment of this modification marked the end of attempts 
at this route and a further revision of strategy (scheme 1.19). A strategy was proposed 
that would utilise masked aldehyde (1.101) to form the A ring as a butenolide, which 
would undergo conversion to the lactone only after the B ring had been closed and the 
methoxy group installed. 
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Scheme 1.19 : Revised strategy for AB ring formation. 
Regressing to benzaldehyde (1.82) (scheme 1.20) the synthesis proceeded by the 
addition of a methyl dioxolane Grignard reagent, subsequent Tatsuta-Diels-Alder 
cyclisation, oxidation and dihydroxylation steps worked as per the model precedent to 
give diol (1.107). When this was exposed to acid, the anticipated 
deprotection/cyclisation step occurred to give the butenolide (1.108), which proved 
suitably stable to allow deprotection of the benzyl ether; the newly exposed primary 
alcohol (1.109) then underwent a methanol induced cyclisation to give the acetal (1.110) 
with the required methoxy group in place. The acetal was readily cleaved to the 
corresponding lactol with acid. Oxidation to furnish the lactone of (±)-lactonamycinone 
(1.3) was not quite as simple as anticipated, requiring a quite specific oxidant. The 
presence of catalytic TEMPO and the use of PIDA as a stoichiometric oxidant44 proving 
to be the only efficacious combination. 
The completion of this compound was a substantial achievement for Danishefsky et al. 
with the target molecule being finished by what ultimately proved to be a very concise 
route. Persistence proved to be a valuable asset in the synthesis as the model chemistry 
that has been so well established failed to be replicated on the full hexacyclic construct. 
The failure of such reasonable model systems to faithfully replicate the chemistry of the 
AB-ring systems is certainly a warning sign to any chemist intent on tackling this 
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problem. It was also most unfortunate that the planned route to an asymmetric synthesis 
was nullified through necessity, whether such an opportunity can be reintegrated at a 
future point remains to be seen.  
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Scheme 1.20 : Reagents and Conditions: (a) (1,3-Dioxolan-2-ylmethyl)magnesium bromide, LiBr, THF, 
reflux (69%); (b) CAN, 0 °C, MeCN/H2O (1:1) (80%); (c) NaH, (1.80) THF, (42%); (d) DMP, CH2Cl2 
(quant.); (e) OsO4, TMEDA, CH2Cl2 then HCl, NaHSO3, THF (89%); (f) HCl, acetone, THF, reflux, (82% 
based on recovered SM); (g) BBr3, CH2Cl2, -78 °C; (h) HCl, dioxane, MeOH, 65 °C (51% based on 
recovered SM, over 2 steps); (i) HCl, THF, (quant.); (j) TEMPO, PIDA, CH2Cl2 (58%). 
1.2.2 Behar and Deville. 
Behar and Deville, reporting shortly after Danishefky’s initial work, proposed a route to 
the CDEF ring system of lactonamycin (scheme 1.21).45 This route would utilise a 
tandem conjugate addition of cyanide to alkyne (1.111) with a subsequent Dieckmann-
type condensation of the intermediate anion (1.112), this would give enone (1.113) 
which would rapidly tautomerise to napthol (1.114). Reduction of the nitrile would give 
the free amine (1.115) that should rapidly cyclise onto the nearby ester, giving lactam 
(1.116). 
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Scheme 1.21 : Proposed tandem conjugate addition/ Dieckmann condensation route. 
A model system was prepared to test the hypothesis and this would prove to be most 
successful (scheme 1.22). Commercially available iodobenzoic acid (1.117) was first 
converted to the acid chloride by the action of oxalyl chloride, before reaction with 
diazomethane gave diazoketone (1.118).  Treatment with silver benzoate effected a 
Wolff rearrangement and in the presence of methanol the intermediate ketene reacted to 
give methyl ester (1.119). A Sonogashira coupling with triethylorthopropynoate, 
followed by reaction with methanol and acid gave the diester (1.120). This compound 
was then treated with a number of different cyanides (NaCN, KCN, [Bu4N]CN) in 
DMSO. Whilst all effected the required addition-condensation to give benzonitrile 
(1.121) NaCN was found to be the most consistently high-yielding and this protocol 
was adopted as standard. The phenol was incompatible with the reaction conditions of 
the reduction and so this was quantitatively protected as the TIPS ether (1.122). 
Treatment of the aryl cyanide with sodium borohydride in the presence of cobaltous 
chloride allowed selective reduction of the nitrile.46 This gave the expected lactam 
(1.123) after cyclisation of the intermediate amine. 
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Scheme 1.22 : Reagents and Conditions: (a) (COCl)2, DMF, THF, benzene, 0 °C then CH2N2, Et2O, 0 
°C (79%); (b) AgOBz, NEt3, MeOH, 0 °C (86%); (c) HCCC(OEt)3, PdCl2(PPh3)2, CuI, NEt3, MeCN, 0 °C to 
rt then pTSA, MeOH (85%); (d) NaCN, DMSO, rt (88%); (e) NaH, TIPSCl, DMF (quant.); (f) NaBH4, CoCl2, 
MeOH, THF (71%). 
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Now confident in their methodology the authors elected to attempt the synthesis of a 
more elaborate model that would more closely replicate the functionality needed for a 
total synthesis of lactonamycin (scheme 1.23). Known napthol (1.124)47  was selected 
and this underwent bromination ortho to the phenol with pyridinium bromide 
perbromide to give napthyl bromide (1.125). Standard methylation conditions protected 
both the phenol and the secondary alcohol as their methyl ethers giving methyl ether 
(1.126). The aryl bromide was converted to the corresponding iodide (1.127) via a 
lithiated intermediate. The benzylic methoxy group was then converted to the 
corresponding benzyl bromide (1.128) by treatment with HBr in acetic acid. The 
bromide was displaced with KCN to give the nitrile (1.129) and this underwent 
methanolysis to give the methyl ester (1.130). An analogous Sonogashira coupling and 
subsequent hydrolysis gave diester (1.131), it was noted that Sonogashira conditions 
were tried on the equivalent bromo compound but were found to be ineffective. This 
necessitated the slightly less elegant conversion to the iodide.  
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Scheme 1.23 : Reagents and Conditions: (a) PHPB, THF, 0 °C (99%); (b) NaH, MeI, DMF (84%); (c) 
nBuLi, THF, I2, -78 °C (91%); (d) HBr, AcOH, 50 °C (65-79%); (e) KCN, EtOH, H2O, reflux (82%); (f) TfOH, 
MeOH, reflux (86%); (g) HCCC(OEt)3, PdCl2(PPh3)2, CuI, NEt3, MeCN, 0 °C to rt then pTSA, MeOH (97%); 
(h) NaCN, DMSO; (i) NaH, TIPSCl, DMF (68% two steps); (j) NaBH4, CoCl2, MeOH, THF, 50 °C (52%). 
Exposure of diester (1.131) to the previously optimised cyclisation conditions gave the 
desired product, although the reaction was significantly slower than that of the model. 
Concerns over the stability of intermediate phenol (1.132) led them to TIPS protect the 
crude material to give silyl ether (1.133). This material was reduced using the same 
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borohydride-cobalt chloride system and whilst requiring longer reaction times and 
heating, the lactam (1.134) was successfully obtained. This sluggishness seems 
reasonable given the large amount of oxygen functionality in this system. 
1.2.3 Kelly et al. 
Published only shortly after the effort of Behar and Deville was a second model study of 
the CDEF ring system from the Kelly laboratory.48 They proposed to make the key step 
of their synthesis a Diels-Alder reaction between a quinone and the silyl enolate of a 
tricyclic phthalide system (scheme 1.24). 
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Scheme 1.24 : Proposed Diels-Alder formation of C&D rings. 
The route began with the formation of the known anhydride (1.138)49 (scheme 1.25), 
this was selectively reduced to the desired lactone (1.139) with L-Selectride®, the work 
of Makhlouf and Rickborn suggesting that the observed selectivity (≥95%) is a result 
predominantly of sterics,50 though the electronics of this particular system are also 
favourable for reduction at the more electron poor carbonyl. It was intended that this 
phthalide system would then undergo bromination on the methyl group via a radical 
reaction pathway to give benzyl bromide (1.140), however even under very strong 
radical conditions (AIBN as an initiator and performed under an intense light source) 
the only observed bromination product was the ring-substituted product (1.141). This 
reactivity was driven by the strong activation of the aryl position by the ortho-phenol, 
this could be counteracted by the protection of the phenol as its acetate ester, however 
this compound still did not undergo the desired transformation, instead undergoing 
bromination at the methylene position of the lactone. Treatment of aryl bromide (1.141) 
with a further equivalent of NBS under free radical conditions allowed advancement to 
the corresponding benzyl bromide (1.142) albeit as one of a mixture of competing 
bromination products, the mild selectivity towards the methyl rather than methylene 
position was attributed to hindrance from the bromine on the ring. The lactam (1.143) 
was formed through reaction with methylamine, displacing the benzyl bromide and then 
closing onto the adjacent ester. The aryl bromide was then removed and the phenol 
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protected as its TBS ether (1.145).  
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Scheme 1.25 : Reagents and Conditions: (a) L-Selectride, THF, -78 °C to rt (87%); (b) NBS, CCl4, H2O, 
rt (91%); (c) NBS, AIBN, P2O5, CCl4, H2O, reflux (32% based on recovered SM); (d) NEt3, MeNH2, MeOH; 
reflux; (e) Zn, NaOH, H2O, reflux; (f) TBSCl, imidazole, DMF, rt (51% over 3 steps). 
With phthalide system (1.145) in hand, it was thought that treatment with a single 
equivalent of base would be sufficient to deprotonate at the lactone methylene, this 
would generate the enolate, which could then be trapped with TMSCl to give the 
isobenzofuran (1.146). However what actually occurred was that the first equivalent of 
base instead deprotonated the lactam, generating the isoindole (1.148). Unfortunately, a 
second deprotonation/trapping resulted in the C-silylated product (1.149) and only with 
a third equivalent of base was the isobenzofuran (1.150) generated. 
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Scheme 1.26 : Reagents and Conditions: (a) LDA then TMSCl. 
Fortunately it was found that if TBSCl was substituted for TMSCl then it was possible 
to avoid C-silylation entirely (scheme 1.27) and that 2 equivalents of base with an 
excess of silylating agent would allow direct access to furoisoindole system (1.151) in 
situ. The generation of two dienes did briefly raise the issue of selectivity in the reaction 
with a dienophile, however addition of quinone (1.152)51 to the highly reactive 
furoisoindole resulted in rapid reaction of the furan diene. Fragmentation of the bridged 
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intermediate (1.153) was achieved by stirring with TFA for 5 days, giving the model 
CDEF ring system (1.147). 
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Scheme 1.27 : Reagents and Conditions: (a) KHMDS, TBSCl, THF, -78 °C to rt then (1.152), CHCl3, -60 
°C to rt; (b) TFA, 5 days (74% over 2 steps).  
This was a remarkably concise synthesis of the tetracyclic ring system and would have 
been even more so if not for the unfortunate complication with the bromination which 
added an additional two steps. However it serves only as a proof of concept that the in 
situ use of the furan was viable as a Diels-Alder partner, no methodology was suggested 
for a reasonable coupling partner for a full synthesis and it was not indicated how 
stereocontrol would be exerted in the case of an addition to a non-symmetric quinone. 
In his second publication two years later Kelly seemed to acknowledge this issue and 
instead proposed an alternate means of forming the quinone with the chiral AB ring 
already intact (scheme 1.28).52  
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 Scheme 1.28 : Proposed coupling strategy with fully formed asymmetric AB rings. 
It was thought that the core of the AB ring system could be synthesised starting from a 
readily available tartrate ester (scheme 1.29). Use of enantiomerically pure tartrate 
would then allow configuration of the later stereochemistry from the very beginning.   
D-Tartrate was chosen, with the intention of inverting one of the stereocentres during 
the synthesis. The synthesis started from readily available D-tartaric acid, which was 
readily converted to the known acetonide diester (1.157).53  
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Scheme 1.29 : Reagents and Conditions: (a) LDA, THF, HMPA, -78 °C then BOMCl (60%); (b) LDA, 
THF, -78 °C then MeO2CCl (45%); (c) H2, Pd/C, MeOH (89%); (d) LiCH2COOtBu, THF, -78 °C (46%).  
This acetonide was selected due to the well established enolate chemistry associated 
with such systems; the cyclic acetal plays a crucial role in restricting the orbital overlap 
necessary for the system to undergo β-elimination.54 As such treatment with LDA 
results in the formation of the anion (1.158), treatment with BOMCl then installs the 
protected hydroxymethyl group required. Deprotonation of the remaining enolisable 
position in diester (1.159) then allows access to the triester (1.161) by the addition of 
methyl chloroformate. It should be noted that both of these substitutions proceeded with 
retention of stereochemistry, the adjacent stereocentre directing substitution as such. 
Most importantly the addition did not proceed with stereochemical randomisation, 
though an inversion would still have been acceptable, as the L-tartrate derivative could 
have been used as an alternative. 
Hydrogenation of the benzyl group generated the primary alcohol (1.162) which rapidly 
cyclised to give the thermodynamically favourable cis-fused lactone (1.163) as 
confirmed by crystallography. Addition of the enolate of tert-butyl acetate to the lactone 
gave a single unspecified diastereomer of hemiacetal (1.164). Attempts were then made 
to remove the acetonide, but this proved to be impossible under a broad range of 
conditions. 
The failure to remove this led Kelly to search for an alternative acetal protecting group, 
whilst a diverse mixture of acetals were prepared, only the cyclopentylidene acetal 
(1.166) underwent the necessary substitution with BOMCl (scheme 1.30). Knowing that 
cyclopentylidene acetals had been shown to be more labile than the equivalent 
acetonides the synthesis was continued with the new protecting group in place.55 
Progression to the lactone (1.170) proceeded smoothly, however in this modified 
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sequence addition of the enolate to give the tert-butyl ester did not go as planned. 
Instead of adding at the lactone carbonyl as one might have anticipated, addition instead 
occurred at the ester carbonyls giving β-ketoesters (1.172) and (1.173). 
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Scheme 1.30 : Reagents and Conditions: (a) LDA, BOMCl, THF, HMPA, -78 °C (60%); (b) LDA, THF,     
-78 °C then MeO2CCl (66%); (c) H2, Pd/C, MeOH, (quant.); (d) LiCH2COOtBu. 
As the change in reactivity between lactones (1.163) and (1.170) can only be attributed 
to the altered protecting group it was hoped that a further revision to this acetal would 
restore the original mode of enolate addition. Lactone (1.170) was completely resilient 
to hydrolysis yet in a serendipitous turn of events attempting to deprotect uncyclised 
precursor (1.168) with TFA led not only to deprotection of the acetal, but also to the 
cleavage of the benzyl group, leading to formation of the desired lactone (1.174) as the 
major product (scheme 1.31). 
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Scheme 1.31 : Reagents and Conditions: (a) TFA, H2O, CH2Cl2, sealed tube, 65 °C. 
Numerous attempts were made to reprotect the diol as various acetals, esters and silyl 
ethers, the result was that either the formation of these would fail, or the addition of the 
enolate would be directed to the incorrect position. Work was also undertaken to 
Studies Toward a Total Synthesis of Lactonamycin                                                                Introduction 
43 
establish whether the action of a Lewis acid could be used to modify the site of enolate 
attack. The result of extensive work on optimising this sequence resulted in the 
following route (scheme 1.32); the diol (1.174) was first reprotected to give the pair of 
benzylidene acetals (1.177) and (1.178), addition of the enolate proceeded at the desired 
position under the chelating influence of TiCl4 to give the corresponding hemiacetals 
(1.179) and (1.180). The benzylidene was removed by hydrogenation to give the diol 
(1.165) and this in turn underwent a relatively straightforward conversion to the lactone 
(1.181), the stereochemistry being dictated by the thermodynamic imperative to form 
the favoured cis-fused ring system under the equilibration conditions of the reaction. 
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Scheme 1.32 : Reagents and Conditions: (a) PhCHO, pTSA, reflux (30% of (1.177) and 60% of (1.178)); 
(b) LiCH2COOtBu, TiCl4, Et2O, -40 °C (62%); (c) LiCH2COOtBu, TiCl4, Et2O, -40 °C (41%); (d) H2, Pd/C, 
MeOH; (e) CSA, MeOH, reflux (63% over 2 steps). 
Kelly’s efforts constituted the first chiral synthesis of the AB ring system and while the 
brevity of the route may have suffered somewhat due to the challenges presented by the 
various protecting groups used, overall it is a significant piece of work. The use of a 
simple chiral building block such a tartrate ensures not only an elegant synthesis, but 
should also allow this system to be produced in significant quantity. From all the studies 
published on the molecule as a whole, the AB system appears to prove the most 
problematic area of lactonamycin synthesis making this a significant step towards a 
total chiral synthesis. 
1.2.4 Barrett et al. 
The first publication by the Barrett group concerned the development of new 
methodologies for tackling the problem of introducing the L-rhodinose residue at the 
hindered tertiary position of a lactonamycinone type system.56 It was thought this could 
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be achieved by the conjugate addition of the alkoxide of the sugar to a highly reactive 
nitro or nitrosoalkene (scheme 1.33). 
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Scheme 1.33 : Proposed conjugate addition to a nitro or nitrosoalkene. 
To investigate this hypothesis a series of anomeric alcohols were prepared. Barrett also 
proposed modifications to the procedure of Schlessinger and Graves for the synthesis of 
silyl-protected L-rhodinose (1.191)57 that would avoid the use of pharmaceutically 
undesirable toxic tin and chromium reagents. Starting from methyl L-lactate (1.186), the 
free alcohol was benzyl protected, allowing for reduction of the ester with DIBAL to 
give aldehyde (1.187), this in turn was reacted with allylmagnesium bromide, with 
chelation controlling the stereochemistry of addition, yielding the desired 
diastereoisomer (1.188) in 95% d.e. Hydroboration of the double bond allowed 
sequential oxidation to the alcohol and then the aldehyde (1.190). Hydrogenolytic 
debenzylation gave L-rhodinose derivative (1.191) after cyclisation. 
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Scheme 1.34 : Reagents and Conditions: (a) NaH, TBAI, BnBr, THF (85%); (b) DIBAL, CH2Cl2, -78 °C; 
(c) Allylmagnesium bromide, MgBr2·Et2O, CH2Cl2, -78 °C; (d) TBSCl, imidazole, DMAP, DMF (89% over 3 
steps); (e) Cyclohexene, BH3·SMe2, THF, NaOH, H2O2, 50  °C (81%); (f) DMP, CH2Cl2 (89%); (g) H2, 
Pd/C, EtOH (81%). 
The result obtained for the addition of the rhodinose derivative (1.191) to 
nitrocyclohexene (1.192) (scheme 1.35) was broadly representative of the general trends 
noted. The sugar was first converted to the alkoxide by the addition of n-butyllithium, 
followed by addition of the nitroalkene. Quenching with acetic acid at low temperature 
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then gave the addition products as the mixture of isomers (1.193) to (1.196). Yields 
were reasonable (44-65%) and where established there was a 3:1 or better selection in 
favour of the desired α-anomer. The relative stereochemistry was seen to be cis however 
no significant selectivity was noted in the absolute stereochemistry.  
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Scheme 1.35 : Reagents and Conditions: (a) nBuLi, THF, (1.192), -10 °C to 25 °C then AcOH, -78 °C 
(55%). 
This methodology was extended to the use of nitrosoalkenes, which were generated in 
situ through a fluoride initiated elimination of an O-silylated α-chloro-ketoxime 
(scheme 1.36). This reaction was successful in the case of the analogous 
nitrosocyclohexene as well as the more hindered tetrasubstituted alkene (1.199). The 
successful attack of the more hindered system gave hope that this approach may 
actually be a viable method for the introduction of the required residue in an equivalent 
lactonamycinone type construct. 
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Scheme 1.36 : Reagents and Conditions: (a) nBuLi, THF, -10 °C then TBAF, -78 °C (62%). 
The success of these additions was then elaborated upon with the demonstration of how 
the resultant α-nitro or α-oximino glycosides can be converted to ketones, equivalent to 
the ketoglycoside unit of lactonamycin (1.1). Taking alkylated rhodinose derivative 
(1.202) as the previously described 3:1 α:β mixture of anomers and exposing it to the 
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modified Nef reaction58 conditions of Steliou and Poupart59 allowed conversion of the 
nitroalkane to the ketone (1.203) with retention of anomeric configuration (scheme 
1.37).  
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Scheme 1.37 : Reagents and Conditions: (a) KMnO4, KOH, MgSO4, MeOH (50%). 
The oxime (1.204) resulting from the nitroso addition sequence could be converted into 
the corresponding ketone (1.205) (scheme 1.38) through oxidation with manganese 
dioxide. This work seemed to provide a much needed route towards forming the 
necessary tertiary glycosidic linkage required for any lactonamycinone based synthesis 
to be successful. Indeed Barrett has been able to form the viable silyloxime precursor 
(1.224) as part of his further studies on lactonamycin (vide infra, scheme 1.42).  
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Scheme 1.38 : Reagents and Conditions: (a) MnO2, hexane (71%). 
Barrett’s subsequent publication tackled the ABC ring system.60 He proposed to form 
this system through the intramolecular Michael addition of a protected quinone enolate 
to a pendant α,β-unsaturated ester (scheme 1.39). This paper also included some 
mention of how to integrate the newly developed glycosidation methodology into a full 
synthesis.  
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Scheme 1.39 : Proposed conjugate addition sequence for the formation of the B ring. 
The synthesis began with the known ketal (1.210)61  which underwent a 1,4-addition 
with methylene nitronate to give nitroalkane (1.211) (scheme 1.40), this was converted 
to the aldehyde (1.212) via a Nef reaction and this in turn was reduced to the alcohol 
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(1.213). Conjugate addition of this alcohol to a variety of propynoate esters (methyl, 
ethyl, and tert-butyl) proceeded smoothly to give enoate esters (1.214a), (1.214b) & 
(1.214c) exclusively as their trans isomers. The intramolecular Michael addition was 
initially promoted using LDA and whilst this successfully granted access to the 
tetrahydrofurans (1.215a), (1.215b) & (1.215c) the reactions proceeded with poor 
yields. Attempts to remedy this issue found that the tert-butyl ester (1.214c) could be 
converted in excellent yields using Barton’s base62 to provide a 4:6  syn to anti ratio of 
(1.215c). Heating the ketals in acetic acid under an atmosphere of air allowed for the 
restoration of the ketone and oxidation to give quinones (1.216a) and (1.216c).    
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Scheme 1.40 : Reagents and Conditions: (a) MeNO2, NEt3 (83%); (b) KMnO4, KOH, MeOH (55%); (c) 
NaBH4, MeOH (77%); (d) HCCO2R, N-methylmorpholine, Et2O (a = 88%, b = 74%, c = 68%); (e) LDA, 
THF, -78 °C to rt (a = 41%, b = 45%, c = 28%); (f) tBuNC(NMe2)2, THF (c = 96%); (g) AcOH/H2O (7:3), 65 
°C (a = 70%, c = 57%). 
The tert-butyl ester (1.216c) was then taken forward (scheme 1.41), the first course of 
action saw this system undergo an Upjohn dihydroxylation to give a mixture (7:3 dr) of 
the diols (1.217) and (1.218) respectively. Sadly separation of the diastereomers proved 
impossible and as such the crude mixture was treated with TFA, the result of which was 
that only the minor all cis diastereomer underwent the necessary cyclisation to give 
lactone (1.37). Evidence suggested that unfortunately major isomer (1.217) was unable 
to epimerise under the reaction conditions and as such simply underwent degradation to 
the acid without cyclising. The selectivity of the initial dihydroxylation could not be 
increased in favour of the desired isomer and as a result it was felt that the exploration 
of an alternative route might prove more rewarding. When the same tert-butyl ester 
(1.216c) was treated with basic hydrogen peroxide to give a mixture of epoxides (1.219) 
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and (1.220) (3.7:6.3 dr) these were separable and treatment of each with TFA gave the 
free acid (1.221) and the lactone (1.222) respectively.  
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Scheme 1.41 : Reagents and Conditions: (a) OsO4, NMO, tBuOH (70%); (b) TFA, CH2Cl2 (27%); (c) 
H2O2, Na2CO3, THF, H2O (93%); (d) TFA, CH2Cl2 (91%); (e) TFA, CH2Cl2 (97%); (f) TMSCl, LiHMDS, 
imidazole, CH2Cl2 (95%). 
Attempts to convert lactone (1.222) to its epimer (1.37) under either basic or acid 
conditions were unsuccessful, however this compound was readily converted to the silyl 
ether (1.223) and these two compounds were used to conduct model studies on the 
introduction of the ever problematic angular methoxy group. This epimeric form would 
also prove equally useful if it was decided to introduce the sugar residue via the 
nitrosoalkene methodology established previously (vide supra, scheme 1.36). Barrett 
demonstrated the successful conversion of α-hydroxy ketone (1.222) to viable nitroso 
precursor (1.224), however the yields were somewhat disappointing (scheme 1.42).  
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Scheme 1.42 : Reagents and Conditions: (a) 4Å MS, TBSONH2, CH2Cl2/MeCN (10:1) 0 °C (18%); (b) 
MsCl, 2,6-Lutidine, CH2Cl2, 0 °C (51%). 
Whilst the addition reaction was not attempted using this substrate, it was hoped that it 
would proceed with inversion of stereochemistry, this would not only be 
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thermodynamically favourable but hopefully kinetically favourable as the desired 
product would be derived from attack on the less hindered convex face of nitrosoalkane 
(1.225). 
Barrett felt (as Danishefsky initially had) that given the strain inherent in the γ-lactone 
ring it should be possible to install the angular methoxy group through a conjugate 
addition to strained butenolide (1.226). Further work towards forming said butenolide 
was sadly fruitless. Despite trying a large selection of reagents and conditions Barrett 
observed only starting material or inseparable, polar mixtures (possibly the same 
elimination products observed by Danishefsky) (scheme 1.43). Oxidation of ester 
(1.216c) proved equally ill-fated. 
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Scheme 1.43 : Reagents and Conditions: (a) IBX-NMO, (b) IBX-MPO, (c) Fenton’s reagent, (d) RuCl3 
and NaIO4, (e) PIDA, (f) Pb(OAc)4 and I2, (g) CrO3 and (Bu4N)IO4, (h) O3 and SiO2, (i) DMDO. 
Perhaps inevitably the conclusion was drawn that integration of the methoxy group was 
a far from simple proposition from the unadorned lactone (1.37) as Danishefsky found 
with his protracted endgame sequence (vide supra, scheme 1.6). Luckily for Barrett a 
fairly simple modification to his existing route would allow the methoxy to be 
incorporated early on in a concealed form.  It was proposed that replacement of the 
alkylpropynoates of the initial route with the acetylene dicarboxylate (1.227) (scheme 
1.44) would introduce the methoxy group masked as an ester, which could later be 
converted to the desired functionality through a cleavage and decarboxylation sequence. 
To this end, existing alcohol (1.213) was coupled with the di-tert-butyl 
acetylenedicarboxylate (1.227) catalysed by DMAP to give diester (1.228), this 
underwent a second Michael addition when deprotonated with Barton’s base to give the 
tetrahydrofuran (1.229) as the major product, the undesired epimeric product was 
produced only as a minor by-product.  
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Scheme 1.44 : Reagents and Conditions: (a) (1.227), DMAP (86%); (b) tBuNC(NMe2)2 (65%);  (c) KOH 
then BnBr (78%); (d) TFA, H2O, air (70%); (e) K2CO3, H2O2, THF then TFA, CH2Cl2 (42%); (f) RuCl3, 
NaIO4 (64%); (g) TFA, CH2Cl2 (26%). 
When exposed to saponification conditions the diester underwent an unforeseen 
transformation. Instead of the observing cleavage of the less hindered primary ester, the 
tertiary ester group was cleaved instead and the intermediate anion substituted with 
benzyl bromide to give the differentiated diester (1.230). Barrett explained this 
unexpected reactivity as the result of the formation of 5-membered lactone alkoxide 
intermediate (1.231) activating the tertiary carboxyl. Cleavage of the ketal under an 
atmosphere of air resulted in the formation of quinone (1.232). This quinone could be 
epoxidised with basic hydrogen peroxide forming a crude 1:1 mixture of epoxides 
which could then be converted to the trans lactone (1.233) with TFA, though this 
reaction proceeded in low yield so presumably only the epoxide that forms trans to the 
butyl ester will undergo cyclisation as seen previously (vide supra, scheme 1.41).  
The quinone (1.232) would not react with osmium tetroxide in either catalytic or 
stoichiometric amounts, but the substitution of the more reactive ruthenium tetroxide 
species (formed in situ from ruthenium chloride and sodium periodate)63 gave the 
desired diol (1.234). In acidic solution this diol would undergo intramolecular 
transesterification producing the desired cis-lactone (1.235) albeit in slightly 
disappointing yield.  
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With the benzyl esters (1.233) and (1.235) in hand Barrett had suitable substrates for 
both his nitroso-glycosylation methodology, and a more traditional sugar coupling 
respectively.  A brief examination of the literature showed that the trans-lactone could 
be converted to the acid (1.236) by transfer hydrogenation (scheme 1.45), the intention 
was then to use Hunsdiecker64 or Simonini65 chemistry to install an alkyl halide at that 
position followed by a displacement to introduce the methoxy group. This chemistry 
was not explored, presumably due to a lack of material by this point. Debenzylation of 
earlier intermediate (1.230) was also investigated with no notable success. 
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Scheme 1.45 : Reagents and Conditions: (a) Pd/C, cyclohexene, EtOH, 80 °C (91%). 
This concluded Barrett et al.’s very thorough dissection of the ABC system. Synthesis 
of the unadorned 6,5,5-tricycle (1.37) does of course constitute a formal synthesis of 
Danishefsky’s model compound (1.45). The formation of oxime mesylate (1.224) was 
also a valuable indication of the viability of the earlier rhodinosylation methodology, 
though sadly an actual addition to this system was not demonstrated.  Barrett also 
explored the promising introduction of the methoxy group masked as an ester, sadly this 
too was not quite taken to its conclusion, confidence in the route however was clearly 
sufficient for Barrett to proceed toward a total synthesis. 
In a subsequent paper Barrett directed attention to the CDEF ring system where he 
envisaged forming the phenolic D ring through an intramolecular Friedel-Crafts 
acylation (scheme 1.46).66 The precursor would in turn be derived from a Negishi 
coupling.67 
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Scheme 1.46 : Proposed Negishi coupling/Friedel-Crafts acylation route. 
Synthesis of the first Negishi precursor began with the commercially available 
trihydroxybenzoic acid (1.242), this was permethylated before one of the more electron 
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deficient ortho-methoxy groups was deprotected with boron trichloride to give the 
phenol (1.243). Vilsmeier chemistry was used to formylate at the activated ortho 
position giving benzaldehyde (1.244), which in turn was oxidised to the acid with 
sodium chlorite. The presence of a chlorine scavenger in the form of methylbutene was 
required to inhibit chlorination of the aromatic ring. The diacid was then methylated to 
give the diester (1.245) in excellent yield.  
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Scheme 1.47 : Reagents and Conditions: (a) Me2SO4, K2CO3, acetone (84%); (b) BCl3, CH2Cl2, -78 °C 
(91%); (c) POCl3, DMF, 0 to 25 °C (75%); (d) NaClO2, NH2SO3H, 2-methyl-2-butene, THF, H2O, DMSO; 
(e) Me2SO4, KHCO3, DMF (94% over 2 steps); (f) Tf2O, pyridine, CH2Cl2 (95%); (g) Zn(CN)2, Pd2(dba)3, 
dppf, DMF, 60 °C (95%); (h) PtO2, H2, THF, AcOH, (94%); (i) NaH, MeI, DMF, 0 °C (91%); (j) BCl3, CH2Cl2, 
-78 °C (82%); (k) PhNTf2, NEt3, CH2Cl2, reflux (92%). 
The free phenol was converted to the triflate which underwent a cross coupling with 
zinc cyanide to give the benzonitrile (1.246). Following the example of Behar and 
Deville the nitrile was reduced with cobaltous sodium borohydride (vide supra, scheme 
1.22), however it was found that on a multigram scale the effectiveness of this method 
was substantially diminished. Attempts to optimise the reaction with different solvent 
systems and alternative transition metals all failed to produce the lactam (1.247) in 
sufficiently high yield. Hydrogenation of the nitrile however proved to be quite viable 
as long as stoichiometric amounts of platinum oxide were used, this method provided 
excellent yields and the expense was attenuated through very effective recycling of the 
platinum. Methylation of the lactam was carried out under standard conditions giving 
ether (1.248). This underwent selective demethylation of the methoxy group adjacent to 
the ester and the resulting phenol was converted in situ to the triflate Negishi precursor 
(1.249). 
With this precursor in hand Barrett was eager to test the route and as such the coupling 
was carried out with the commercially available alkylzinc species (1.250) (scheme 1.48) 
under standard Negishi conditions giving ester (1.251) in excellent yield. The ester was 
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then converted to the corresponding acid (1.252) by saponification with lithium 
hydroxide in what proved to be a somewhat capricious reaction due to both the 
insolubility of the acid as well as its apparent instability during chromatography. Initial 
attempts at performing the Friedel-Crafts coupling were unsuccessful, the use of 
trifluoroacetic anhydride, oxalyl chloride or triflic anhydride failing to catalyse the 
desired reaction. However the use of polyphosphoric acid gave the required tetracycle 
(1.253), this phenol was unstable in air however and would readily undergo oxidation to 
the anthraquinone, this undesired reactivity was first tempered by the in situ protection 
of the phenol as its methyl ether (1.254). Attempts to advance this product to the 
necessary quinone (1.255) with PIFA encountered the same difficulty as Behar in his 
synthesis of TcmA268 where the electron donating methoxy group made it favourable 
for oxidation to occur at the central ring rather than revealing the terminal quinone as 
hoped. Following Behar’s example, the phenol protecting group was switched to the 
electron-withdrawing acetate (1.256), which as predicted allowed CAN oxidation of the 
correct ring to give quinone (1.257). 
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Scheme 1.48 : Reagents and Conditions: (a) (1.250), Pd(PPh3)4, THF (94%); (b) LiOH, THF/MeOH/H2O 
(2:1:1) (37-64%); (c) PPA, 110 °C; (d) Me2CC(Cl)NMe2, CH2Cl2, ZnCl2; (e) Me2SO4, K2CO3, acetone, 50 
°C (<30% over 2 steps); (f) Ac2O, DMAP, pyridine (80% over 2 steps); (g) CAN, MeCN, H2O (65%). 
Having concisely completed the model system, Barrett wished to extend the synthesis to 
include a protected hydroxymethyl group on the quinone, this would then be elaborated 
to the full lactonamycinone system via a series of Michael additions (vide supra, 
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scheme 1.44). This necessitated a new Negishi coupling partner and the decision was 
made to synthesise two such alternatives, corresponding to different protecting groups 
in the final tetracyclic construct. Both syntheses began with known triol (1.258)69 
(scheme 1.49), towards the first Negishi substrate the triol was protected as the 
acetonide (1.259), the remaining free alcohol methyl-protected and the acetonide 
hydrolysed under acidic conditions to give diol (1.261), the phenolic hydroxyl was then 
methylated under standard conditions before the final hydroxyl group was treated with 
NBS and triphenylphosphine to give the benzyl bromide (1.262a) which would be 
converted to the required zinc species in situ (vide infra, scheme 1.50). The second 
synthesis proceeded from the same triol (1.258) via methylation of the phenolic 
hydroxyl. The resulting diol (1.263) could then be mono-protected with para-
methoxybenzyl chloride to give benzyl alcohol (1.264) which was in turn converted to 
the benzyl bromide (1.262b) by treatment with carbon tetrabromide and 
triphenylphosphine. 
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Scheme 1.49 : Reagents and Conditions: (a) Me2C(OMe)2, pTSA, acetone (93%); (b) MeI, NaH, THF; 
(c) pTSA, THF, H2O (98% over 2 steps); (d) Me2SO4, K2CO3, acetone; (e) NBS, PPh3, THF (76% over 2 
steps); (f) Me2SO4, K2CO3, acetone (70%); (g) NaH, PMBCl, TBAI, THF/DMF (5:1) (64% based on 
recovered SM); (h) PPh3, CBr4, THF (73%). 
The benzyl bromides (1.262a) and (1.262b) were converted to the necessary zinc 
species by stirring with zinc dust with 1,2-dibromoethane acting as an initiator. The zinc 
species were then used in situ for the Negishi coupling with triflate (1.249) which 
proceeded smoothly in both instances. Saponification of both esters (1.265a) and 
(1.265b) proceeded in quantitative yield with none of the issues observed previously, 
possibly due to the side chains conferring greater solubility.  
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Scheme 1.50 : Reagents and Conditions: (a) (1.262a) or (1.262b), Zn, (BrCH2)2, THF then Pd(PPh3)4 (a 
= 85%, b = 92%); (b) LiOH, THF/MeOH/H2O (2:1:1) (a = quant., b = quant.); (c) Me2CC(Cl)NMe2, ZnCl2; 
(d) Ac2O, DMAP, pyridine (a = 82%, b = 92% both over 2 steps); (e) CAN, MeCN, H2O (a = 61%, b = 
71%). 
Unfortunately treatment of acid (1.266a) with PPA gave only decomposition products, 
examination of a range of conditions concluded that using an excess of Ghosez’s 
reagent70 and zinc chloride as a mild Lewis acid proved most effective. The Ghosez 
reagent allows for the reaction to be carried out under very mild conditions, resulting in 
exceptional yields. The phenols (1.267a) and (1.267b) produced were once again 
protected in situ as the acetates (1.268a) and (1.268b). Both compounds underwent 
CAN oxidation to give the corresponding quinones (1.269a) and (1.269b), with only the 
methyl ether showing signs of anthraquinone formation as a minor (<10%) by-product. 
As well as this successful synthesis of the CDEF model, Barrett et al.71 also published 
some of the alternate approaches they had taken towards these systems which whilst 
unsuccessful, still proved to be an edifying experience. The first of these routes focused 
on using benzyne intermediate (1.270) to form the D ring (scheme 1.51). 
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Scheme 1.51 : Proposed benzyne Diels-Alder route to formation of the D ring. 
Towards this end work began to develop an appropriate benzyne precursor (scheme 
1.52), despite some issues in the reduction of imide (1.275) to give an appropriate 
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lactam the synthesis of precursor (1.288) proceeded as planned, however attempts to 
generate and utilise the benzyne (1.270) proved to be entirely unsuccessful. 
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Scheme 1.52 : Reagents and Conditions: (a) NEt3, ZnCl2, TMSCl (quant.); (b) (1.277), CH2Cl2, 40 °C 
then TFA, 0 °C (92%); (c) Zn/Hg, HCl, AcOH, reflux (30%); (d) nBuLi, TBSCl, THF, -78 °C to rt (18%); (e) 
Cs2CO3, BnBr, KI, DMF (92%); (f) NaBH4, MeOH, CH2Cl2, 0 °C (quant.); (g) Triethylsilane, TFA, CH2Cl2, 0 
°C (81%); (h) MgBr2.Et2O, toluene/Et2O (6.5:1), reflux (73%); (i) MeI, K2CO3, acetone, reflux (91%); (j) 
Pd/C, H2, MeOH, EtOAc (quant.); (k) Br2, NaOAc.H2O, AcOH (52%); (l) Tf2O, NEt3, CH2Cl2, -78 °C to rt 
(55%). 
A second approach was developed that would mirror their successful approach (vide 
supra, scheme 1.50). This approach would also utilise a palladium mediated cross 
coupling, followed by a Friedel-Crafts reaction to complete the E ring (scheme 1.53).  
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Scheme 1.53 : Reagents and Conditions: (a) NaNH2, furan; (b) HCl, (93%); (c) Br2, CH2Cl2,  -78 °C to rt 
(84%); (d) MeI, Cs2CO3, acetone, reflux (94%); (e) nBuLi, B(OiPr)3, THF, -78 °C to rt then HCl (92%). 
Synthesis of a suitable Suzuki coupling precursor utilised a successful benzyne 
cycloaddition as the key step in the generation of boric acid (1.296). The initial strategy 
had been to convert bromide (1.295) into either an aryllithium or the equivalent 
Grignard reagent and to use this to attack a Michael acceptor such as lactam (1.298) or 
butenolide (1.300) (scheme 1.54). Failure of this approach was likely due to the acidity 
of the methylene protons in the lactam and lactone rings. 
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Scheme 1.54 : Reagents and Conditions: (a) Lithiate or Grignard formation. 
 
Adaptation of this strategy to utilise a Suzuki coupling proved both straightforward and 
successful (scheme 1.55). Progress to dimethoxyacetal (1.305) was uninterrupted 
however attempting to perform the cyclisation on this substrate led to decomposition, 
concluding that this was due to the inactivating effect of the conjugated pyrrolinone 
carbonyl the pyrrole (1.306) was prepared. When the cyclisation was attempted on this 
compound only the undesired compound tentatively assigned as (1.308) resulted.72 
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Scheme 1.55 : Reagents and Conditions: (a) (1.302), PdCl2(PPh3)2, KF(aq), THF, reflux (91%); (b) 
MeNH2, MeOH, 65 °C then HCl, dioxane, reflux (76%); (c) Bu2BOTf, CH2Cl2, NEt3, -78 °C then 
(MeO)2CHCHO (65%); (d) TMSOTf, DIPEA, CH2Cl2, -78 °C to rt then TBSOTf, DIPEA, 0 °C to rt then 
ZnBr2 (32%). 
This route was modified, by the reduction of pyrrolinone (1.304) (scheme 1.56) 
however the modified cyclisation precursors (1.310) and (1.311) gave only inseparable 
mixtures of products when exposed to the acidic reaction conditions. 
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Scheme 1.56 : Reagents and Conditions: (a) Mg, MeOH, 0 °C (93%); (b) LDA, (MeO)2CHCO2Me, THF, 
-78 °C (69%); (c) LDA, AcCl, THF, -78 °C to rt (40%). 
Whilst these alternative routes were certainly of value in shaping the form of later 
routes, they were ultimately superceded by the successful strategy detailed previously. 
Barrett et al.’s extensive efforts on this system do grant a particularly detailed insight 
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into the development of said route and a greater understanding of the chemistry of these 
ring systems.  
1.2.5 Nakata et al. 
After a gap of nearly 3 years, Nakata et al. published a synthesis of the ABCD ring 
system.73 This synthesis featured a particularly elegant construction of the racemic AB 
ring system (scheme 1.57). This strategy would involve the palladium catalysed 
intramolecular addition of a benzyl alcohol to an alkyne, which, when performed in 
methanol under an atmosphere of carbon monoxide would then undergo 
methoxycarbonylation. The resulting strained α,β-unsaturated ester should then readily 
undergo addition of methanol which would in turn allow lactone closure. 
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Scheme 1.57 : Proposed methoxycarbonylation/methanol induced cyclisation route to AB rings. 
The construction of the precursor for this transformation built on the methods of a 
number of previous strategies towards lactonamycinone, the synthesis began with the 
known tri-halogenated benzene derivative (1.317)74 selective lithium halogen exchange 
was then used to introduce a hydroxymethyl group and subsequently a formyl group to 
give benzaldehyde (1.320). The carbonyl was then converted to the ethynylbenzene 
(1.322) with the Ohira-Bestmann reagent (1.321) which generates a vinyl carbene that 
then spontaneously rearranges to give the terminal alkyne.75 
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Scheme 1.58 : Reagents and Conditions: (a) nBuLi, toluene, -78 °C then HCO2Me (87%); (b) NaBH4, 
EtOH, 0 °C; (c) MOMCl, DIPEA, CH2Cl2 (98%, over two steps); (d) nBuLi, THF, -78 °C then HCO2Me 
(90%); (e) (1.321), K2CO3, MeOH (70%). 
The alkyne was then converted to silyl alkynes (1.323a) to (1.323d) through the use of 
n-butyllithium and the corresponding silyl chloride. The silyl acetylenes were converted 
to the quinones (1.324a) to (1.324d) by CAN oxidation. The C ring was then appended 
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through a Tamura-Diels-Alder reaction76 with the lithiate of homophthalic anhydride 
(1.325) akin to that used in Danishefsky’s total synthesis (vide supra, scheme 1.15), 
selectivity in this case was derived from the directing effect of the chlorine.  
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Scheme 1.59 : Reagents and Conditions: (a) nBuLi, THF, -78 °C then TMSCl (a = 96%) or TESCl (b = 
89%) or TBSOTf (c = 99%) or TIPSCl (d = 73%); (b) CAN, H2O, MeCN (a = 92%, b = 92%, c = 85%, d = 
54%); (c) (1.325), LDA, THF then (1.324a) to (1.324d) (a = 51%, b = 52%, c = 58%, d = 22%); (d) RuCl3, 
NaIO4, MeCN/EtOAc/H2O (3:3:1), 0 °C (a = 13-18%, b = 11-16%, c = 17-33%, d = 35%); (e) TBAF, THF,  
0 °C to rt (from a = 93%, b = 94%, c = 98%, d = 98%). 
The resulting addition products (1.326a) to (1.326d) proved to be almost entirely inert 
towards osmium tetroxide dihydroxylation providing only traces of the desired product, 
attempts to increase the rate of this reaction by pyridine coordination resulted in 
decomposition. Switching to a ruthenium oxide setup instead promoted limited 
conversion of the TMS and TES alkynes with increased amounts of oxidant resulting in 
decomposition rather than return of starting material in exchange for very limited 
increases in yield. The TBS and TIPS alkynes however were converted to the diols 
(1.327c) and (1.327d) in more respectable yield. Diols (1.327a) to (1.327d) were then 
converted to the terminal alkyne (1.328) in excellent yield with TBAF. After 
methoxymethyl deprotection the palladium (II) chloride/benzoquinone mediated 
cyclisation/methoxycarbonylation sequence proceeded under the mild conditions of 
Kato et al.77 (scheme 1.60) to give the cyclised product (1.330) as a single stereoisomer, 
tentatively assigned as the Z-isomer (shown) based on the mechanism of Kato. Acid 
induced methanolysis of this compound resulted in an equilibrium mixture of the ring 
closed and ring open products (1.331) and (1.332) respectively. Redissolving the 
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resulting crude product in benzene and heating allowed the equilibrium to be driven 
entirely towards the desired ring closed system. 
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Scheme 1.60 : Reagents and Conditions: (a) TFA, CH2Cl2 (98%); (b) PdCl2, 1,4-benzoquinone, CO, 
MeOH (62%); (c) CSA, MeOH, 80 °C; (d) Benzene, 80 °C (93% over 2 steps). 
This synthesis of the ABCD ring system was remarkable for both its brevity and the 
ease with which the AB system in particular was completed. The uncomplicated 
introduction of the angular methoxy group which had caused so much trouble for other 
groups must have been particularly gratifying. One can imagine the expansion of the 
Tamura cyclisation to include a more developed anhydride coupling partner like that of 
Danishefsky (vide supra, scheme 1.13) which would allow synthesis of a full 
lactonamycinone system. The one downfall with this route would appear to be a lack of 
any simple means of converting it to an asymmetric synthesis. 
1.2.6 Tatsuta et al. 
The first and only total synthesis of lactonamycin was described by Tatsuta et al. in 
2010.78 The route utilised was highly convergent with the key step a Michael-
Dieckmann cyclisation between glycosylated tricycle (1.334) and a thioester (1.333) 
(scheme 1.61). 
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Scheme 1.61 : Proposed convergent Michael-Dieckmann route to the lactonamycin. 
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The synthesis of the required thioester (1.343) started from bromophenol (1.336) 
(scheme 1.62). The free phenol was initially methyl protected to allow subsequent 
lithiation of the bromide; addition to methylchloroformate gave methyl ester (1.337). A 
modification of Danishefsky’s formylation procedure79 allowed conversion to 
benzaldehyde (1.338). The aldehyde was oxidised to the corresponding acid with 
sodium chlorite and this acid was treated with phthalimidylmethyl bromide under basic 
conditions to give the phthalimidylmethyl ester, further treatment with NBS under 
radical conditions gave the dibromide (1.339). Displacement of bromide with 
methylamine generated the benzylamine which underwent subsequent lactamisation to 
give isoindolinone (1.340). The methyl ether was then cleaved with boron trichloride 
and the free phenol reprotected with benzyl bromide. This protection strategy allowed 
lactonamycin (1.1) to be revealed from protected derivative (1.360) (vide infra, scheme 
1.66) under reductive conditions, leaving the O-glycosyl linkage untouched. The benzyl 
bromide was then converted to sulfide (1.341) with ethanethiol. Hydrolysis of the 
methyl ester was achieved with LiOH solution and the acid generated was coupled with 
ethanethiol using EDCI as the coupling agent, to give thioester (1.342). Oxidation of the 
sulfur of the thioether with mCPBA gave key sulfone (1.343). 
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Scheme 1.62 : Reagents and Conditions: (a) Me2SO4, K2CO3, acetone, 40 °C (99%); (b) nBuLi, 
ClCO2Me, THF, -78 °C (88%); (c) Cl2CHOMe, SnCl4, CH2Cl2, 0 °C (95%); (d) NaClO2, NaH2PO4, 2-methyl-
2-butene, H2O/tBuOH, rt; (e) PhthNCH2Br, K2CO3, acetone, 40 °C; (f) NBS, AIBN, CCl4, 80 °C (40% over 3 
steps); (g) MeNH2, THF, rt (42%); (h) BCl3, CH2Cl2, 0 °C to rt (78%); (i) BnBr, Ag2O, MeCN, rt (78%); (j) 
EtSH, DBU, toluene, 60 °C (89%); (k) LiOH, H2O, THF, 70 °C; (l) EtSH, EDCI, DMAP, CH2Cl2, rt (87% 
over 2 steps); (m) mCPBA, CH2Cl2, rt (73%). 
The synthesis of the asymmetric portion began with 2,5-dihydroxybenzoic acid (1.344) 
(scheme 1.63). Selective methylation of the acid and the more nucleophilic phenol gave 
methyl ester (1.345), the ester was then reduced to the alcohol with lithium borohydride 
before exposure to PIFA allowed ethylene glycol to undergo an oxidative addition to the 
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aromatic ring, generating acetal (1.346). Oxidation of the more electron rich double 
bond with osmium tetroxide gave triol (1.347).  
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Scheme 1.63 : Reagents and Conditions: (a) Me2SO4, K2CO3, acetone, 50 °C (94%); (b) LiBH4, THF,  
50 °C; (c) (CH2OH)2, PIFA, CH2Cl2, 0 °C, (84% over 2 steps); (d) OsO4, NMO.H2O, acetone, rt (48%); (e) 
NaBH4, MeOH, 0 °C; (f) TBSCl, imidazole, DMF, 0 °C to rt (67% over 2 steps); (g) (COCl)2, DMSO, NEt3, 
CH2Cl2, -78 °C (71%); (h) TESOTf, pyridine, rt (93%); (i) Methyl propynoate then NaHMDS, THF,      -100 
°C (93%); (j) TBAF, THF, rt; (k) AcCl, MeOH, 0 °C to rt then addition of toluene and concentration (55% 
over 2 steps); (l) IBX, CH2Cl2, 70 °C (94%). 
Stereoselective reduction of the ketone with sodium borohydride (13:1 dr) proceeded 
via the least hindered face to give the tetraol which could then be stereoselectively silyl 
protected to give diol (1.348). Swern oxidation of the secondary alcohol followed by 
TES protection of the tertiary alcohol gave ketone (1.349). Addition of the anion of 
methyl propynoate to the carbonyl in a stereoselective fashion gave the cis-alcohol 
(1.350). Global desilylation of this compound allowed the exposed primary alcohol to 
cyclise onto the conjugated alkyne in a 5-exo-dig fashion to give alkene (1.351). 
Exposure of this compound to methanol under acidic conditions added methanol in a 
conjugate addition to the double bond, this allowed the ester to undergo a 
transesterification with the adjacent secondary alcohol. The acetal was also removed 
under these conditions, giving lactone (1.352). Oxidation of the remaining secondary 
alcohol with IBX gave tricyclic intermediate (1.353). 
The tricylic intermediate was then reacted with the activated rhodinose derivative 
(1.357a). This derivative was prepared from commercially available 3,4-di-O-acetyl-L-
rhamnal (1.354) which undergoes a Ferrier rearrangement in the presence of methanol 
and boron trifluoride diethyl etherate to give a methyl ether, deprotection of the 
remaining acetyl group with sodium methoxide in methanol gave allyl alcohol (1.355). 
The stereocentre at the alcohol was inverted by the use of a Mitsunobu reaction to 
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introduce a formyl ester, which was subsequently cleaved by the action of sodium 
methoxide in methanol, the addition of Amberlite® CG-50 allowed hydrogenation of the 
alkene in one pot. Protection of the free alcohol with benzyl bromide in the presence of 
sodium hydride gave benzyl ether (1.356).  This was converted to the active thio 
compound (1.357a) by displacement of the methoxy group with thiophenol in the 
presence of catalytic CSA. 
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Scheme 1.64 : Reagents and Conditions: (a) MeOH, BF3·Et2O, CH2Cl2, rt, (73%); (b) NaOMe, MeOH, rt 
(84% over 2 steps); (c) HCO2H, PPh3, DEAD, THF, rt; (d) NaOMe, MeOH, rt then CG-50, H2, Pd/C, MeOH, 
rt; (e) BnBr, NaH, THF, 60 °C (64% over 3 steps); (f) PhSH, CSA, CH2Cl2, rt (93%). 
With the activated glycoside in hand it was possible to couple this with racemic alcohol 
(±1.353) using silver triflate as the activating agent, this gave a mixture of the 
glycosides (1.358a) and (1.359a) and these were separable by chromatography.  para-
Bromobenzoate derivatives (1.358b) and (1.359b) were also prepared and from this it 
was possible to identify the correct diastereoisomer by crystallography. Removal of the 
glycosyl residues with TFA allowed confirmation that glycoside (1.358a) displayed the 
correct stereochemistry and this compound was carried forwards. 
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Scheme 1.65 : Reagents and Conditions: (a) 2-Cyclohexenone, AgOTf, 4Å MS, CH2Cl2, -40 °C to rt. 
With the chiral glycoside (1.358a) and thioester (1.343) in hand, Tatsuta completed 
lactonamycin in just two further steps (scheme 1.66). The thioester was added to a mixture 
of glycoside (1.353a) and KHMDS allowing the predicted Michael-Dieckmann 
condensation to occur. If criticism were necessary then the selectivity of the final 
addition would be questionable with very little to distinguish the two ends of the 
quinone, the low yield and lack of comment to the contrary would seem to support this 
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notion. The benzyl-protected lactonamycin (1.355) that resulted could be deprotected by 
hydrogenation over palladium black to give lactonamycin (1.1). 
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Scheme 1.66 : Reagents and Conditions: (a) (1.343), KHMDS then (1.358a), THF, -78 °C to reflux 
(37%); (b) H2, Pd/C, THF, rt (40%). 
This was a substantial achievement for Tatsuta et al.; providing a solution to all three 
areas of lactonamycin’s challenge in such short order was an impressive feat. The 
methodology for the incorporation of the sugar was also made to look a remarkably 
uninvolved process given the extensive concern it had generated on the part of other 
investigators. The resolution of the material evolved from the racemically generated cis 
diol was a particular highlight of the approach. However at 34 discreet steps, the 
synthesis leaves significant room for improvement and as ever the more useful 
information to the synthetic chemist is often the details of what didn’t work on a given 
system. 
1.3 Previous Work Within the Parsons Group.  
1.3.1 Model Studies for the Synthesis of Lactonamycin. 
A retrosynthetic analysis of lactonamycin by Parsons et al. had led to the conclusion 
that the chiral AB(C) ring system of lactonamycin (1.1) could be derived from the 
relatively simple pentacyclic system (1.361) (scheme 1.67).  
OH
O
O
O
OH
OMe
O
N
O
Me
HO
O
(1.3)
OMe
OMe
OHN
O
Me
O
O
(1.361)
HO
 
Scheme 1.67 : Partial retrosynthesis of lactonamycin, identification of a key intermediate. 
It was also thought that the (C)DEF ring system might be prepared relatively simply, as 
exemplified by the efforts of other groups. Specifically it was thought that the largely 
planar portion of the molecule might be efficiently constructed through a palladium or 
radical mediated cascade sequence. With this in mind the tetracyclic construct (1.362) 
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was selected as a model target. 
OHN
O
Me
(1.362)
HO
CDE
F
 
Figure 1.8 : A model (C)DEF ring system. 
The bulk of the work on the Lactonamycins was carried out by John Board,80 with the 
bulk of the associated mechanistic studies (and some minor total synthesis work) carried 
out by Alexander J. Waters.81 Ongoing work is being carried out by Davide Faggiani,82 
Lee Walsh and the author. To date three publications have been presented by Parsons et 
al. on this work.83 
1.3.2 A Palladium Cascade. 
It was originally suggested that the amide (1.363), when treated with a palladium (0) 
catalyst would undergo a series of insertions generating the triene (1.367) which would 
then undergo a Cope rearrangement84 followed by aromatisation to give the tetracycle 
(1.368) (scheme 1.68).  
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OHN
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Me
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Scheme 1.68 : Proposed palladium mediated cascade mechanism: (a) Oxidative addition, (b) 
Cyclisation cascade (c) β-elimination, (d) Cope rearrangement and aromatisation. 
Two routes to target molecule (1.363) were proposed, one a slightly more convergent 
variant of the other and both were investigated (scheme 1.69). 
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Scheme 1.69 : Proposed routes to a cascade precursor: (a) Ortho metalation then (1.370); (b) (1.372), 
nBuLi then (1.371); (c) Amide formation with (1.374); (d) Amide formation with (1.372); (e) nBuLi then 
(1.371). 
Formation of the trans-3-trimethylsilanylacrylic acid (1.374) was common to both 
routes and was investigated first. Despite an abundance of published protocols for the 
synthesis of the acid,85 it was felt that improvement was possible, specifically in the 
avoidance of highly toxic reagents and the development of reproducible yields. After 
some optimisation an effective and reliable route was developed (scheme 1.70). 
Propargyl alcohol (1.368) could be doubly deprotonated with n-butyllithium and this 
dianion would preferentially undergo silylation on carbon to give the terminal silane 
(1.369). The trans reduction product (1.378) was obtained exclusively when the alkyne 
was reduced with Red-Al®.86 A two step alcohol oxidation protocol proved most 
effective with conversion to the aldehyde (1.379) achieved using MnO2 and then a 
further increase in oxidation level was achieved through the use of sodium chlorite, 
which worked cleanly in the presence of an alkene acting as a chlorine scavenger. This 
gave the desired acid (1.374). The key to increasing the efficiency of this synthesis was 
the ability to go from propargyl alcohol to the target acid with very little workup, as the 
volatility of the intermediates resulted in a pernicious effect on the yield. 
OHTMS
O
TMS
TMS TMS
OHOH OH O
ba c d
(1.376) (1.377) (1.378) (1.379) (1.374)  
Scheme 1.70 : Reagents and Conditions: (a) nBuLi, TMSCl, THF, -78 °C (98%);  (b) Red-Al, Et2O; (c) 
MnO2, CH2Cl2, reflux then partial removal of solvent; (d) NaClO2, 2-methyl-2-butene, NaH2PO4, 
tBuOH/H2O (2:1) (69% over 3 steps). 
The cis isomer of the acid was also prepared. Following the literature precedent,85c,87 
this was achieved by the partial hydrogenation of the alkynoic acid (1.381) using 
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Lindlar’s catalyst that was further deactivated by the presence of quinoline, this gave the 
acid (1.382) (scheme 1.71). This reduction however proved to be somewhat capricious 
with a tendency to produce a mixture of over-reduced product and starting material. As 
such it was never possible to produce sufficient material for a viable synthesis. 
TMS
a
(1.380)
TMS
OH
O
TMS OH
Ob
(1.381) (1.382)  
Scheme 1.71 : Reagents and Conditions: (a) MeLi, Et2O then CO2(s) (36%); (b) H2, Lindlar’s catalyst, 
quinoline, hexane (42%). 
Thankfully the trans-acid (1.374) successfully coupled to N-methylpropargylamine to 
give the amide (1.375) and after some optimisation the most successful protocol was 
found to use isobutyl chloroformate as a coupling agent, delivering the amide in high 
yield. 
OHTMS
O
(1.374)
NTMS
O
Me
(1.375)
a
Me
N
H
(1.372)
 
Scheme 1.72 : Reagents and Conditions: (a) ClCO2iBu, N-methylmorpholine, THF, 0 °C to rt then 
(1.372), 0 °C to rt (74%). 
With the amide in hand work on the benzaldehyde (1.371) began. Taking the readily 
available 2-bromobenzaldehyde (1.369) it was apparent from the work of Harris et al.88 
and Corriu et al.89 that conversion of the aldehyde into an aminal, would allow the 
formation of the lithiate under relatively mild conditions. Synthesis of the known aminal 
(1.383)90 proceeded smoothly (scheme 1.73). However it was shown that as predicted 
by Snieckus et al. the lithiate (1.384) would not displace the allyl bromide of 2,3-
dibromopropene, instead simply abstracting bromine and returning the starting aminal.91 
As such the lithiate was exposed to magnesium bromide etherate, undergoing a 
transmetalation, to give the Grignard reagent (1.385), upon addition of 2,3-
dibromopropene, this species did undergo the required addition and with an acidic 
workup the labile aminal was removed to give the desired benzaldehyde (1.371). 
However the early success with this reaction was misleading and subsequent attempts 
would show it to be entirely unreliable. Frustration with this route led Board to examine 
alternative transmetalations principally those involving copper salts. Indeed 
transmetalation with cuprous iodide gave a classic Gilman cuprate (1.386a) and 
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produced the desired product in respectable yield. However the yield restrictions 
imposed by the formation of the dialkylcopper Gilman system led to the use of the 
mixed cuprate (1.386b) formed by transmetalation with cuprous cyanide. This brought 
the yield of the reaction to a more practical 73%. 
Br Br
NNMe Me
a b
(1.369) (1.383)
Li
NNMe Me
(1.384)
BrMg
NNMe Me
LiRCu
NNMe Me
(1.386a) R = R'
(1.386b) R = CN
O Br O
(1.385)
(1.371)
c
d or e
f
 
Scheme 1.73 : Reagents and Conditions: (a) N,N'-Dimethylethylenediamine, EtOH (91%); (b) nBuLi, 
THF, -78 °C; (c) MgBr2.Et2O, -78 °C to rt; (d) CuI, -78 °C; (e) CuCN, -78 °C to -40 °C; (f) 2,3-
dibromopropene, -78 °C to rt then HCl, H2O (79% from (1.383) via (1.385), 40% via (1.386a), 73% via 
(1.386b). 
Whilst work toward 2-allylbenzaldehyde (1.371) was underway, the integration of the 
side chain was also being examined, however due to a paucity of the fully 
functionalised benzaldehyde 2-bromobenzaldehyde (1.369) was used for the 
optimisation of this chemistry. It was initially assumed, quite reasonably, that it may be 
possible to simply deprotonate the terminal position of N-methylpropargylamine (1.372) 
with butyllithium and that this lithiate would undergo 1,2-addition at the carbonyl of 
benzaldehyde (1.369) (scheme 1.74). Attempts at such a reaction yielded only 
decomposition products and this was attributed to unanticipated competitive 
deprotonation of the amine proton. In order to counteract this the amine was protected 
as the carbamate (1.388) using di-tert-butyl dicarbonate. 
(1.369)
O
Br
OH
Br
HN
Me
HN
Me
N
Me
Boc
a
(1.387)
(1.372) (1.388)  
Scheme 1.74 : Reagents and Conditions: (a) Boc2O then N,N'-dimethylethylenediamine, CH2Cl2 (95%). 
The now-protected amine was successfully converted to the lithiate with n-butyllithium 
and this underwent the required addition to both bromobenzaldehyde (1.369) and 
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bromoallylbenzaldehyde (1.371) (scheme 1.75), giving the corresponding alcohols 
(1.389a) and (1.389b) in good yields. Initial attempts revealed the removal of the Boc 
group to be a more challenging proposition than expected; treatment with a large excess 
of acid failed to reveal the amine functionality. 
a
(1.369) R = Br
(1.371) R = CH2CBrCH2
O
R
OH
R
N
Me
Boc
OH
R
HN
Me
(1.389a) R = Br
(1.389b) R = CH2CBrCH2
(1.387) R = Br
(1.390) R = CH2CBrCH2
N
Me
Boc
(1.388)
 
Scheme 1.75 : Reagents and Conditions: (a) (1.388), nBuLi then (1.369) or (1.371) then tBuBr, THF,       
-100 °C (80% from (1.369), 65% from (1.371)). 
Hampered by this inability to deprotect the Boc group the alternate side chain addition 
methodology was investigated and the preformed amide (1.375) was to be used instead 
(scheme 1.76). Substitution of this for the Boc-propargylamine (1.388) in the existing 
methodology gave the aryl bromide (1.391) in moderate yield. However the use of the 
allylbenzaldehyde (1.371) resulted in no product at all. 
(1.369) R = Br
(1.371) R = CH2CBrCH2
O
R
OH
Br
N
Me
O
TMS
OH
N
Me
O
TMS
Br
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(1.391) (1.363)
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(1.375) b
 
Scheme 1.76 : Reagents and Conditions: (a) (1.375), nBuLi then (1.369) then tBuBr, THF, -100 °C (73% 
yield based on recovered SM); (b) (1.375), nBuLi then (1.371) then tBuBr, THF, -100 °C. 
After the trouble encountered in forming allylbenzaldehyde (1.371) and also in 
advancing the Boc-protected intermediate (1.389b) the idea of using a Stille coupling92 
was briefly entertained, however it was hoped that not only could it be used to attach the 
bromopropene unit, but that if the amide side chain was already in place then the 
palladium based Stille catalyst may also go on to facilitate the palladium cascade 
(scheme 1.77). 
X
N
Me
O
OH
TMS
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O
Me
(1.368)
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Me
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(1.392) (1.363)
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Scheme 1.77 : Proposed Stille coupling/palladium mediated cascade sequence: (a) Stille coupling 
with suitable allyl bromide/stannane, (b) Palladium cascade facilitated by Stille catalyst. 
Studies Toward a Total Synthesis of Lactonamycin                                                                Introduction 
71 
With the aryl bromide (1.391) already available and the required tin compound reported 
in the literature by Corey et al.93 it was thought this route would be relatively simple to 
follow. However whilst conversion of the allyl alcohol (1.393) to the mesylate (1.394) 
was straightforward (scheme 1.78), displacement with tributylstannyllithium94 failed to 
deliver the allylstannane (1.395). 
OH
Br
OMs
Br
SnBu3
Bra
(1.393) (1.394) (1.395)
b
 
Scheme 1.78 : Reagents and Conditions: (a) MsCl, NEt3, CH2Cl2, 0 °C (71%); (b) Bu3SnCl, LDA, THF,   
-10 °C then CuBr.DMS, -70 °C then (1.394), THF, -78 °C. 
Whilst the failure to synthesise the allylstannane was disappointing the reversed Stille 
coupling was still a possibility (scheme 1.79) and the stannyl benzaldehyde (1.396) was 
also known in the literature.95  
O
Br Br
N
N
Me
Me
O
Bu3Sn
OH
Bu3Sn
N
Me
O
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a b
(1.369) (1.383) (1.396) (1.397)
 
Scheme 1.79 : Reagents and Conditions: (a) N,N'-dimethylethylenediamine, EtOH (91%); (b) nBuLi, 
Bu3SnCl, Et2O then HCl (75%). 
This work was easily replicated to derive the arylstannane but introduction of the side 
chain by the established method was unsuccessful. This led to a hiatus in the 
development of the palladium cascade routes and subsequent success along alternate 
lines would ultimately lead to its abandonment. 
1.3.3 A Radical Cascade. 
The continuing difficulties posed by the palladium cascade route led to the development 
of the second of the originally planned routes, the radical cascade. It was apparent that a 
lot of the methodology developed for the construction of the palladium cascade 
precursor (1.363) would be directly transferable to the new target. In fact only one 
subtle change was required, where the palladium route required an alkene adjacent to 
the silyl residue (to facilitate elimination), a radical sequence could utilise an alkyne 
(scheme 1.80). This would both shorten and simplify the route by avoiding the use of 
the unstable acrylates. 
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Scheme 1.80 : Proposed radical cascade mechanism: (a) Radical initiation; (b) Cyclisation cascade;  
(c) Radical quenching; (d) Aromatisation. 
Further investigation into the deprotection of the carbamate (1.389b) eventually resulted 
in an effective protocol for its removal. Treatment with HCl in dioxane or ether gave the 
ammonium salt (1.403) which readily coupled with the acid chloride of 
trimethylsilylpropynoic acid (1.381) generated in situ to give the enediyne (1.398) in a 
succinct sequence. 
BocN
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OH
Br
(1.389b)
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Me
OH
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Scheme 1.81 : Reagents and Conditions: (a) HCl, dioxane, CH2Cl2 (47%); (b) HCl, Et2O (77%); (c) 
(1.381), (COCl)2, DMF then (1.403), NEt3, CH2Cl2 (86%). 
1.3.4 A Novel Cyclisation Reaction. 
The enediyne was then subjected to radical cyclisation conditions using tributyltin 
hydride and AIBN as the initiator, the product of this reaction however was quite 
distinct from the radical cyclisation product (1.402) that had been predicted (vide supra, 
scheme 1.80). The compound that in fact resulted was the tetracycle (1.404) in poor 
yield and with an exceptionally messy reaction profile (scheme 1.82). Whilst attempting 
to improve the yield of this cyclisation a thermal decomposition study was carried out 
by simply heating the precursor in benzene. It was found that even in the absence of 
tributyltin hydride the tetracyclic lactam was still produced and in increased yield! As 
the reaction was clearly not occurring via the originally proposed radical mechanism, 
the reaction was carried out utilising BHT as a radical inhibitor.96 The success of this 
reaction appeared to confirm that not only was the desired reaction not radical in nature, 
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but a further increase in yield suggested that there may be one or more detrimental 
reaction pathways that were. 
OH
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a, b or c
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Scheme 1.82 : Reagents and Conditions: (a) Bu3SnH, AIBN, benzene, reflux (14%); (b) Benzene, reflux 
(26%); (c) Benzene, BHT, reflux (51%). 
As a result of this information a mechanism was proposed to explain this unanticipated 
transformation. As the evidence seemed to suggest a radical pathway was not at work, 
an acid catalysed mechanism was suggested (scheme 1.83).  
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Scheme 1.83 : Proposed acid catalysed mechanism. 
It was thought a small quantity of HBr could be generated by decomposition of the 
starting material, or perhaps through interaction with the glassware. The first doubts 
about this mechanism arose when it was found that when switching from toluene to 
DMF as the solvent the reaction proceeded in much better yield, 41% compared to 63% 
respectively. With the knowledge that at reflux DMF undergoes a slow decomposition 
to give a concentration of dimethylamine, which would act to neutralise any HBr, it 
seemed possible that once again the agent thought to be driving the reaction was in fact 
causing decomposition. This led to experimentation with epoxide based acid 
scavengers, the use of which was inspired by Corey’s synthesis of gibberelic acid 
during which epoxypropane was employed to scavenge HCl.97 Whilst the low boiling 
point of epoxypropane resulted in suppression of the maximum reflux temperature, the 
results were favourable, with a much cleaner reaction returning a good yield of the 
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tetracycle despite the low reaction temperature. Use of the higher boiling epoxyhexane 
resolved the temperature issues and led to a significantly boosted yield (76%). 
This evidence against an acid-catalysed mechanism, led to further consideration of 
possible radical pathways as whilst BHT had failed to inhibit the reaction it was not 
unreasonable to think that the spontaneous generation of a diradical system within the 
starting material itself would allow a radical reaction to proceed as the relative rates of 
intra and intermolecular radical quenching would be greatly in favour of the former 
process. An ongoing examination of the literature showed numerous examples of the 
spontaneous generation of diradical intermediates in systems containing proximal 
alkynes or allenes. The work of Bergman,98 Myers,99 Saito100 and Schmittel101 appeared 
particularly apposite (figure 1.9). 
Bergman mode
Myers - Saito mode
Schmittel mode
 
Figure 1.9 : Known modes of diradical formation. 
Extensive work by Nicolaou et al.102 had shown that one of the key factors in this type 
of reaction is the distance between the two reacting bonds and in the classic examples 
shown above this results from the cis geometry of the non-reacting alkene.  
Computational modelling of cyclisation precursor (1.398) suggested that in its iminol 
tautomer the amide may attain a configuration where the two alkynes are sufficiently 
close in space that a spontaneous reaction may occur to generate diradical species 
(1.407). This knowledge led to the proposal of a new radical based mechanism (scheme 
1.84). 
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Scheme 1.84 : Initially proposed radical mechanism. 
This mechanism was also short-lived as work being undertaken in parallel by               
A. J. Waters resulted in a further revelation of mechanistic information.81,83c During 
work on a series of analogous enediyne cyclisations towards various heterocyclic targets 
as well as an alternate route to the Lactonamycins (vide infra, scheme 1.97) the 
cyclisation of the ethers (1.410) and (1.413) were attempted (scheme 1.85). Whilst the 
unadorned ether underwent the anticipated cyclisation to give the furan (1.412) the gem-
dimethyl equivalent failed to deliver any product at all even after protracted periods of 
heating. 
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Scheme 1.85 : Reagents and Conditions: (a) Toluene, epoxyhexane, reflux (90%). 
Fortunately a straightforward revision of this reaction mechanism (scheme 1.86), 
involving a well-established 1,6-hydrogen abstraction was all that was required to 
explain this new experimental data. This also removed the necessity for the slightly 
awkward double bond rearrangement of the initial radical mechanism and explained 
away the absence of elimination product (1.417) arising from diene (1.408) which 
would have two discreet aromatic rings rather than the observed naphthalene product 
(1.398). 
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Scheme 1.86 : Revised radical mechanism including a 1,6-hydrogen abstraction. 
The synthesis and cyclisation of the deuterated compound (1.418b) appeared to confirm 
this hypothesis and also suggested that this abstraction may be the rate-limiting step 
with a clear primary KIE of some three and a half times over the corresponding 
hydrogen bearing ether (1.418a) (scheme 1.87). 
N
O
Me
O
TMS
O
N
O
Me
a
R R
R
R
TMS
Reaction time
(1.418a) R = H
(1.418b) R = D
(1.419a) 1 hr
(1.419b) 3.5 hrs  
Scheme 1.87. Reagents and Conditions: (a) Toluene, reflux. 
The mechanism of this fascinating series of transformations remains a source of interest 
for the Parsons group and work towards fully elucidating it is ongoing. The work of D. 
Faggiani should prove particularly insightful when it is published in short order.82  
1.3.5 Attempted Functionalisation of Cyclisation Products. 
With the cyclisation reaction optimised to deliver the key tetracyclic compound (1.404) 
in good yield it was thought that conversion to the required phenolic state of the E-ring 
should prove relatively straightforward. This required an aromatisation of the ring and 
an oxidation of the silane to a hydroxyl group, though not necessarily in that order. The 
first strategy to this end focused on the dehydrogenation of the ring to acquire the 
desired aromaticity (scheme 1.88). It was proposed that the resulting aryl silane (1.368) 
could be oxidised to a phenol via a Tamao103-Fleming104 oxidation, however this 
seemed rather optimistic given the known stability of the trimethylsilyl group under 
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such conditions (vide infra, section 2.7.1). A variety of reagents were used with little 
success with the silane (1.404) undergoing decomposition quite readily and failing to 
give the fully aromatic tetracycle. Fearing that the unprotected phenol of the D-ring may 
be interfering, either through coordination to reagents, or possibly by promoting 
oxidation of the D-ring (vide supra, scheme 1.48) it was decided that protecting the 
phenol as the acetate ester (1.412) may prevent such reactivity. Sadly the acetylated 
compound still would not undergo the required dehydrogenation. 
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(1.421)
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Scheme 1.88 : Reagents and Conditions: (a) Pd/C; (b) DDQ; (c) Sulfur; (d) MnO2; (e) O2; (f) BHT; (g) 
Benzoyl peroxide; (h) AcCl, NEt3, THF, rt (quant.). 
Abandoning the initial aromatisation strategy, the work of Clawson et al. led Board to 
believe that the cyclisation product may be converted directly to the ketone (1.423) by 
the use of sodium dichromate (scheme 1.89).105 The ketone generated would likely 
tautomerise rapidly to the desired phenol (1.424). Sadly the use of this and other 
chromium based oxidants resulted in the fully aromatic, but defunctionalised tetracycle 
(1.425), it was thought this most likely resulted from the generation of the required 
chromate ester (1.422) which was then undergoing β-elimination, possibly due to the 
sterically crowded nature of the hydrogen that must undergo abstraction for the 
oxidation to proceed. 
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Scheme 1.89 : Reagents and Conditions: (a) Na2Cr2O7, AcOH; (b) PDC, TMSCl; (c) PDC; (d) PCC. 
Board’s final attempt to functionalise the cyclisation product involved attempting to 
perform a Tamao-Fleming oxidation on the aliphatic silane (scheme 1.90). As 
mentioned previously the trimethylsilane was a very poor substrate for such an 
oxidation as both Tamao and Fleming variants of the oxidation require at least one 
activating group around the silane which would be extremely challenging to generate 
from the fairly inert TMS group. But it was nonetheless hoped that it would be possible 
to form the alcohol (1.426) which could be oxidised to the ketone (1.423) and that this 
would rapidly tautomerise to the phenol (1.424). Perhaps unsurprisingly attempted 
oxidation with hydrogen peroxide and a source of fluoride did not yield any of the 
desired product. 
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Scheme 1.90 : Reagents and Conditions: (a) H2O2, KF, KHCO3, THF/MeOH (1:1), reflux. 
The conclusion was drawn that a different, more reactive silyl group would be required 
at this position in a new system to allow the synthesis to proceed. 
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1.3.6 The Beginnings of a Total Synthesis. 
Board was eager to apply the lessons learned throughout the model studies toward a full 
synthesis of lactonamycin. Returning to the initial retrosynthesis the aim became to 
devise a synthetic route to the pentacyclic lactam (1.361) (scheme 1.91), this compound 
would contain all the functionality to allow a total synthesis of lactonamycin (1.1), the 
1,4-dimethoxy moiety constituting a masked quinone and the lactone would be 
elaborated to the chiral portion of the molecule. This gave the benzaldehydes (1.427) 
and (1.428) as suitable targets onto which the necessary side chain might be appended. 
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Scheme 1.91 : Identification of short term targets. 
In his excitement Board also identified the same structures with the lactone inverted as 
potential targets and whilst it is clear how lactone (1.427) might be elaborated to 
lactonamycin (vide infra, scheme 2.5), it is somewhat less so for its inverted equivalent 
(1.429). However Board proposed routes to both. The first proposed route (scheme 
1.92) required the somewhat unlikely bromination of gentisic acid (1.430) at the 
position para to the acid, the rest of the route would then utilise standard aromatic 
chemistry to give benzaldehyde (1.434) in a very concise sequence.  
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Scheme 1.92 : Proposed lactone formation sequence: (a) Br2, AcOH (31%); (b) Formylation; (c) Ring 
closure; (d) Oxidation. 
Attempts at the bromination gave exclusively the meta-bromide (1.435) as one might 
reasonably expect it to. The literature suggested that access to the para-substituted 
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bromide was only possible through the deactivation of the phenol ortho to the acid, this 
was achieved via a 4 step sequence by Linderberg et al.106 but it was felt this would 
make the route unwieldy, with an excess of protection-deprotection steps lengthening 
the route substantially. As such it was abandoned.  
A second proposed route (scheme 1.93) involved another potentially challenging 
bromination. The dialdehyde (1.437) was produced via a known route from para-
methoxyphenol (1.436).107 Bromination of the dialdehyde was unsuccessful, with 
undesired reaction of the aldehydes cited as the most likely cause. This route too was 
swiftly abandoned. 
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Scheme 1.93 : Reagents and Conditions: (a) Formalin, CaO, H2O (58%); (b) MeI, K2CO3, acetone 
(82%); (c) PDC, acetone (71%); (d) Bromination; (e) Aminal formation; (f) Lithium halogen exchange then 
paraformaldehyde; (g) Lithium halogen exchange then transmetalation with CuCN then 2,3-
dibromopropene and acidic workup; (h) Oxidation.  
A subsequent route, this time towards the inverted lactone mentioned previously, 
focused on utilising an alternate method of generating the lactone (scheme 1.94).  
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Scheme 1.94 : Reagents and Conditions: (a) 2,2-Dimethoxypropane, acetone, H2SO4 (62%); (b) 
Phosgene; (c) Deprotection; (d) Methylation; (e) Oxidation; (f) Aminal formation; (g) Deprotonation then 
transmetalation with CuCN then 2,3-dibromopropene and acidic workup.  
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Taking the previously used triol (1.258), this was protected as the acetonide (1.259). It 
had been hoped that treating the free benzyl alcohol with phosgene would generate the 
chloroformate (1.440) and that this would undergo a further electrophilic addition to the 
aromatic ring to furnish the lactone. There was some concern however that 
deprotonation of the aminal (1.443) would prove troublesome as the previously 
established methodology had only been applied to the ortho-lithiation of aryl bromides. 
Without the bromide in place the deprotonation would require significantly more 
forcing conditions which may in turn be incompatible with the lactone. It was therefore 
considered desirable to integrate a ring bromination into the synthesis. Knowing that the 
benzyl alcohol (1.259) could be converted to the dibromide (1.444) (scheme 1.95), it 
seemed not unreasonable to think the aliphatic bromide might be readily hydrolysed to 
give the alcohol (1.445) which would undergo chemistry as per the previous route (vide 
supra, scheme 1.94) and then allow a milder lithium halogen exchange process to install 
the bromopropene unit.  
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Scheme 1.95 : Reagents and Conditions: (a) Br2, AcOH (63%); (b) Hydrolysis; (c) Phosgene, acidic 
workup; (d) MeI, K2CO3, acetone; (e) Oxidation; (f) Aminal formation; (g) Lithium halogen exchange then 
transmetalation with CuCN then 2,3-dibromopropene and acidic workup. 
Sadly, due to time constraints, this chemistry was never developed beyond the 
dibromide (1.444), though whilst this methodology was being explored a couple of 
alternative aspects of this chemistry were clarified. Firstly the deprotonation of the ring 
with just the aminal and no bromine in place was attempted (scheme 1.96). As predicted 
by Board, this approach proved fruitless, with no evidence for the formation of the 
desired lithiate (1.450), let alone being able to couple it with 2,3-dibromopropene via 
the cuprate. With the failure of this route even without the labile lactone in place further 
efforts towards the direct deprotonation were not undertaken. 
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Scheme 1.96 : Reagents and Conditions: (a) MnO2, CH2Cl2, (94%); (b) N,N'-Dimethylethylenediamine, 
EtOH (76%); (c) nBuLi, Et2O then CuCN, -30 °C to rt then 2,3-dibromopropene.  
The lactone formation step was also examined (scheme 1.97), initially this was 
investigated with the mixed carbonate (1.445) which was sufficiently stable to be 
isolated before attempted cyclisation. Treatment with Lewis acid failed to give the 
lactone (1.441) and as such the more reactive chloroformate was to be formed by the 
reaction of alcohol (1.259) with phosgene. Upon attempting this reaction however none 
of the anticipated product was formed. This failure cast a significant shadow of doubt 
upon the proposed syntheses and suggested further work would be required to develop a 
viable route to fully functionalised benzaldehyde (1.429). 
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Scheme 1.97 : Reagents and Conditions: (a) MeO2CCl, N-methylmorpholine, THF (50%); (b) 
MgBr2.Et2O, toluene, reflux; (c) (COCl)2, CH2Cl2, rt.  
As mentioned previously, Waters was also working on an alternative strategy for the 
formation of lactonamycin (scheme 1.98), which would also utilise the novel cyclisation 
methodology being developed within the Parsons group.  
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Scheme 1.98 : Retrosynthesis of a Diels-Alder approach to a key pentacycle. 
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It was proposed that the pentacycle (1.453) may be constructed by a Diels-Alder 
reaction between a quinone and a furan, the furan partner being constructed simply and 
efficiently by the cyclisation methodology mentioned previously (vide supra, scheme 
1.85). Synthesis of a model for this approach proved quite straightforward and applied a 
great deal of the knowledge gained throughout the aforementioned precursor syntheses 
(scheme 1.99). Starting from the N-Boc-N-methylpropargylamine (1.388) this could be 
easily hydroxymethylated by treatment with base and then quenching with 
paraformaldehyde. The newly appended alcohol (1.455) underwent Williamson 
etherification with the familiar 2,3-dibromopropene using sodium hydride to give amine 
(1.456) and then Boc deprotection and coupling with propynoic acid (1.381) occurred 
under what were now standard protocols to give cyclisation precursor (1.410). Once 
again the cyclisation proved to be highly reliable and heating in toluene in the presence 
of an acid scavenger gave the furan (1.412) in excellent yield. An initial test of a Diels-
Alder reaction with the dienophile maleic anhydride (1.458) gave hope that such a 
strategy may indeed prove fruitful with the exo Diels-Alder product (1.459) formed 
exclusively. 
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Scheme 1.99 : Reagents and Conditions: (a) nBuLi, (CH2O)n, THF, -78 °C (82%); (b) NaH, THF, 2,3-
dibromopropene (81%); (c) TFA, CH2Cl2; (d) (1.381), CH2Cl2, NEt3 (82% over 2 steps); (e) Toluene, 
epoxyhexane, reflux (90%); (f) (1.458), Et2O, rt (50%). 
1.4 A Brief Overview of ortho-Quinone Methides.  
1.4.1 Introduction to Quinone Methides. 
The quinone methides (QMs) may be thought of quite simply as quinones in which one 
of the constituent carbonyls has been replaced with a methylene unit. There are two 
variants (figure 1.10), corresponding to ortho-quinone (1.460) and para-quinone (1.462) 
and these are simply termed ortho-quinone methide (o-QM) (1.461) and para-quinone 
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methide (p-QM) (1.463) respectively. This overview will focus on the former. 
O
O
O
CH2
O
O CH2
O
(1.460) (1.461) (1.462) (1.463)  
Figure 1.10 : Structural relationship of quinones and quinone methides. 
The substantial increase in polarity relative to their quinone equivalents results in a 
significant increase in the reactivity of such compounds. Indeed most QMs exist only 
fleetingly, with the ability to form a fully aromatic ring providing a constant, strong 
driving force for reaction. Where QMs have been isolated as distinct products there is 
always some significant stabilising influence at work, usually in the form of extended 
conjugation or the presence of electron donating groups.  
The reactivity of these systems meant that for an extended period of time their existence 
was regarded as mere conjecture. They were first invoked by Fries in 1907 to explain 
the formation of dimerised products from the reaction he was studying.108 The structure 
was frequently cited for a period of some 56 years before the first experimental 
evidence for its existence was gathered. Gardner et al. were able to trap the simple QM 
(1.461) in a liquid N2 trap after pyrolysing the ether (1.464) at high temperature (scheme 
1.100).109 The QM appeared to be stable at temperatures up to -50 °C above which it 
went on to form the trimer (1.465). This discovery was rapidly followed by reports of 
the isolation of stabilised QM intermediates. 
O
(1.461)
OH
(1.464)
OMe O
O
O
(1.465)
a b
 
Scheme 1.100 : Reagents and Conditions: (a) 500-650 °C in a stream of N2 passed through a quartz 
tube then trapped at -196 °C; (b) -50 °C to rt.  
The subject of QMs has generated a significant interest over the years and there has 
been a much larger body of work published than is included in this brief overview. For a 
more in depth analysis please see any of the more substantial reviews110 that have been 
published as well as a weighty tome on the subject by Rokita.111 
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1.4.2 ortho-Quinone Methides in Nature. 
Whilst QMs appear relatively infrequently in synthetic endeavours, where they do they 
are frequently referred to as forming part of a biomimetic sequence. The QM is 
frequently posited as a key intermediate in the synthesis of compounds in nature and 
crucially it is the action of QMs that is proposed to account for the biological activity of 
a number of drugs and potential drugs. It is frequently proposed that where QMs are 
generated in vivo they act as potent alkylating agents with cytotoxic effect. They may 
also be utilised by nature when forming certain structural motifs. 
This is of particular relevance to the anthraquinone daunomycin (1.466), which belongs 
to the anthracycline class of antibiotics (though they exhibit significant toxicity in 
humans and as such are only used in their anti-tumour capacity). Its potent 
chemotherapeutic activity is explained as the result of the quinone system undergoing 
bioreduction due to the oxygen starved nature of many tumour cells (scheme 1.101). 
This results in a localised concentration of the QM system (1.468) which then binds to 
DNA and proteins in the tumour cells.112 This reactivity is believed to be general to a 
wide range of anthracyclines.  
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Scheme 1.101: Bioreductive conversion of daunomycin to cytotoxic QM (1.468). 
QM formation can however be an unwelcome side reaction in therapeutic drugs. It has 
been proposed that the hepatotoxicity of the failed anti-diabetic and anti-inflammatory 
drug troglitazone (1.469) is due to its ability to form the cytotoxic QM (1.470) (scheme 
1.102) after being oxidised by cytochrome P450 in the liver.113 
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Scheme 1.102 : The oxidation of troglitazone by cytochrome P450. 
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Salicortin (1.471), is one of many phenol glycosides distributed across the plant 
kingdom, it is a toxic compound thought to play a role in repelling herbivorous insects. 
It has been suggested that its toxicity arises due to the enzymatic cleavage of the 
glycosidic bond, this allows for the elimination of the benzoate residue generating the 
highly reactive QM (1.461) at the enzymes active site (scheme 1.103). This results in 
irreversible alkylation of the enzyme and inactivation.114 
O
HO
HO
OH
O
OH
O
O
Ph
O
(1.461)(1.471)
Glycosidase
 
Scheme 1.103 : Enzymatic QM formation, the mechanism of salicortin toxicity. 
In contrast to the deleterious effects of many QMs in vivo the K vitamins including 
vitamin K1 (1.472) are an important example of the role of QMs in electron transfer 
chains. It is thought that in plants exposure to sunlight results in excitation and that in 
the triplet state the molecule undergoes an intramolecular hydrogen abstraction, 
resulting in tautomerisation to the highly conjugated QM (1.473) (scheme 1.104).115 
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Scheme 1.104 : Tautomerisation of vitamin K1. 
A number of biomimetic syntheses are detailed below (vide infra, schemes 1.134 & 
1.135) and with QMs appearing in such a diverse range of natural systems, it is no 
surprise they serve as an inspiration to the synthetic chemist. 
1.4.3 Generating ortho-Quinone Methides. 
Whilst there are a multitude of ways in which QMs may be generated, these conditions 
are highly varied. When attempting to integrate a QM approach into a more general 
synthesis it can be challenging to prevent these reactive intermediates from dimerising if 
their concentration in the reaction mixture becomes too high, it is thus usually desirable 
to keep the concentration of QM generated as low as possible, whilst reacting it with a 
great excess of the reaction partner. The method of generation is also of great 
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significance when considering the stability of other reactants in a given system; 
frequently it is found that the most convenient method of generation is incompatible 
with the desired reaction pathway.  
The simplest method of generation is limited to para-quinone precursors, which if there 
are protons present on a carbon beta to the carbonyl then tautomerisation may occur to 
generate an o-QM. This was demonstrated by Jurd and Roitman who showed that the 
quinone (1.474) could be converted to the o-QM (1.475) simply through heating in 
methanol (scheme 1.105).116 This QM was of course further stabilised by conjugation 
with the electron rich aromatic ring.  
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Scheme 1.105 : Tautomeric generation of a QM. 
However the most frequent method by which o-QMs are prepared synthetically is 
through the thermolysis of a suitable precursor. Generally this will involve the presence 
of a suitable leaving group at the benzylic position of an ortho-hydroxybenzyl system 
(1.477) which can undergo elimination assisted by the phenol (scheme 1.106). In the 
simplest case this may be 2-hydroxybenzyl alcohol. The temperature at which 
thermolysis occurs are generally high though there is significant reduction where the 
QM is stabilised by conjugation. The effectiveness of the leaving group under the 
reaction conditions will also have a significant effect.  
OH X
R'
O
R'
(1.477) (1.478)
∆
 
Scheme 1.106 : QM generation by thermolytic elimination. 
Among the leaving groups to have been proved effective (figure 1.11) are alcohols 
(1.479),117 ethers (1.480),109a,118 esters (1.481),119 amines (1.482)120 and their 
ammonium salts (1.483),121 sulfides (1.484),122 and halides (1.477).117b,123 ortho-Vinyl 
phenols (1.485) have been converted through a 1,5-sigmatropic rearrangement.124 
Cyclic systems such as dioxaborinanes (1.486)125 and sulfonates (1.487)126 have also 
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found use. More exotic precursors include benzoaxazines (1.488),127 the benzoxetene 
(1.489),128 and chromans (1.490).129 
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Figure 1.11 : Known thermal precursors to QMs. 
Whilst thermal generation methods are well precedented and reliable, the high 
temperatures involved obviously preclude the use of any thermally unstable reactants 
and heating can also promote alternate reaction pathways which may not be readily 
anticipated. There are a number of methods of lowering the temperature required for the 
thermal reaction to operate. This can be achieved both chemically, through catalysis 
with acid or base and physically through irradiation. Whilst these methods can be used 
to avoid thermal decomposition of both starting material and reagents, they have their 
own incompatibilities that can limit their use. 
Photolysis has been used to achieve the same reaction at much lower temperatures for a 
number of the thermal precursors listed above. For example, in the case of the simple 
benzyl alcohol (1.491) Kresge et al. found that with irradiation at 254 nm the QM 
(1.461) could be generated at room temperature (scheme 1.107).130 The equivalent 
reaction initiated purely thermally has been found to require temperatures in excess of 
270 °C.131 
OH OH
hv
248 nm
O
1.491 (1.461)  
Scheme 1.107 : QM generation by photolysis. 
Photochemistry also allows access to alternative precursors such as the diazirine (1.492) 
which upon irradiation decomposes to the carbene (1.493) which upon further exposure 
to UV light undergoes rearrangement to the QM (1.494) (scheme 1.108).132 
Studies Toward a Total Synthesis of Lactonamycin                                                                Introduction 
89 
(1.492) (1.494)
O
Cl
N
N
hv
433 nm
(1.493)
O
Cl
O
Cl
hv
313 nm
 
Scheme 1.108 : A novel photolabile precursor. 
The main disadvantage of photochemical formation is that the amount of energy 
required to form the QM is high, as such wavelengths of 250-300 nm are common. Such 
high energy radiation will often activate other functional groups in both the starting 
material and in any reagents resulting in potentially complex reaction profiles. 
Acid or base catalysis by comparison tends to produce rather more predictable results. 
There are many reports in the literature of catalysis by a wide variety of Lewis acids. As 
seen with photolytic methods a drastic reduction in reaction temperature can be 
achieved with acid catalysis.  In the case of the dioxaborinanes (1.495) examined by 
Lau and Dufresne temperature reductions of greater than 200 °C were attributed to the 
presence of an acid catalyst (scheme 1.109).125b 
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Scheme 1.109 : Effect of acid catalysis on dioxaborin elimination. 
Acid catalysis can also be used in conjunction with an acid sensitive protecting group 
strategy to generate QMs from relatively stable precursors. This is of importance, as due 
to this same sensitivity to acid and base the thermal precursors mentioned previously 
can be somewhat unstable, limiting the degree of structural complexity that can be 
installed before the QM generation step. Inoue et al. demonstrated how use of an 
appropriate protecting group can allow for the development of a more elaborate 
precursor (scheme 1.110). Taking the benzaldehyde (1.498) the two phenols were 
protected as their methoxymethyl ethers. A nucleophilic addition of the side chain was 
then possible to give alcohol (1.499). At this point treatment with acid would deprotect 
both MOM groups leaving the free phenols, the remaining acid catalysing the 
elimination of the alcohol to give QM intermediate (1.500) which would in turn 
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undergo an intramolecular cyclisation with the pendant alkene to give the tricycle 
(1.501).133 
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Scheme 1.110 : Acid triggered QM generation sequence. 
Whilst acid catalysis has its clear advantages over thermal variants, it also comes with 
certain incompatibilities, a number of nucleophiles by their very nature are intrinsically 
unsuited to acidic conditions. The presence of acid has an effect on electrocyclic 
reactions too, making them more ionic in nature and hence limiting 
diastereoselectivity.134 
Base catalysis offers similar benefits to acidic methodology, with decreased reaction 
temperatures and the ability to utilise more complex QM precursors. However base 
catalysis also offers significantly improved tolerances in terms of nucleophiles. Base 
can catalyse both tautomeric formation as well as thermolytic eliminations. We see the 
former in the case of the dimerisation of duroquinone (1.502) (scheme 1.111).135 
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Scheme 1.111 : Base catalysed QM formation through tautomerisation. 
Thermal style reactions generally involve the deprotonation of a phenolic precursor, 
which has the effect of accelerating the elimination of a suitable benzylic leaving group. 
This approach was utilised in the low temperature generation of the QM (1.506) from 
the novel precursor (1.505) in Pettus et al.’s synthesis of berkelic acid (scheme 
1.112).136 
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Scheme 1.112 : Quinone methide intermediate in the synthesis of Berkelic acid. 
Lewis bases can also be used to trigger the formation of QMs by acting as a 
nucleophile. This is seen frequently in the work of Rokita et al. where they use fluoride 
to cleave silyl phenol ethers such as TBS ether (1.509) under only very mildly basic 
conditions to generate the phenolate (1.510) which rapidly undergoes elimination to 
give QM (1.461) (scheme 1.113).137 
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Scheme 1.113 : Fluoride triggered elimination sequence. 
The reverse strategy has also been seen, with the desilylation equivalent of the 
deprotonation seen for duroquinone (1.502) (vide supra, scheme 1.111). Moore et al. 
demonstrated this through heating the silane (1.511) in ethanol whereupon the silane is 
removed generating the QM (1.514) to which a further molecule of ethanol can add 
giving the α-ethoxy hydroquinone (1.515) (scheme 1.114).138 
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Scheme 1.114 : Atypical desilylation method of forming QM’s. 
QMs may also be generated through the direct oxidation of a suitable precursor. This 
precursor is structurally restricted due to the relative stability of para-quinone methides 
meaning such a precursor must be either unsubstituted at the para position, or if it is, 
must contain no protons alpha to the ring. We see this in the comparison of the 
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oxidation of butylated phenol (1.516)139 and the methylated equivalent (1.518)140 
(scheme 1.115). 
MetBu
tBu
OH
tBu
tBu
O
(1.516) (1.517)
Oxidant
MeMe
Me
OH
MeMe
O
(1.518) (1.519)
Oxidant
But
 
Scheme 1.115 : Selectivity of quinone oxidations. 
A number of reagents have proved effective in oxidatively forming QMs from 
appropriately substituted phenols, these include silver (I) oxide,139,141 potassium 
ferricyanide,142 lead (IV) oxide,142 DDQ,143 Bromine.123 Chiba et al. were also able to 
form the QM (1.522) through an electrochemical one electron oxidation of benzyl 
sulfide (1.520) resulting in the elimination of a sulfur-based radical (scheme 
1.116).122,144 
OH
(1.520)
e
LiClO4
EtNO2MeO OMe
SPh OH
MeO OMe
SPh O
MeO OMe
SPh
H+
(1.521) (1.522)  
Scheme 1.116 : Electrochemical QM formation by radical fragment elimination. 
A more minor method of forming QMs is the direct olefination of ortho-quinones, this 
has been achieved in a number of ways, the first attempts at this route utilised Wittig145 
type ylids to install the olefin, however these reactions were not particularly useful 
given the propensity of the resulting QM to react preferentially with a further equivalent 
of ylid.146 Later attempts involving condensation reactions proved more effective, a 
condensation of the ynamine (1.524) with the ortho-quinone (1.523) produced the stable 
QM (1.525) through a [2+2] cyclisation of the alkyne with the quinone carbonyl 
followed by an electrocyclic rearrangement (scheme 1.117).147 
OtBu
tBu
tBu
tBu
O O
O NEt2
NEt2
(1.523)
(1.524)
(1.525)   
Scheme 1.117 : Conversion of an ortho-quinone to the corresponding o-QM. 
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An aldol condensation between β-lapachone (1.526) and a number of different ketones 
has also been employed by Ferreira et al. to isolate QMs such as (1.528) (scheme 
1.118).148 
O
O
O
Me Me
(1.526)
O
O
Me Me
O
Me
(1.528)
I2
O
(1.527)
Me
 
Scheme 1.118 : Aldol route to QM formation. 
1.4.4 The Reactions of ortho-Quinone Methides. 
As mentioned previously QMs are highly reactive, with their polarity making them 
ready conjugate acceptors and participants in electrocyclic reactions. The restoration of 
aromaticity is the key driving force in these reactions and as such it is rare to observe a 
reaction that fails to do so. Importantly for synthetic applications they also exhibit a 
high degree of fluxionality in the olefin geometry, this being due to a significant degree 
of zwitterionic character in the QM intermediate. 
In the absence of external reactants QMs readily undergo dimerisation and trimerisation 
through [4+2] hetero-Diels-Alder reactions with a second and third equivalent of 
themselves (scheme 1.119). In the case of the simple unsubstituted QM (1.461) the 
second equivalent of QM is known to react with the more exposed exo-alkene to give a 
spirocyclic chroman such as (1.490) and the third equivalent reacts at the less electron 
deficient of the two remaining double bonds to give the pentacyclic construct (1.465).149 
The dimerisation and trimerisation positions in substituted systems are decided 
predominantly by sterics, with the process frequently stopping at the dimer stage if the 
remaining alkenes are sufficiently hindered. Such reactions are the only examples of a 
QM acting as the two-membered component of such a cyclisation. 
O
O
O
O
O
O
O
O
(1.490)
(1.461)
(1.465)
 
Scheme 1.119 : Trimerisation mechanism for unsubstituted QM (1.461). 
The logical extension of this behaviour is the [4+2] cycloadditions with other substrates. 
Studies Toward a Total Synthesis of Lactonamycin                                                                Introduction 
94 
Such reactions are seen frequently and both inter and intramolecular variants have been 
observed. The core principal of these reactions is demonstrated by the early work of 
Hultzsch, who demonstrated the reaction of the simple QM (1.461) with styrene to 
generate the chroman (1.529) (scheme 1.120).117a  
OH OH O
Ph
O
Ph
(1.491) (1.461) (1.529)
∆
Styrene
 
Scheme 1.120 : [4+2] Cycloaddition of a QM with styrene. 
This concept has been extended to a wide variety of alkenes allowing for the production 
of an equally broad range of chromans. A suitable substituent at the β-position of the 
alkene can also allow access to the chromenes through a hetero-Diels-Alder/elimination 
sequence (scheme 1.121).150 
OH
OH
N O
O2N O N
O
NO2
O
NO2
(1.491)
(1.530)
(1.531) (1.532)
H
 
Scheme 1.121 : Cycloaddition/elimination sequence to give chromenes. 
Similarly Pettus et al. demonstrated that an appropriately substituted alkene such as the 
enolate (1.536) could be used to generate a δ-lactone after cyclisation and workup 
(scheme 1.122).151 
O
Ph
O
Ph
MeO
O
OMe
ONa
O
O
CO2MeOBoc O
Ph
OBoc OBoc OBoc OBoc
(1.533) (1.534) (1.535) (1.537)
(1.536)PhMgBr
OtBuO
O
 
Scheme 1.122 : δ-Lactone formation through [4+2]-cycloaddition. 
[4+2] Cycloadditions have also been extended to include nitrogen and sulfur based 
multiple bonds (scheme 1.123) generating oxazines (1.541) through a reaction with 
nitriles (1.540)152 and oxathianes (1.544) with thiocarbonyl compounds (1.543).153 
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∆
 
Scheme 1.123 : Nitrogen and sulfur containing heterocycle formation. 
There is also a wealth of examples of QMs acting as conjugate acceptors. In this 
capacity they behave simply as an enone of enhanced reactivity. The primary issue that 
prevents the use of QMs in such a fashion is the side reaction to form dimers, as such it 
is necessary to prevent this either by generating a QM intermediate that is sufficiently 
stable with respect to cyclisation that the desired nucleophile has sufficient time to react 
or alternately a reactive QM may be utilised provided it is only ever present in low 
concentration and the nucleophile concentration is high. 
Brown et al. formed the sulfone (1.547) by treating the starting diol (1.545) with acid 
and by doing so at low concentration they were able to identify the intermediate QM 
(1.546) spectroscopically before using a large excess of sodium benzenesulfinate to both 
quench the acid and undergo a nucleophilic addition to the QM (scheme 1.124).154 
O Ph
OHOH
O
O
Ph O Ph
OH SO2Ph
[H+] PhSO2Na
(1.545) (1.546) (1.547)  
Scheme 1.124 : Nucleophilic addition to a QM. 
An interesting piece of work by Angle and Yang demonstrated the nucleophilic addition 
of the nucleoside adenosine (1.550) to the stable oxidatively formed QM (1.549) which 
is a proposed model of the manner in which the anthracyclines (vide supra, scheme 
1.101) act to cross-link DNA strands (scheme 1.125).155 
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(1.549)
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Scheme 1.125 : A QM DNA alkylation model. 
As with an enone it is also possible to simply reduce a QM if it is formed in the 
presence of an appropriate reducing agent, however this has been observed to occur 
exclusively as an effective 1,4-addition of hydride to the conjugated ketone as opposed 
to the predominantly 1,2-addition one would expect from a typical enone, the result 
being that it is the benzylic position rather than the carbonyl that is reduced. Frequently 
this is carried out with aluminium or boron hydrides. In the case of the ketone (1.552) 
(scheme 1.126) the carbonyl is first reduced in the standard manner, the resulting 
alkoxide is then able to facilitate a transfer of the adjacent acetyl group to give the 
activated QM precursor (1.554), this rapidly eliminates to generate the QM (1.555) and 
this species is further reduced by a second equivalent of borohydride.156 
AcO
NHAc
nPrO
O
NHAc
nPrO
O O
NHAc
nPrAcO
NHAc
nPr
O
H
HO
NHAc
nPr
(1.552) (1.553) (1.554) (1.555) (1.556)
NaBH4 H+
H3B
 
Scheme 1.126 : Borohydride mediated QM formation and subsequent reduction. 
Reduction via single electron transfer has also been recorded. Borchardt and Sinhababu 
demonstrated such a reduction, which they integrated into a novel method of 
methylating aromatics (scheme 1.127). The benzoic acid (1.557) was first converted to 
benzylamine (1.558) by a Mannich reaction. This compound then underwent base 
catalysed QM formation, which when carried out on the presence of Raney nickel is 
reduced to give the ortho-methyl phenol (1.560).157 
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Scheme 1.127 : Raney nickel reduction of a QM. 
Another interesting if minor application of QM methodology has been in the synthesis 
of furans. For example, the DCC facilitated elimination of the tetraol (1.561) allowed 
for the intramolecular addition of the remaining phenol to the QM intermediate (1.562) 
giving the dihydrobenzofuran (1.563) DCC activation of the aliphatic hydroxyl 
promoted its elimination to furnish benzofuran (1.564) (scheme 1.128).158 
OH
OH
HO
HO
OH
HO
O
OHO
HO
O
HO
(1.561) (1.562) (1.563) (1.564)
DCC
 
Scheme 1.128 : Benzofuran synthesis via a QM intermediate. 
A further example shows the formation of the furan after the addition of the nucleophile 
(scheme 1.129). In this case the enolate (1.566) acts as both the triggering base as well 
as the nucleophile, upon addition the resulting anion (1.567) is able to displace the 
benzyl chloride to form the dihydroisobenzofuran (1.568).159 
OH MeO
O
Cl
OMe
O
NO2
O
NO2
O
NO2
(1.565)
(1.566)
(1.567) (1.568)
NEt3
Cl CO2Me
CO2Me
MeO2C CO2Me
 
Scheme 1.129 : Benzohydrofuran synthesis via a QM intermediate. 
As well as being formed by photochemistry the reactivity of QMs may also be affected 
by exposure to light. Earlier we saw how the QM (1.494) could be generated from the 
carbene (1.493) by exposure to UV light at 313nm (vide supra, scheme 1.108). 
Continued exposure at 313 nm resulted in a further transformation to the fused 
cyclobutene (1.570) whilst a shift to less energetic wavelengths (430 nm) resulted in the 
strained cyclic allene (1.569) (scheme 1.130). 
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Scheme 1.130 : Applications of photolabile QM precursor (1.489). 
An investigation into the photochemistry of phenyl substituted QM (1.525) (scheme 
1.131) further exemplifies the alternate modes of reactivity accessible through 
photoexcitation. Exposure of the QM to light resulted in the formation of the 5,7-ring 
system (1.572) where as allowing the same QM to react under thermal conditions 
resulted in the 6,6-ring system (1.573).147,160 
Ph
O
O NEt2
O
O
O NEt2
tBu
tBu
tBu
tBu
O NEt2
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tBu
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Scheme 1.131 : The differing reactivity of QM (1.525) under photochemical and thermal conditions. 
Finally, in a few rare cases QMs have been observed to undergo formal [4+4] 
cyclisations. The atypical dimerisation of the benzyl chloride (1.574) was noted by 
Soucek et al. in which the macrocyclic dioxin (1.577) was formed rather than the usual 
[4+2] addition product (scheme 1.132), presumably due to the significant steric bulk 
around the QM due to the two aromatic rings.161 
Cl
Ph
Ph
OH
Ph
Ph
O
Cl
Ph
Ph
O O O
Ph
Ph
Ph
Ph
O
Ph
Ph
O
PhPh
ClNEt3
(1.574) (1.575) (1.576) (1.577)  
Scheme 1.132 : The atypical dimerisation of a sterically hindered QM. 
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An example of another [4+4] reaction was discovered only recently, with the 
observation of Hanson et al. that the sulfonamide (1.578) when exposed to the simple 
QM (1.461) underwent cyclisation to give the sultam (1.580) (scheme 1.133).162 Both of 
these examples are thought to operate via stepwise rather than concerted mechanisms. 
(1.461) (1.581)
S
N
H
OO
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O
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(1.578) (1.580)
OTBSOAc
(1.579)
TBAF
 
Scheme 1.133 : A rare example of a hetero [4+4] cyclisation. 
1.4.5 ortho-Quinone Methides in Synthesis. 
Despite the extensive examination of both their formation and reactivity very few 
examples of QMs being used in synthesis are found in the literature and where they are 
they almost exclusively focus on [4+2] cycloadditions to form chroman ring systems, 
with intermolecular reactions being again the most common form of such reactions. A 
number of interesting examples are described below. 
In Baldwin et al.’s synthesis of the sesquiterpene natural product lucidene (1.583) we 
see the use of the simple QM (1.461) undergoing a double [4+2] cycloaddition with 
naturally derived α-humulene (1.582) to furnish the more complex natural product 
(scheme 1.134), this was believed to be a biomimetic route. The QM in this case was 
generated by thermolysis of 2-hydroxybenzyl alcohol.163 
O
Me
Me
MeMe
MeMe
O
O
Me
Me
H
H
(1.461)
(1.582) (1.583)  
Scheme 1.134 : The biomimetic synthesis of lucidene (1.576). 
In a further biomimetic approach toward the natural product guajadial (1.586) (scheme 
1.135) Lee et al.164 utilised a rather more complex QM system (1.585) in a 
cycloaddition reaction with macrocyclic alkene (1.584). 
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Scheme 1.135 : Utilising a highly developed QM in the synthesis of guajadial. 
In a particularly elegant synthesis of carpanone (1.589) by Chapman et al. the alkene 
(1.587) underwent an oxidative coupling with a second molecule generating the bis-QM 
intermediate (1.588), this underwent an intramolecular hetero-Diels-Alder reaction to 
generate the 5 contiguous stereocentres of the hexacyclic product in a single synthetic 
operation (scheme 1.136).165 
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(1.587) (1.588) (1.589)  
Scheme 1.136 : The efficient synthesis of carpanone. 
Work by Penttila et al. demonstrated a rare example of a nucleophile trapping reaction, 
the QM (1.590) was found to undergo an electrophilic addition to the electron rich ring 
of the trisphenol (1.591) to give the natural product margaspidin (1.592) (scheme 
1.137).166 
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HO OH
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nPr O
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nPr O
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Me
nPrO
(1.591)
(1.590) (1.592)  
Scheme 1.137 : Electrophilic addition to a QM in the synthesis of margaspidin. 
Finally, Pettus et al. utilised a nucleophilic addition to the benzaldehyde (1.593) to 
generate the QM (1.595) via a transfer of a Boc group to the intermediate alkoxide and 
subsequent elimination of the carbonate. Reduction of the QM with sodium borohydride 
then gave an early intermediate (1.596) in the synthesis of a number of the cleroindicins, 
including cleroindicin C (1.597) (scheme 1.138).167 
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Scheme 1.138 : A general scheme for the cleroindicins including an early QM reduction. 
Whilst a handful of other syntheses have integrated a QM approach into their grander 
schemes, it is clear that the vast majority of research in this area has been focused on the 
theory and methodology of these sometimes ephemeral intermediates. The broad range 
of reactivities these intermediates display in nature is surely an indication of their huge 
synthetic potential in the synthesis of chromans and ortho-substituted phenols. However 
the reluctant use of this particular tool is understandable given the sometimes complex 
nature of both its generation and utilisation, but this only emphasises the need for 
further research on the subject, with a focus on developing practical synthetic methods. 
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2. Results and Discussion 
 
 
“There’s hardly a thing a man can name 
Of beauty or use in life’s small game, 
But you can extract in alembro or jar, 
From the physical basis of black coal tar: 
Oil and ointment, and wax and wine, 
And the lovely colours called aniline: 
You can make anything, from salve to star 
    (If only you know how), from black coal tar.” 168 
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2.1 Retrosynthetic Approach. 
The combined work of Parsons, Board and Waters constituted significant progress 
towards the synthesis of lactonamycin and as such our retrosynthetic analysis aimed to 
incorporate the key cyclisation they had developed as its key step (scheme 2.1). This 
would allow us to form key pentacycle (2.2) in a very short sequence from 
commercially available starting materials. 
OH
Br
N
Me
O
TMS
N
Me
O
TMS
OH
a
(1.398) (1.404)
OH
Br
N
Me
O
SiR3
N
Me
O
R3Si
OH
a
(2.1) (2.2)
O
OOMe
OMe
OMe
OMe
O
O
 
Scheme 2.1 : Reagents and Conditions: (a) Epoxyhexane, toluene, sealed tube, 150 °C, 6 hrs. 
To form the precursor, it was decided to continue working toward the lactone (1.427) 
identified as a target by Board, though in our case we would focus on forming the 
lactone in the orientation shown (scheme 2.2) as we were confident this would enable us 
to proceed onward to lactonamycin. Board’s unsuccessful attempts at forming this key 
intermediate also made it clear that an entirely new approach would be necessary. 
OMe
OMe
O
O
O
(1.427)
OMe
OMe
OH
O
O
(2.1)
Br
H
NO
SiR3
Br
 
Scheme 2.2 : Key intermediates and short term targets. 
It was equally clear that we would need to develop an alternative propynoic acid to 
replace the TMS propynoic acid (1.381) as Board had established that the 
trimethylsilane moiety of tetracycle (1.404) could not be converted to the necessary 
phenol (1.362) (scheme 2.3). 
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Scheme 2.3 : The need for an alternate propynoic acid. 
With these three broad aims in mind, we devised a new retrosynthesis of lactonamycin 
(scheme 2.5) (overleaf). We envisioned the formation of cyclisation precursor (2.1) 
from benzaldehyde (1.427) by the well established side chain insertion methodology 
developed by Board, though with the inclusion of a new silyl propynoic acid derivative 
to circumvent the issues Board had with subsequent oxidation of the trimethylsilanes. 
The benzaldehyde would itself be formed from bromophthalide (2.13) in one pot, 
utilising a metal-halogen exchange to form the lithiate then in situ formylation with the 
formamide (2.4). The transient addition product would direct a second metalation to the 
ortho position allowing for ring alkylation to take place before acid workup give the 
benzaldehyde. This approach was demonstrated by Comins et al. during the synthesis of 
pyridine derivative (2.6) (scheme 2.4).169 
N OCH2OEt
(2.3)
(2.5)
(2.6)
Cl
N OCH2OEtCl
NLi
N
OLi
Me
Me
Me
N OCH2OEtCl
OH
I
(2.4)
a-c
d, e
N
N
Me
Me
Me
O
 
Scheme 2.4 : Reagents and Conditions: (a) nBuLi, THF, -10 °C, 10 min; (b) (2.4), -23 °C, 30 min; (c) 
nBuLi, -23 °C, 4 hrs; (d) I2; (e) NaBH4 (41% yield over 5 steps). 
Brominated phthalide (2.13) (scheme 2.5) should be accessible by a simple aromatic 
substitution on the more electron rich position of the known phthalide (2.14). The 
pentacycle (2.2) resulting from the cyclisation of ene-diyne (2.1) would contain all the 
necessary functionality to allow elaboration to the natural product (1.1), the proposed 
route is described in greater detail below (vide infra, section 2.9.3). 
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Scheme 2.5 : Retrosynthesis of lactonamycin. 
2.2 Synthetic Approach.  
2.2.1 Synthesis of Dimethoxyphthalide (2.14). 
Work began with commercially available 2,5-dimethoxybenzaldehyde (2.16), which 
was efficiently converted to the corresponding 2,5-dimethoxybenzyl alcohol with 
sodium borohydride in methanol according to the method of Kumar et al.170 (scheme 
2.6). 
(2.16)
OMe
OMe O
OMe
OMe OH
a
(2.15)   
Scheme 2.6 : Reagents and Conditions: (a) NaBH4 (1 eq.), MeOH, -20 °C to rt, 3 hrs (97%). 
Whilst benzyl alcohol (2.15) was commercially available, the benzaldehyde was 
available on a kilogram scale and the yield of the conversion was such that this was the 
most economical method of obtaining large quantities of the benzyl alcohol for scale up. 
Whilst generally reliable, it was on a number of occasions necessary to further purify 
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the commercially provided material, due to an unidentified inorganic impurity, that 
appeared to act as a Lewis acid catalysing the formation of the dimethyl acetal (2.17) 
causing the reaction to stall and lowering yields to between 50-70% (scheme 2.7). 
Filtration through silica gel resulted in starting material that did not undergo this 
undesired side reaction. 
(2.16)
OMe
OMe O
OMe
OMe OH
(2.15)(2.17)
OMe
OMe OMe
OMe
LA
MeOH
 
Scheme 2.7 : Proposed reason for the stalling of the reduction. 
Magnus et al. had already described a method of forming the desired phthalide (2.14) as 
part of his partial synthesis of Dynemicin A.171 This involved a deprotonation of benzyl 
alcohol (2.15) with two equivalents of n-butyllithium (scheme 2.8). The first equivalent 
deprotonating the alcohol and the second removing one of the aromatic protons. The 
dianion (2.18) was then allowed to undergo equilibration, resulting in the negative 
charge residing ortho to the hydroxymethyl group, this position being stabilised by 
coordination of the negative charge on the oxygen to lithium. Attack of the carbanion 
(2.19) on carbon dioxide at low temperature installed a carboxylate residue at that same 
position and subsequent acidification during workup resulted in rapid cyclisation to 
furnish the lactone. 
(2.15)
OMe
OMe OH
OMe
OMe
(2.20)(2.18)
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OMe OLi
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Scheme 2.8 : Mechanism of lactone formation. 
Our methodology differed from Magnus’ due to the fact we added carbon dioxide to the 
reaction mixture as a solid. This allowed for very rapid quenching, with comparable 
yields. We also established that it was essential to allow the reaction mixture to 
equilibrate for sufficient time and also that it was crucial to cool the reaction mixture to 
at least -20 °C before quenching (scheme 2.9). This was necessary to avoid the 
production of undesired by-product (2.21). This compound was isolated in low (10-
20%) yield if the aforementioned requirements were not adhered to. The formation can 
be explained by the attack of the kinetically generated carbanion (situated para to the 
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hydroxymethyl group) on carbon dioxide before it had a chance to equilibrate to the 
thermodynamically favoured ortho lithiate (2.19). Interestingly none of the 
corresponding meta-substituted product (2.22) was identified under any conditions even 
though one might imagine this to be comparably stable to the para product, perhaps 
marginally more so. 
(2.15)
OMe
OMe OH
(2.21)
OMe
OMe OH
O
OOMe
OMe
+
(2.14)
OMe
OMe
HO
O OH
HO
O
(2.22)
a
 
Scheme 2.9 : Reagents: (a) 2.5M nBuLi in hexanes (2.2 eq.), THF. Conditions: See table below. 
Conditions Yield (2.14) (%)a Yield (2.21) (%)a 
-78 to 70 °C, 3.0 hrs then CO2(s), -20 °C, 1 hr. 65% -- 
-78 to 70 °C, 1.5 hrs then CO2(s), -20 °C, 1 hr. 48% 20% 
-78 to 70 °C, 3.0 hrs then CO2(s), rt, 1 hr. 55% 14% 
a Isolated yield. 
2.2.2 Aromatic Bromination. 
It seemed logical that an electrophilic bromination of phthalide (2.14) would occur at 
the required position. The two aromatic positions were distinguished only by their para 
substituents and as such the 6 position should prove slightly activated by the inductively 
electron donating para-methylene, while the 5 position should be deactivated by the 
para-carbonyl. N-bromosuccinimide has frequently been used to perform aromatic 
brominations,172 with Kelly using it on a similar phthalide system in his model synthesis 
of the CDEF ring system (vide supra, scheme 1.25). However upon exposure to NBS in 
carbon tetrachloride, the phthalide was instead converted in high yield to the γ-
bromolactone (2.23) (scheme 2.10).  
It seemed that the reaction may be proceeding via a resonance-stabilised benzyl radical; 
under the right conditions NBS is known to undergo homolytic cleavage of the nitrogen 
bromine bond generating bromine radicals and this could result in the observed non-
aromatic substitution. It was hoped that a change of solvent to dichloromethane, the 
addition of catalytic conc. sulfuric acid and performing the reaction shielded from light 
may close down this radical pathway in favour of the desired ionic one. However the 
same result was obtained, albeit in reduced yield. The ring system simply did not seem 
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to be sufficiently electron rich to undergo reaction with NBS, which was somewhat 
surprising given the electron-donating effect of the two methoxy groups. It was hoped 
the use of more ionic reaction conditions would allow us access to the desired product. 
Bromine became our preferred brominating agent and treatment of the phthalide with 
bromine and iron powder was intended to generate a quantity of ferric bromide in situ, 
which would act as a Lewis acid, sadly this too gave only the undesired product. 
Addition of a more powerful Lewis acid however proved to be the key and the addition 
of aluminium chloride combined with a move to acetic acid as the solvent produced the 
desired 6-bromophthalide (2.13). Whilst a yield of 69% was good, there appeared to be 
some degradation of material which was attributed to the instability of the lactone ring 
under the strongly acidic reaction conditions. 
(2.23)
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Scheme 2.10 : Reagents and Conditions: See table below. 
 Reagent Conditions Product Yield (%)a 
(a) NBS (1.0 eq.) CCl4, rt, 24 hrs. (2.23) 91 
(b) NBS (1.0 eq.) H2SO4 (cat.), CH2Cl2, rt, 12 hrs. (2.23) 78 
(c) Br2 (1.2 eq.) Fe(s) (0.2 eq.), CCl4, 2 hrs, 70 °C (2.23) 45 
(d) Br2 (1.0 eq.) AlCl3 (0.2 eq.), AcOH, 70 °C, 6 hrs. (2.13) 69 
a Isolated yield. 
2.2.3 Attempted Functionalisation of Bromophthalide (2.13). 
With the bromine in place it was hoped this would act as a synthetic handle allowing 
further functionalisation of the ring. As we intended to functionalise the bromide 
through a lithium-halogen exchange process it was anticipated that the acidic protons of 
the lactone may give rise to complications. The phthalide ring system would therefore 
need to be masked. We had hoped to achieve this by treating the benzolactone (2.13) 
with base and trapping the resulting enolate as the silyl ether (2.24) (scheme 2.11). The 
resulting furan should then be stable under lithium-halogen exchange conditions 
allowing the functionalisation of both ring positions in a single pot, as per the example 
of Comins et al. (vide supra, scheme 2.4).169 
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Scheme 2.11 : Reagents and Conditions: (a) Silylation; (b) Lithiation; (c) Addition of amide (2.4); (d) 
Amine stabilised deprotonation; (e) Addition of 2,3-dibromopropene followed by acidic workup. 
It was clear from the literature that the protection of the phthalide may not be entirely 
straightforward. Bloomer and Lankin had found that attempts to silyl protect a similar 
phthalide system with TMS or TES chlorides had invariably resulted in silylation at the 
benzylic carbon rather than the desired oxygen.173 Kelly et al. had also struggled with a 
similar protection in their own work on lactonamycin (vide supra, scheme 1.26), they 
too had found that the use of TMS chloride resulted in preferential C-silylation. Only by 
switching to the bulkier TBS chloride did they manage to direct addition to the oxygen. 
This seems to suggest that the anion is principally localised on the carbon and that the 
degree of O-silylation is determined purely by the steric bulk of the incoming silyl 
group. As it was thought we may need to isolate the intermediate silyl enol ether we 
opted for the bulkier TIPS group, we also elected to utilise the triflate rather than the 
chloride as this would hopefully prove more oxophilic.174 Deprotonation of the 
phthalide (2.13) with LDA appeared to produce the brightly coloured anion in solution 
as expected, but quenching with the TIPS triflate did not produce any of the desired 
product (2.24a) (scheme 2.12).  
OMe
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Scheme 2.12 : Reagents and Conditions: (a) LDA -78 °C to -20 °C, Et2O then TIPSOTf -20 °C to rt; (b) 
MeLi -95 °C to -70 °C, Et2O  then  TIPSOTf -70 °C to rt; (c) LDA -78 °C to -20 °C, Et2O then TBSCl -20 °C 
to rt. 
Concerned that the LDA may be reacting in an undesired manner we also attempted the 
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reaction, using methyllithium as a base, unfortunately this resulted in polymerisation of 
the material. With these setbacks we resorted to using TBS chloride as per Kelly et al.’s 
example reasoning that the TIPS group had simply been too bulky, however the reaction 
with TBS chloride also failed to deliver any of the silylenol ether (2.24b).  
The unexpected failure of these silyl protections forced us to consider functionalising 
the bromide by alternate means. To rule out the possibility of direct lithium-halogen 
exchange, this area was briefly investigated (scheme 2.13). Treatment of the bromide 
(2.13) with either tBuLi or nBuLi and then attempting to simply quench the lithiate 
(2.28) with methyl iodide resulted in extremely messy reactions and an intractable 
mixture of products. 
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Scheme 2.13. Reagents and Conditions: (a) tBuLi (2 eq.), -78 °C to -10 °C, Et2O then MeI (excess); (b) 
nBuLi, -78 °C to -10 °C, Et2O then MeI (excess). 
With the bromine in place we were keen to persist with attempts to functionalise it. It 
was hoped that the aryl bromide would serve as a suitable substrate for palladium 
chemistry and that this may allow for the introduction of a formyl group via a reductive 
carbonylation (scheme 2.14).  
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Scheme 2.14 : Reagents and Conditions: (a) Reductive carbonylation; (b) Aminal formation; (c) 
Bromination; (d) Lithium halogen exchange then transmetallation wih CuCN; (e) 2,3-Dibromopropene then 
acid workup. 
The resulting benzaldehyde (2.31) would be converted into the aminal (2.32) as 
favoured by Board. The formation of this aminal would invert the electron demand of 
the remaining unsubstituted ring position allowing a further aromatic bromination to 
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proceed giving bromide (2.33). With the bromide in position and the stabilising aminal 
at the ortho position lithium halogen exchange would allow us to access the lithiate 
cleanly, even in the presence of the lactone. Transmetalation to the cuprate (2.34) would 
in turn allow a coupling with 2,3-dibromopropene to furnish key intermediate (1.427) 
after hydrolysis of the aminal. 
Reductive carbonylation of aryl halides has traditionally been carried out using a 
gaseous mixture of carbon monoxide and hydrogen (synthesis gas) over a palladium 
catalyst, however this reaction required extremely high pressures, in excess of 80 
atms.175 Without suitable equipment available it was necessary to seek an alternative 
procedure; the use of an alternate source of hydride was found to lower the pressures 
required substantially. Stille et al. presented the use of alkyltin hydrides, where 
reactions proceeded under an atmospheric pressure of CO.176 The appeal of those 
procedures was lessened by the subsequent revelation that silanes may prove equally 
effective at reasonable temperatures and pressures.177 It was the work of Kotsuki et al. 
on aryl triflates that we hoped to extend to our system (scheme 2.15).178  
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Scheme 2.15 : Mechanism of palladium mediated reductive carbonylation. 
As such the aryl bromide (2.13) was treated with the palladium (II) acetate DPPP 
catalyst system under an atmospheric pressure of CO (scheme 2.16). For reasons of cost 
and availability we opted to use triisopropylsilane as our hydride source as opposed to 
the tri-n-octylsilane used by Kotsuki. However despite extended heating time only 
starting material was returned. Repeating the reaction under higher overpressures of CO 
failed to give any improvement, though this was not entirely surprising as the primitive 
pressure apparatus we had available was unable to heat the reaction mixture whilst it 
was under pressure. 
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Scheme 2.16 : Reagents and Conditions: (a) Pd(OAc)2(dppp) (4 mol%), CO (1 atm), DMF then NEt3, 
triisopropylsilane, 48 hrs, 70 °C; (b) Pd(OAc)2(dppp) (4 mol%), CO (2 atm), DMF, NEt3, triisopropylsilane, 
48 hrs, rt; (c) Pd(OAc)2(dppp) (4 mol%), CO (5 atm), DMF, NEt3, triisopropylsilane, 24 hrs, rt. 
Unable to gain access to the combined temperatures and pressures required this line of 
enquiry was also abandoned. Reading around this area it was shown that similar 
chemistry could be performed using the isoelectronic isonitriles to effect analogous 
imidoylations (scheme 2.17).179 Whilst no reductive variant had been reported, the 
surrounding chemistry was so similar that a brief examination of a reductive variant 
seemed prudent. The isocyanide could be added into the reaction mixture as a liquid, 
simplifying our previous procedure substantially. Sadly repeating the earlier procedure 
with tert-butylisonitrile in place of gaseous CO returned only starting material. 
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Scheme 2.17 : Reagents and Conditions: (a) Pd(OAc)2(dppp) (4 mol%), tBuNC (excess), DMF, NEt3, 
triisopropylsilane, 24 hrs, 70 °C. 
Whilst it was decided to abandon palladium chemistry at this point a later publication 
gave some insight into a likely reason for the failure of this work. Ashfield and Barnard 
had also attempted to extend the method of Kotsuki to aryl bromides, with great success 
and whilst they found that the general conditions used in our attempts were near 
optimal, the choice of silane was more critical than we had anticipated.178 They 
established that whilst the overall mass of the alkyl groups of the silane was 
unimportant, it was crucial that these groups were straight chains to prevent excessive 
hinderance of the silicon-hydrogen bond. Thus triethyl, tri-n-butyl and tri-n-octyl 
silanes were all highly effective, but the use of triisopropyl silane along with other 
branched silanes was found to result in low yields where it was effective at all. 
2.2.4 Alternate Electrophilic Substitutions of Parent Phthalide (2.14). 
After encountering so many difficulties in our attempts to advance the synthesis from 
bromophthalide (2.13) we decided to attempt the formylation of parent phthalide (2.14) 
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directly. A review of the literature suggested a number of protocols for the direct 
formylation of aromatic rings.180 The preceding work with carbon monoxide naturally 
drew attention to work of Gattermann and Koch where CO is used in conjunction with 
HCl to form the unstable formyl chloride (2.40) in situ (scheme 2.18).181 A strong Lewis 
acid is then used to form the acylium ion (2.41) which should react readily with the 
aromatic ring. Exposure of the phthalide to these conditions returned only starting 
material. 
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Scheme 2.18 : Reagents and Conditions: (a) CO (5 atm), AlCl3 (1 eq.), CuCl (15 mol%), 4M HCl 
(excess), dioxane, rt, 12 hrs. 
A more reactive variant of this reaction, developed by Gattermann alone, utilises an 
iminium species as the active reagent formed by the addition of HCl across the triple 
bond of hydrocyanic acid.182 The resulting imine (2.44) would then be hydrolysed to 
give the benzaldehyde. The preferred protocol for this reaction involves the use of zinc 
cyanide as this allows the generation of the volatile HCN in situ and generates the 
Lewis acid ZnCl2 as a by-product. However these conditions also failed to deliver any 
of the desired benzaldehyde (2.31) or the intermediate imine (scheme 2.19). 
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Scheme 2.19 : Reagents and Conditions: (a) Zn(CN)2, HCl (g), Et2O, rt, 2 hrs; (b) Zn(CN)2, HCl, dioxane, 
Et2O, rt, 2 hrs. 
Of the remaining standard formylation protocols the Vilsmeier-Haack183 reaction was 
deemed too similar in nature and reactivity to the Gattermann reaction and the 
behaviour of our substrate suggested it was insufficiently electron rich for the Duff 
protocol to be effective.184 As such our attention was turned to the formation of a 
suitable precursor for a carbonylation reaction and it had come to our attention that 
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heavy metals such as mercury and thallium could be introduced to the aromatic ring by 
an electrophilic substitution, transmetalation with palladium then allowed both 
organomercury185 and organothallium186 compounds to act as viable carbonylation 
precursors. 
It was suggested that organomercuration could be achieved relatively simply by stirring 
the aromatic compound with mercuric acetate.187 Heating the phthalide (2.14) in MeCN 
with Hg(OAc)2 did not produce the desired organomercury compound (2.45) and 
returned only starting material (scheme 2.20). It was noted that these metalations were 
often accelerated when carried out in acidic solvents and as such the reaction was 
repeated whilst exchanging the solvent for acetic acid with no change in the result 
observed. 
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Scheme 2.20 : Reagents and Conditions: (a) Hg(OAc)2, MeCN, 80 °C, 12 hrs; (b) Hg(OAc)2, AcOH,     
85 °C, 12 hrs. 
Similarly it was hoped that the organothallium species (2.46) would be prepared by 
stirring the phthalide with thallium (III) trifluoroacetate.188 Once again only starting 
material was returned when heated in MeCN (scheme 2.21). This was not improved by 
the use of TFA as the solvent which resulted in decomposition of the starting material.  
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Scheme 2.21 : Reagents and Conditions: (a) Tl(O2CCF3)3, MeCN, dark, 80 °C, 12 hrs; (b) Tl(O2CCF3)3, 
TFA, dark,  70 °C, 12 hrs. 
 
2.3 A Revised Synthetic Approach.  
2.3.1 Alternate Route to Key Intermediate (1.427). 
With both phthalide systems appearing to be surprisingly inert towards further 
functionalisation it was apparent that a more radical change in direction may be 
required. As phthalide system (2.14) had proved to be less electron rich than 
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anticipated, substitution had been challenging and as such we were keen to try and 
introduce all the necessary functionality before installing the electron withdrawing 
carbonyl of the lactone. It was also clear that installing the 2-bromo-allyl unit through 
anion chemistry would prove challenging with the base-sensitive lactone in place. 
A new route was proposed which would hopefully circumvent these issues (scheme 
2.22). It was known that the tetraol (2.48) could be derived from commercially available 
hydroquinone (2.47) through simple hydroxymethylation. It was then hoped that mono-
protecting one of the 1,3-diols to give the acetonide (2.49) would allow the formation of 
the lactone (2.50) as previously demonstrated either via the trianion or through the use 
of a temporary phenol protection. The ether (2.51) would be derived from the alkylation 
of the free phenol with base and 2,3-dibromopropene and when heated this allyl-phenyl 
ether would undergo a Claisen rearrangement to give the phenol (2.52). Acid hydrolysis 
of the acetal would restore the diol (2.53). Methylation of the phenols under standard 
conditions and the oxidation of the benzylic alcohol would yield the fully functionalised 
key intermediate (1.427). 
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Scheme 2.22 : Reagents and Conditions: (a) Hydroxymethylation; (b) Mono-acetal protection; (c)  
Lactone formation; (d) Alkylation with 2,3-dibromopropene; (e) Claisen rearrangement; (f) Acetal 
deprotection; (g) Oxidation and methylation. 
2.3.2 Hydroxymethylation of Hydroquinone (2.47). 
It had been demonstrated by von Euler et al. that the hydroxymethylation of 
hydroquinone (2.47) to the tetraol (2.48) could be achieved by exposure to 
formaldehyde solution in the presence of base (scheme 2.23).189 Indeed, when exposed 
to the literature conditions conversion to the desired product was successful, though the 
reaction proceeded very slowly and in very poor yield (10%). This reaction mixture was 
very prone to polymerisation and all attempts to increase the yield through standard 
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methods: increasing concentration, employing extra equivalents of formaldehyde or 
raising the reaction temperature resulted in this end. Exposure to light would also 
initiate polymerisation necessitating the use of completely opaque glassware. After 
optimisation a disappointing maximum yield of 15% was obtained. Though woefully 
inefficient this was not deemed excessively problematic as hydroquinone (2.47) was 
readily available in kilogram quantities. 
OH
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OH OH
OH
(2.47)
a
(2.48)  
Scheme 2.23 : Reagents and Conditions: (a) Formalin (37% wt. formaldehyde) (2 eq.), NaOH, H2O, 
dark, rt, 7 days (15%). 
Alternatively the tetraol could also be prepared by the reduction of diester (2.54) with 
lithium aluminium hydride according to the method of Wegner et al. (scheme 2.24).190 
Whilst this route had numerous advantages including more reasonable reaction times 
and superior yields the prohibitively high price of the starting material meant it was still 
more economical to persist with the low yielding route. 
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Scheme 2.24 : Reagents and Conditions: (a) LiAlH4 (4 eq.), THF, reflux, 1 hr (68%). 
2.3.3 Protection of Tetraol (2.48). 
With the tetraol (2.48) in hand, we envisaged that treatment with stoichiometric 
amounts of acetonide protecting agents would deliver the diol (2.49) required (scheme 
2.25). Acetonide formation was therefore attempted with 2,2-dimethoxypropane,191            
2-methoxypropene191a,192 and acetone193 under a variety of conditions.  
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Scheme 2.25 : Reagents and Conditions: (a) See table below. 
Studies Toward a Total Synthesis of Lactonamycin                                                 Results and Discussion 
117 
Reagent Equivalents Conditions Result 
2,2-Dimethoxypropane 1 pTSA (cat.), DMF, rt to 80 °C. SM. 
2,2-Dimethoxypropane 2 pTSA (cat.), DMF, rt to 80 °C. SM. 
2,2-Dimethoxypropane 5 pTSA (cat.), DMF, rt to 80 °C. SM. 
2-Methoxypropene 1 PPTS (cat.), DMF, rt to 80 °C. SM. 
2-Methoxypropene 2 PPTS (cat.), DMF, rt to 80 °C. SM. 
2-Methoxypropene 5 PPTS (cat.), DMF, rt to 80 °C. SM. 
Acetone excess pTSA (cat.), rt to reflux. SM. 
Acetone excess H2SO4 (cat.), rt. (2.55)a 
2-Methoxypropene 5 H2SO4 (cat.), MeCN, rt to reflux. SM. 
2,2-Dimethoxypropane 5 H2SO4 (cat.), MeCN, rt to reflux. SM. 
a 35% isolated yield  
Sadly the reactions with restricted quantities of protecting agents failed to deliver the 
desired product, despite extended periods of time both with and without heating only 
starting material was returned. Attempting to use a large excess of protecting agent in 
the hope of stopping the reaction before it progressed past the mono-acetonide (2.49) 
also proved impossible due to the formation of bisacetonide (2.55). All these reactions 
were hindered by the limited solubility of the tetraol in even very polar solvents. This 
meant that where the monoacetonide formed it was significantly more soluble than the 
starting material, leading to preferential formation of a second acetonide.  
With attempts at acetal protecting one of the diol units having failed it was hoped we 
may instead be able to protect the two phenolic hydroxyl groups of tetraol (2.48) as the 
corresponding methyl ethers (scheme 2.26). The resulting diol (2.56) should then 
undergo the required lactonisation with 3 equivalents of n-butyllithium and the resulting 
lactone could be converted to the phenol (2.50) through sequential demethylation and 
acetal formation. Methylation of the tetraol proved more challenging than anticipated, 
but some limited success was had, the limited solubility of the starting material once 
again proving problematic. The desired diol (2.56) was obtained, albeit in very low 
yields when the tetraol was treated with either methyl iodide or dimethyl sulfate in the 
presence of base. This material was sufficient to test the lactonisation, though 
disappointingly a modification of the earlier procedure (vide supra, scheme 2.9) gave 
only decomposition products. This resulted in the abandonment of this route prior to 
optimisation of the methylation. 
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Scheme 2.26 : Reagents and Conditions: (a) MeI (excess), K2CO3, MeCN, 8 hrs, 60 °C (18%); (b) 
Me2SO4 (2.5 eq.), K2CO3, Acetone, 12 hrs, reflux (14%); (c) nBuLi (3 eq.), -78 °C to 70 °C, 3 hrs then    
CO2 (s). 
2.4 Finalised Synthetic Approach.  
2.4.1 Alternate Route to Lactone (2.50). 
It was at this point that a route was devised that would allow us access to the lactone 
intermediate (2.50) without needing to proceed through troublesome tetraol (2.48) 
(scheme 2.27). It was proposed that by demethylating our existing dimethoxyphthalide 
(2.14) to give the hydroquinone (2.58) we would activate the aromatic ring, allowing an 
electrophilic hydroxymethylation to occur, generating the benzyl alcohol (2.59). This 
would allow us to selectively protect the alcohols of the 1,3-diol unit as the acetonide 
(2.50) which would be converted to the hexasubstituted key intermediate (1.427) by the 
previously described chemistry (vide supra, scheme 2.22). 
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Scheme 2.27 Reagents and Conditions: (a) Demethylation; (b) Hydroxymethylation; (c) Acetonide 
protection; (d) Alkylation with 2,3-dibromopropene; (e) Claisen rearrangement; (f) Acetonide deprotection; 
(g) Oxidation and methylation. 
2.4.2 Demethylation of Dimethoxyphthalide (2.14). 
The dihydroxyphthalide (2.58) had been prepared previously by Myers et al. by a rather 
ponderous route that eventually revealed the target lactone by a silyl deprotection of the 
two phenols.194 This resulted in some initial concern that the strongly Lewis-acidic 
reagents typically used to perform the demethylation could lead to degradation of the 
lactone ring. However Duan et al. had shown that iodocyclohexane could be used as a 
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very mild reagent for carrying out this transformation on a similar methoxy-substituted 
phthalide through the generation of small quantities of hydrogen iodide in situ.195 
Heating dimethoxyphthalide (2.14) with cyclohexyl iodide at 80 °C in DMF returned 
only starting material (scheme 2.28). It occurred that it may in fact be the thermal 
decomposition of DMF generating small quantities of dimethylamine at reflux that 
catalyses the elimination of iodide from iodocyclohexane and that 80 °C may not have 
been a sufficient temperature to allow this to occur; repeating this reaction at higher 
temperature produced the same result. 
O
OOMe
OMe
O
OOH
OH
(2.14)
a or b
(2.58)  
Scheme 2.28 : Reagents and Conditions: (a) CyI (10 eq.), DMF, 80 °C; (b) CyI (10 eq.), DMF, reflux. 
With this failure in mind an attempt was then made to obtain the dihydroxyphthalide 
(2.58) via a more traditional Lewis acid mediated route. Staunton and Evans used boron 
tribromide to reveal a similar methoxyphthalide system in their work on citromycetin 
and whilst their yields were only moderate,196 we had accepted that some degree of 
decomposition would be associated with such forcing conditions. When we exposed 
dimethoxyphthalide to BBr3 initial yields of 60-70% of the deprotected phthalide were 
recorded (scheme 2.29). This was deemed high enough to carry through and we were 
pleased to note that upon scale-up using a freshly prepared solution of boron tribromide 
yields were increased significantly to 94%, suggesting fears about the stability of the 
lactone moiety may have been excessive. 
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Scheme 2.29 : Reagents and Conditions: (a) BBr3 (2 eq.), CH2Cl2, -78 °C to rt, 4 hrs (94%). 
2.4.3 Hydroxymethylation of Dihydroxyphthalide (2.58). 
Given the unfavourable results experienced in the hydroxymethylation of hydroquinone 
(2.58) (vide supra, scheme 2.23) we were keen to avoid the use of the same conditions. 
Casiraghi et al. had demonstrated the efficient hydroxymethylation of electron rich 
Studies Toward a Total Synthesis of Lactonamycin                                                 Results and Discussion 
120 
aromatics utilising a microwave based method.197 Heating a large excess of 
paraformaldehyde in a sealed tube should lead to thermal depolymerisation, generating 
a significant pressure of formaldehyde gas, in the presence of the phenolic phthalide 
(2.58) this should undergo a rapid hydroxymethylation. However in our hands this 
method never produced any of the desired product (2.59) (scheme 2.30). 
O
OOH
OH
O
OOH
OH
OH
(2.58) (2.59)
a or b
 
Scheme 2.30 : Reagents and Conditions: (CH2O)n (10 eq.), DME, p-xylene, 135 °C, MW, 12 hrs; (b) 
Formalin (37% wt. Formaldehyde), CaO, H2O, dark, rt. 
A formalin based approach using calcium oxide as the base was also attempted, with no 
success.198 However a test reaction using the earlier conditions was surprisingly 
successful with hydroxymethylation actually proceeding in good yield (scheme 2.31). 
The reaction was still painfully slow and prone to polymerisation but the desired triol 
(2.59) was delivered in 65-80% yield depending on the degree of polymerisation 
observed.  We were pleased to observe complete selectivity for the desired substitution 
position as anticipated. 
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Scheme 2.31 : Reagents and Conditions: (a) Formalin (37% wt. Formaldehyde), NaOH, H2O, dark, rt, 6 
days (65-80%). 
We were also able to isolate the intermediate tentatively assigned as sodium alkoxide 
salt (2.62) where the reaction mixture was not sufficiently acidified during workup, 
emphasising the notable difference in pKa between the two phenolic protons. 
2.4.4 Selective Alkylation of Triol (2.59). 
The acetal protection of the 1,3-diol unit of the triol (2.59) proceeded smoothly. 
Treatment with 2,2-dimethoxypropane led to ready transacetalisation in the presence of 
catalytic acid to cleanly afford the desired acetonide (2.50) in good yield (scheme 2.32). 
This reaction was slowed due to the poor solubility of the triol in organic solvents, 
however the reaction proceeded cleanly under heterogeneous conditions in acetone and 
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it proved a lot easier to separate our product from this reaction mixture than when more 
polar solvents such as DMF or DMSO were used. This reaction could occasionally 
become sluggish for no obvious reason, but this could be remedied by the addition of a 
few drops of sulfuric acid, though this tended to produce a minor amount of 
decomposition. 
O
OOH
OH
O
OO
OH
OH O
(2.59) (2.50)
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Scheme 2.32 : Reagents and Conditions: (a) 2,2-Dimethoxypropane (5 eq.), acetone, pTSA (cat.),       
60 °C, 3 hrs (87%). 
With the 1,3-diol protected as the benzodioxin (2.50) attachment of the 2-bromoallyl 
chain to the remaining exposed phenol was to be achieved using the Williamson ether 
synthesis. This was achieved simply, using KOH to form the alkoxide, which was able 
to displace the primary bromide of 2,3-dibromopropene giving the ether (2.51) (scheme 
2.33). Prolonged heating seemed to result in some decomposition, as such it was usually 
preferable to halt the reaction early and harvest the product and remaining starting 
material. 
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Br(2.50) (2.51)
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Scheme 2.33 : Reagents and Conditions: (a) 2,3-Dibromopropene, KOH, EtOH, 80 °C, 2.5 hrs (61% 
isolated yield, 81% based on recovered SM). 
There was initially significant variation in the yield of this reaction, this was attributed 
to the variable quality of commercially available 2,3-dibromopropene (1.370) which is 
prone to decomposition with the generation of HBr. Freshly prepared material produced 
superior alkylation yields and was readily synthesised from 1,2,3-tribromopropane 
(2.63) according to a literature procedure which utilised hexadecylpyridinium bromide 
to allow the elimination to occur with aqueous potassium hydroxide under emulsion 
conditions (scheme 2.34).199 It was also found that hexadecylpyridinium chloride could 
be substituted as the phase transfer agent with no ill effect and comparable yields. 
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Br Br
Br
Br
Br
(2.63) (1.370)
a or b
N
15
Hexadecylpyridinium  
Scheme 2.34 : Reagents and Conditions: (a) Hexadecylpyridinium bromide, KOH, H2O, reflux, 2 hrs 
(70%); (b) Hexadecylpyridinium chloride, KOH, H2O, reflux, 2 hrs (66%). 
The literature also noted examples of the formation of 2-bromoallyl ethers from 1,2,3-
tribromopropane directly through an in situ elimination of an intermediate alkyl 
bromide (2.64) (scheme 2.35).200 This alkylation route proved unsuccessful when 
applied to the phenol (2.50) with the reaction returning starting material and 
decomposition products. 
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Scheme 2.35 : Reagents and Conditions: (a) (2.63), NaOH (2 eq.), EtOH, reflux. 
2.5 Effecting the Claisen Rearrangement.  
2.5.1 The Claisen Rearrangement of β-Bromoallyl Phenyl Ethers. 
The Claisen rearrangement was the first of a series of [3,3]-sigmatropic rearrangements 
to be discovered in the early 20th century and it continues to this day to provide a 
powerful method of forming carbon-carbon bonds; converting an allyl vinyl ether into a 
continuous carbon chain terminated with a carbonyl. In the case of the aromatic 
rearrangement the ketone generated undergoes rapid tautomerisation to generate an 
ortho-allyl phenol (scheme 2.36). 
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Scheme 2.36 : Mechanism of the aromatic Claisen rearrangement. 
The structural constraints of our system precluded any of the regioselectivity concerns 
that can sometimes accompany the rearrangement with the para position already 
substituted and only one of the two ortho positions available. In addition, the α,γ-
unsubstituted allyl group would mean that the abnormal rearrangement was not of 
concern. There was also adequate precedent for the rearrangement of the 2-bromoallyl 
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phenyl ether (2.68), with both Baldwin et al.201 and Sarpong et al.202 providing 
examples (scheme 2.37). As such we felt confident that the presence of bromine on the 
β-carbon would not prove deleterious.  
O OH
(2.68) (2.69)
Br
Bra or b
 
Scheme 2.37 : Reagents and Conditions: (a) N,N-Diethylaniline, sealed tube, 200 °C (76%); (b) Et2AlCl, 
hexanes, 0 °C to rt, 15 hrs (75%). 
2.5.2 The Claisen Rearrangement in Practice. 
Microwave heating methods have a number of advantages when trying to perform 
organic reactions and the Claisen rearrangement is no exception.203 The use of sealed 
reaction vessels allowed us to perform reactions at temperatures significantly higher 
than the boiling points of the solvents (at atmospheric pressure) in use. It has also been 
demonstrated that due to the negative ΔV of activation associated with the Claisen 
rearrangement increased pressure will increase the rate of reaction.204 There are also 
suggestions that there may be specific advantageous microwave effects that arise 
entirely separately from the thermal effects of microwave irradiation.205 As such we 
endeavoured to use microwave heating where it was practical to do so.  
Our first attempt at effecting the rearrangement of the ether (2.51) saw it undergo 
microwave heating in toluene at 150 °C (scheme 2.38). This returned only starting 
material though we were aware that the temperature of this reaction was at the low end 
of the range of effective temperatures for aromatic Claisen rearrangements.206 One 
disadvantage to microwave methodology was that non-polar solvents such as toluene 
are very poor microwave absorbers, this gave toluene (and similarly apolar solvents) an 
effective maximum temperature of 150 °C with the equipment available.  
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O
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Br
a or b
(2.51) (2.52)  
Scheme 2.38 : Reagents and Conditions: (a) Toluene, 150 °C, MW, 6 hrs; (b) DMSO, 210 °C, MW. 
Wishing to persist with microwave heating our next approach was to use a higher 
boiling, polar solvent which would be a better microwave absorber. DMSO seemed to 
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meet these requirements, however heating this mixture at 210 °C was found to result in 
explosive decomposition and as such DMSO was quickly abandoned as a solvent. 
With our generic conditions proving ineffectual, a further examination of the literature 
was carried out; Khan et al. recorded the transformation of a similarly substituted 2-
bromoallyl ether by heating the substrate in refluxing mesitylene.207 When the acetonide 
(2.51) was heated under similar conditions (scheme 2.39) we were delighted to see a 
promising new spot by TLC, the product isolated however was not the product of a 
Claisen rearrangement but the unforeseen mesityl adduct (2.70).  
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Scheme 2.39 : Reagents and Conditions: (a) Mesitylene, reflux, 24 hrs (78%).  
There was some initial uncertainty about the mechanism of this transformation; though 
the product appeared to be the result of a nucleophilic displacement at the benzyl 
position of the acetonide (scheme 2.40) there was little evidence of mesitylene acting as 
a nucleophile in the absence of a Lewis acid-activated electrophile and nor did the 
sterics seem particularly favourable. 
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Scheme 2.40 : Proposed mechanism for the addition of mesitylene to acetonide (2.51). 
We were reminded of the work of Boeckman and Perni who through the course of their 
work on the synthesis of ikarugamycin (scheme 2.41) developed a novel 
macrolactamisation method that worked through the thermally induced extrusion of 
acetone from the acetonide (2.73).208 The resulting β-ketoketene (2.74) is rapidly 
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attacked in an intramolecular addition of the hindered secondary amine to give the 
macrocycle (2.75).  
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Scheme 2.41 : Reagents and Conditions: (a) Toluene, 110 °C, 5 hrs (80%). 
This led us to consider whether a similar extrusion of acetone was occurring in the case 
of acetonide (2.51) to generate an analogous enone intermediate. A review of the 
literature revealed a wealth of examples of such enones, and while no such quinone 
methide had been generated from a benzodioxin precursor without acid catalysis there 
was sufficient evidence to suggest it would be entirely reasonable. As such the 
formation of mesitylene adduct (2.70) was explained by the acetonide (2.51) undergoing 
a thermal retro-hetero-Diels-Alder reaction releasing acetone and generating the 
quinone methide intermediate (2.76) in situ (scheme 2.42). This highly reactive 
intermediate would be sufficiently electrophilic to add to the aromatic ring of a solvent 
molecule, rearomatisation of the intermediate adduct (2.72) would give the observed 
product. 
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Scheme 2.42 : Revised mechanism for the addition of mesitylene to acetonide (2.51). 
To further explore this mechanism and hopefully confirm our suspicions an NMR study 
was conducted. A sample of the precursor (2.51) was dissolved in toluene-d8 inside a 
sealed NMR tube, it was hoped that by heating this solution and periodically recording 
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its NMR spectrum we might track the progress of the reaction and observe the 
formation and consumption of the enone intermediate. The use of conventional heating 
allowed us to heat the solution to the higher temperatures required for reaction.  
Sadly no intermediates could be identified in the spectra with the starting material 
appearing to steadily decompose upon heating (figure 2.1). However we did observe the 
gradual disappearance of the methyl protons of the acetonide at 1.39 ppm and this was 
coupled with a corresponding increase in intensity of a peak at 1.58 ppm congruent with 
the methyl protons of acetone in toluene-d8. From this information it was also possible 
to gain a qualitative grasp of the rate of reaction at different temperatures, with acetone 
extrusion occurring only relatively slowly below 170 °C.  These data were also 
consistent with a scenario in which the retro-Diels-Alder was occurring as proposed, 
generating acetone. However the reactive enone generated was then unable to react with 
the solvent, the ring of toluene being less electron rich than in trimethylbenzene, the 
very low concentration also precluded dimerisation resulting in thermal degradation of 
the reactive intermediate preventing it being observed in the NMR spectra (scheme 
2.43). This supports the proposal that the extrusion of acetone is a spontaneous 
pericyclic reaction, rather than one initiated by a nucleophilic attack by the solvent. 
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Scheme 2.43 : Reagents and Conditions: (a) See figure 2.1. 
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Figure 2.1 : Sealed tube NMR studies heating (2.51) in toluene-d8. 
(All heating durations are sequential.) 
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2.5.3 Catalysis of the Claisen Rearrangement and Avoiding QM Formation. 
Before we could effect a synthetically useful Claisen rearrangement it would be 
necessary to identify conditions which would achieve the rearrangement in isolation. 
The literature suggested that QM formation from benzyl alcohol precursors tended to 
require higher temperatures than those we were using to effect the rearrangement. Thus 
it was hoped that deprotecting acetal (2.51) to reveal the 1,3-diol would help to prevent 
the thermolytic elimination and inhibit the undesired mode of reactivity. The 
deprotection was achieved by heating the acetonide at reflux in a 50% aqueous AcOH 
solution to give the corresponding ortho-hydroxybenzyl alcohol (2.78) in quantitative 
yield (scheme 2.44). It was rewarding to note that when heated in mesitylene this 
deprotected substrate did not form the mesityl adduct. The reaction was also attempted 
in decalin209 but that too only resulted in decomposition. 
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Scheme 2.44 : Reagents and Conditions: (a) AcOH/H2O (1:1), 60 °C, 2.5 h (quant.); (b) Mesitylene, 
reflux, 24 hrs. 
With our experiments so far failing to deliver any material which had undergone the 
desired Claisen rearrangement irrespective of the troublesome side reactions, we were 
led to consider why the material had proved so reluctant to rearrange when equivalent 
reactions had been carried out successfully by numerous preceding authors. 
The Claisen rearrangement, whilst being relatively simple on paper, presents a far more 
complicated proposition when trying to understand its true mechanism and hence the 
means by which it can be accelerated. The consensus of many years of research seems 
to suggest that the transition state of the rearrangement displays the mixed 
characteristics of a number of different forms (scheme 2.45).210 These are defined by 
whether they are ionic or radical in nature and whether the compound experiences early 
bond making, or early bond breaking. The specific substituent pattern in the precursor 
and the solvent and catalysis conditions in which the reaction is carried out heavily 
affect the dominant form of the transition state and as ever it is the ability of the 
aforementioned to stabilise that transition state that affects the rate of rearrangement.  
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Scheme 2.45 : The complex nature of the Claisen transition state. 
Whilst there is surprisingly little discussion in the literature about substituent effects in 
the aromatic Claisen there was evidence to suggest that the para-alkoxy residue would 
be mildly activating with respect to the Claisen and that the remaining substituents 
should exhibit very little influence.211 With no apparent reason why our substrate should 
be intrinsically less reactive than the literature examples, we were resolved to press on 
with this course and with a great deal of research dedicated to the catalysis of the 
rearrangement we were confident that an appropriate set of conditions would be 
revealed.212 
It was noted that the Claisen rearrangement may be catalysed by Brønsted acids, with 
protonation of the etheric oxygen acting to alter the transition state further towards the 
ion pair structure (2.81) which is stabilised by the acid. Remarkable rate increases have 
been demonstrated by Svanholm et al. using TFA as both solvent and acid catalyst.213 It 
was appreciated that the use of such conditions would risk forming the trifluoroacetate 
ester (2.84), but this ester could be easily removed should the compound undergo the 
much sought after Claisen reaction simultaneously. When acetonide (2.51) or the diol 
(2.78) were stirred in TFA at room temperature only the esterified product (2.83) was 
isolated (scheme 2.46).  
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Scheme 2.46 : Reagents and Conditions: (a) TFA, rt, 3 hrs (97%); (b) TFA, rt, 2 hrs (96%); (c) TFA, 60 
°C, 12 hrs. 
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It is unclear whether this compound resulted from a QM based mechanism, which may 
also be catalysed by the strongly acidic conditions.214 Alternatively a simple 
esterification may have been responsible, the prior deprotection of the acetonide 
precursor being attributable to the 0.5% water present in commercially supplied TFA.215 
Further exposure of the ester (2.83) to TFA at elevated temperature still failed to deliver 
the rearranged product (2.84). 
Lewis acids accelerate the rate of the Claisen rearrangement through a similar 
polarisation of the transition state. Wipf and Ribe found that a methylaluminoxane 
based catalyst generated in situ from trimethylaluminium and water was highly effective 
at catalysing the Claisen at low temperature.214 It was hoped that this would avoid the 
generation of the QM intermediate allowing the Claisen reaction to occur exclusively. 
Exposure of the acetonide (2.51) to the aluminoxane catalyst resulted in a further 
example of a benzyl substituted product (scheme 2.47).  The acid catalyst was able to 
generate the enone (2.76) and then a source of methyl anion from either the mixed 
polymeric aluminoxane or residual AlMe3 was able to add to this system generating the 
ethylphthalide derivative (2.85). The unprotected diol (2.78) displayed no reactivity 
under the same conditions, presumably due to chelation of the catalytic species by the 
1,3-diol. 
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Scheme 2.47 : Reagents and Conditions: (a) AlMe3 (4.5 eq.), H2O (1 eq.), CH2Cl2, -30 °C, 10 mins then 
(2.51) or (2.78) -30 °C to rt overnight (64% from (2.51)). 
Solvent effects have been shown to have a significant effect on the rate of the Claisen 
rearrangement, with the rate of reaction becoming more rapid with an increase in the 
polarity of the reaction solvent due to improved solvation of the polarised transition 
state.211b,215 It was therefore desirable to identify a solvent that was not only polar but 
also sufficiently high boiling to enable access to workable reaction temperatures. 
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N-methylpyrrolidinone was utilised as a Claisen rearrangement solvent by Robertson et 
al. in their synthesis of the 5HT3 antagonist zatosetron.216 Initial results with acetonide 
(2.51) proved promising, with the development of promising peaks in the crude NMR 
spectrum. The reaction profile was very messy though and the mixture proved utterly 
intractable. N,N-diethylaniline shared a number of the same solvent properties and it 
was hoped that its slightly more greasy nature would make separation of products 
easier. It had also been successfully utilised by Baldwin et al. (vide supra, scheme 
2.37).201 When the acetonide was heated at 220 °C for 30 minutes only decomposition 
products were observed (scheme 2.48), however reducing the temperature to 200 °C 
produced a single product in which we observed a sadly familiar addition to the 
benzylic position through the para carbon of the aniline, however the resulting phenol 
(2.87) also exhibited the first example of a successful Claisen rearrangement! 
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Scheme 2.48 : Reagents and Conditions: (a) N-Methylpyrrolidone, 220 °C, MW, 1 hr (no yield); (b)  N,N-
Diethylaniline, 220 °C, MW, 30 mins (no yield);  (c) N,N-Diethylaniline, 200 °C, MW, 30 mins (44%). 
Optimistic that we could avoid the addition of the aniline we subjected the deprotected 
Claisen precursor (2.78) to the same reaction conditions with the hope that the diol 
would prove more resistant to enone formation. To our dismay the same product aniline 
(2.87) resulted. This may reasonably be explained as the result of base catalysis, with 
the aniline able to catalyse the extrusion of hydroxide anion under the basic reaction 
conditions (scheme 2.49).  
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Scheme 2.49 : Reagents and Conditions: (a) N,N-Diethylaniline, 200 °C, MW, 30 mins (50%). 
Studies Toward a Total Synthesis of Lactonamycin                                                 Results and Discussion 
132 
The decision to show the Claisen rearrangement occurring after formation of the QM is 
arbitrary, with no evidence gathered from the crude NMR to suggest which process 
occurs first. 
More polar solvents appeared to be the key to success. Extensive research has been 
conducted on the use of water as a medium for organic reactions.203b,217 Most recently 
this has been driven by a desire to develop more environmentally friendly chemistry; 
water is non-toxic, abundant, cheap and safe to dispose of and reaction products are 
often readily separated from it. It is a particularly useful solvent in combination with 
microwave technology as not only is it an exceptional microwave absorber, but at 
temperatures above its atmospheric boiling point its solvent properties become more 
compatible with organic substrates. As temperature increases the angle of the H-O-H 
bonds increases, this results in a decrease in the dipole moment. The result of this is that 
at 150 °C the dielectric constant of water  is roughly equal to that of MeCN at room 
temperature.203c Most importantly water has been shown to offer some of the greatest 
solvent derived rate increases for the Claisen rearrangement, this is derived through a 
combination of hydrophobic effects and as a result of preferential transition state 
solvation.218 Also significant is the fact that if the rearrangement were accompanied by a 
concomitant formation of the QM, the water adduct would simply restore the diol 
functionality nullifying the effect of that side reaction (scheme 2.50). Heating ether 
(2.51) in water at 140 °C returned only a black insoluble tar, lowering the temperature 
produced the same results down to 80 °C below which only starting material was 
returned. 
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Scheme 2.50 : Reagents and Conditions: (a) H2O, 80-140 °C, MW, 10 min. 
With the 1,3-diol (2.78) also able to form the undesired QM intermediate we were still 
unable to isolate the rearranged product without simultaneously introducing some 
undesired substituent at the benzyl position. However by oxidising the benzyl alcohol 
(2.78) to the benzaldehyde (2.89) it was hoped we may finally be able to prevent such 
side reactions. Exposure of the alcohol to a large excess of activated manganese dioxide 
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in acetone on a small scale gave the desired aldehyde in respectable yield (72%) 
(scheme 2.51). This aldehyde had a high affinity for the manganese dioxide and a large 
amount of solvent was required to rinse the product off the solid residue of the reaction. 
Trouble encountered later in the synthesis (vide infra, scheme 2.57 & 2.58) required that 
the product be extensively purified and this had a detrimental effect on yields. 
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Scheme 2.51 : Reagents and Conditions: (a) MnO2 (10 eq.), acetone, rt, 3 hrs (54-72%). 
The benzaldehyde (2.89) was first exposed to a Lewis acid based protocol.219 We had 
hoped to compensate for the coordinating effect of the oxygen functionality by utilising 
a large excess of Lewis acid, however treatment with 20 equivalents of boron trichloride 
at room temperature returned only starting material (scheme 2.52). The diol and 
acetonide also failed to rearrange under these conditions with the diol proving 
completely inert and the acetonide being deprotected. 
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Scheme 2.52 : Reagents and Conditions: (a) BCl3, 1M in CH2Cl2 (20 eq.), rt, 12 hrs; (b) N,N-
Diethylaniline, 200 °C, MW, 30 mins; (c) N,N-Diethylaniline, 180 °C, MW, 30 mins. 
Heating the benzaldehyde in N,N-diethylaniline as per the previously successful Claisen 
conditions resulted in a complex and inseparable mixture of products and significant 
decomposition at 200 °C. Decreasing the reaction temperature to 180 °C would produce the 
same result, this may be a result of Cannizzaro type chemistry affecting the benzaldehyde 
(given the basicity of the aniline) or may simply have been related to the inherent thermal 
instability of phenolic aldehydes at elevated temperatures.220 
With heating in high-boiling, polar solvents so far the only conditions shown to be 
effective as far as enacting the rearrangement was concerned we selected a number of 
other suitable solvents. The first of these to be tried was benzyl alcohol, which would 
also be non-basic, enhancing compatibility with the benzaldehyde. To preserve material 
the method was first examined by using the acetonide (2.51). Heating at 180 °C gave 
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the anticipated benzyl adduct, but the product also exhibited a successful rearrangement 
giving the hydroquinone (2.91a) (scheme 2.53). 
O
OO
O
O
OOH
OH
O
Br Br(2.51) (2.91a)
a O
 
Scheme 2.53 : Reagents and Conditions: (a) BnOH, 180 °C, MW, 15 mins (64%). 
As well as providing a second example of a successful rearrangement this product 
offered significantly more potential than we had anticipated. With the oxygen 
functionality at the benzyl position having been retained (albeit concealed as the benzyl 
ether), removal of the benzyl group would restore the alcohol allowing the synthesis to 
proceed much as previously intended (vide supra, scheme 2.27). 
The deprotection would not be trivial however, given the wide range of other 
functionality present in ether (2.91a) and the fact that the system as a whole is more 
accurately viewed as a hetero benzyl ether, meaning any deprotection would be in 
danger of cleaving the wrong side of the ether bond to reveal the simple benzyl alcohol, 
degrading our desired substrate in the process. 
Benzyl deprotection is commonly carried out by hydrogenolysis but this course would 
likely prove incompatible with the presence of the alkene.191a An acid mediated 
deprotection may also prove incompatible with the allyl moiety and achieving 
selectivity in cleaving the correct side of the ether may prove challenging. Especially 
considering the potential for direction by coordination from the adjacent oxygen 
functionality in the more developed ring. 
The most promising approach would appear to be to cleave the ether oxidatively. Whilst 
this approach would also involve a competitive oxidation of the two benzyl groups, the 
relative rates are significantly altered by the electronic configuration of the aromatic 
rings. The oxidative removal of benzyl ethers with DDQ has been studied in some depth 
by Yonemitsu et al.221 and specifically the relative rates of oxidation of different 
methoxy substituted benzyl groups.222 The mechanism of the oxidation (scheme 2.54) 
involves the formation of the benzyl cation (2.93) and it is primarily the ability of the 
ring substituents to stabilise this charge that determines the rate of reaction. 
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Scheme 2.54 : Mechanism of oxidative benzyl ether cleavage. 
Therefore, if we were to consider the phthalide side of ether (2.91a) as a simple 2,5-
dimethoxybenzyl moiety (the phenols would need to be protected as their methyl ethers 
to inhibit oxidation of the ring to the quinone) then it would seem likely that oxidative 
cleavage would favour the generation of the benzaldehyde (1.427) (scheme 2.55). This 
would conveniently deliver the key intermediate with a decreased step count relative to 
the original scheme. Should the real system prove less labile than the simplified system, 
possibly due to the electron withdrawing carbonyl ortho to the methoxy group, or if the 
para-dimethoxy system were still prone to ring oxidation adjustments could be made to 
invert the selectivity of the oxidation, by using an alternate, electron rich benzyl alcohol 
such as 4-methoxybenzyl alcohol (2.98b)221a or 3,4-dimethoxybenzyl alcohol (2.98c)221b 
as the Claisen solvent, the appropriately substituted ethers (2.99b) & (2.99c) could be 
produced. Both of these ethers would undergo oxidation much more rapidly than either 
the unsubstituted benzyl moiety, or the highly substituted benzyl group, the benzyl 
alcohol (2.100) would result in both cases. This inverted oxidation would require a 
separate oxidation step to deliver the benzaldehyde (1.427) though this should be 
relatively straightforward. 
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Scheme 2.55 : Reagents and Conditions: (a) Tandem Claisen, QM formation/addition sequence with 
(2.98a) R = Bn, (2.98b) R = PMB or (2.98c) R = PMB; (b) Methylation; (c) Selective oxidative cleavage of 
the benzyl ether with DDQ. 
This direction appeared promising, but whilst its merits were still being evaluated we 
decided to attempt one further experiment with the goal of effecting a Claisen 
rearrangement without side reactions. With the rearrangement in benzyl alcohol 
successful we were confident that it would be repeated with the benzaldehyde precursor 
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(2.89) given that the neutral alcohol should not display the incompatibility associated 
with the basic aniline. Heating the benzaldehyde in benzyl alcohol (scheme 2.56) finally 
delivered the rearranged product (2.90) with all the other functionality intact. This result 
was a great relief after so much time had been invested in delivering this key 
intermediate. This initial reaction was also relatively high-yielding.  
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Scheme 2.56 : Reagents and Conditions: (a) BnOH, 180 °C, MW, 15 mins (0-72%). 
This result led to the abandonment of the work proposed in scheme 2.55, with the 
planned chemistry seeming a safer prospect. Unfortunately this success was achieved 
with the last of a batch of the precursor and such positive results would not be observed 
when attempting to repeat this reaction. Subsequent batches of the benzaldehyde (2.89) 
resulted in extremely capricious results when the rearrangement was attempted. Results 
included rapid and complete decomposition, extremely slow reactions giving <5% 
conversion after extended periods of heating and abnormal reaction products. These 
abnormal products included the benzofuran (2.102), arising as the result of a cyclisation 
of the rearranged product (2.90) (scheme 2.57). This is a known side reaction of the 
Claisen rearrangement223 though it had not been produced at any detectable level in the 
original attempt at this reaction. 
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Scheme 2.57 : Mechanism for the formation of tricyclic by-product (2.102). 
A further abnormal result came in the form of the benzyl ether (2.91a) the product of an 
apparent reductive etherification (scheme 2.58).  
O
OOH
O
O
OOH
OH
O
Br Br(2.89) (2.91a)
a O
 
Scheme 2.58 : Reagents and Conditions: (a) BnOH, 180 °C, MW, 30 mins (12%). 
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Initially there was evidence to suggest that these effects may have occurred as the result 
of contamination with manganese residues from the preceding oxidation step, with 
apparent paramagnetic line broadening present in the NMR spectrum. This broadening 
had not been observed when the material was prepared on a smaller scale and purified 
by recrystallisation. The presence of acidic metal ions may be consistent with the acid 
catalysed formation of tricycle (2.102). There is also some precedent for transition metal 
catalysed reductive etherifications, though they have all required an external hydride 
source, commonly a silane.224  However the formation of tricycle (2.102) may also be 
base catalysed219 and a base catalysed Cannizzaro reaction could produce diol (2.78) 
which might reasonably produce the benzyl ether (2.91a) through a QM addition 
sequence. 
Column chromatography of the SM removed the line broadening but failed to remedy 
the inconsistent reactivity of the material. To further purify the material it was stirred 
with activated charcoal under acidic conditions, with the intention of removing any 
trace impurities and to ensure the phenol was present in its protonated form. This 
protocol reversed the trend in reactivity (though neither charcoal nor acid was effective 
separately) and allowed the consistent formation of the Claisen product (2.90). The 
reaction was never restored to its original high yield however and all subsequent 
attempts produced yields of 20-25%. 
Working on the hypothesis that the difficulties experienced and the continuing low 
yields were the result of manganese residues retained due to chelation through the 
extensive oxygen functionality in benzaldehyde (2.89) and/or due to acid catalysed 
processes resulting from the acidity of the highly conjugated phenol, it was thought that 
a minor adjustment to the substrate would remedy the problem. Protection of the free 
phenol would remove the acidic proton and prevent the oxygen chelating as the 
phenolate. This would also have the added benefit of removing the thermally unstable 
ortho-formyl phenol unit. 
We hoped to perform a straightforward methylation of the phenol, however due to the 
extensive delocalisation possible in the corresponding alkoxide (2.104) (scheme 2.59) 
this would prove challenging. 
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Scheme 2.59 : Canonical forms of the alkoxide (2.104). 
Standard phenol methylation conditions utilising methyl iodide as the methylating agent 
resulted in gradual decomposition of material with none of the desired methyl ether 
produced (scheme 2.60).225 Moving to the more reactive dimethyl sulfate failed to 
deliver any improvement. The anion (2.104) appeared to be insufficiently nucleophilic 
to attack the methylating agent before decomposing due to the presence of the base. 
Switching to the more reactive trimethyloxonium tetrafluoroborate combined with 
Hünig's base gave a very limited yield of the desired methyl ether (2.106) amongst the 
decomposition products.226 The apparent key to this reaction was to treat the highly 
acidic phenol as if it were a carboxylic acid, accordingly a methylation protocol using 
trimethylsilyldiazomethane in a mixed solvent system of methanol and toluene proved 
very effective.227 On a small scale the reaction with phenol (2.89) was near quantitative, 
however upon scale up the reaction was found to stall at around 50-60% conversion, 
though the starting material was easily recovered. Slowing the rate of addition produced 
no discernible benefit and increasing the number of equivalents of TMSCHN2 resulted 
in some decomposition of residual starting material.  
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Scheme 2.60 : Reagents and Conditions: (a) See table below. 
Reagent Equivalents Conditions Result 
MeI 10 K2CO3, Acetone, Reflux, 8 hr. decomp 
Me2SO4 10 K2CO3, Acetone, Reflux, 12 hr. decomp 
[Me3O]+[BF4]- 1.1 DIPEA, CH2Cl2, rt, 12 hr. 12% 
TMSCN2 1.2 Toluene/MeOH (3:2), rt, 10 mins. 97%a,b 
TMSCN2 1.2 Toluene/MeOH (3:2), rt, 30 mins. 96%a,c 
TMSCN2 1.5 Toluene/MeOH (3:2), rt, 10 mins. 81%a 
a Figure based on recovered starting material; b 55% isolated yield of (2.106); c 52% isolated yield of (2.106). 
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When heated in diethylaniline the methyl ether (2.106) was entirely decomposed 
(scheme 2.61) giving credence to the aforementioned hypothesis that decomposition 
was occurring via a Cannizzaro type reaction at the aldehyde. Heating in benzyl alcohol 
instead also gave no evidence of the Claisen reaction, with the starting material instead 
being slowly converted to an unidentified by-product.  
Finally, methyl ether (2.106) was heated in a mixed solvent system of TFE and water 
with the hope that this more polar solvent system may accelerate the rate of the Claisen 
rearrangement relative to the rate of the by-product formation.228 Sadly whilst some of 
the crude NMR data for this experiment looked promising, the low-boiling point of the 
solvent system meant the highest attainable temperature was between 164-166 °C in the 
microwave before the pressure limit was reached extending the reaction time 
significantly and resulting in substantial decomposition of the material. 
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Scheme 2.61 : Reagents and Conditions: (a) BnOH, 180 °C, MW, 2 hrs; (b) N,N-Diethylaniline, 200 °C, 
MW, 15 mins; (c) TFE/H2O (4:1), 165 °C, MW. 
2.5.4 Conclusions Regarding Capricious Claisen Rearrangements. 
Effecting this deceptively simple Claisen rearrangement was far more challenging than 
anticipated, proving to be something of a case study on the unpredictability of high 
temperature chemistry. Whilst a number of the side-reactions proved to be of some 
academic interest, the ongoing synthesis of lactonamycin became mired in this 
unproductive chemistry for much longer than we would have wished resulting in a real 
dearth of material for the ongoing synthesis. All the precursors we employed proved to 
be less thermally stable than anticipated due to the broad range of functionality present. 
This resulted in a situation where there was a need to strike a fine balance between a 
temperature that was sufficient to effect the rearrangement whilst at the same time not 
being so high as to lead to decomposition and/or side reactions. Frequently this was 
simply not possible.   
The acetonide precursor (2.51) was highly prone to thermolysis of the benzodioxin 
moiety resulting in QM formation and the clean introduction of benzyl substituents with 
all but the most non-nucleophilic solvents where it was observed to slowly degrade. 
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Exposure of the phenol through this side reaction also appeared to have a catalytic effect 
on the Claisen rearrangement and with an appropriate polar solvent this system would 
also undergo the desired rearrangement in good yield. The rate of QM formation always 
appeared to be higher than that of the Claisen and all catalysts of the Claisen also 
catalysed the QM formation preventing us from performing the Claisen rearrangement 
alone. The chemistry of the diol (2.78) was similar, though QM formation was less 
facile requiring acid or base catalysis to occur.   
The chemistry of the aldehyde (2.89) proved to be dominated by the reactivity of the 
highly conjugated phenol. It provided a notable catalytic effect allowing for rapid and 
occasionally efficient rearrangement in benzyl alcohol. However whilst the phenolic 
aldehyde prevented the formation of the QM intermediates that plagued the preceding 
precursors, it rendered the molecule liable to decomposition, being readily decomposed 
thermally and even more readily in the presence of base. Furthermore it exhibited 
capricious reactivity when trying to effect the Claisen rearrangement with a number of 
possible explanations. The low yield and reliability of the rearrangement poses a real 
challenge in the ongoing synthesis.  
That the methylated precursor (2.106) should rearrange less readily than the phenolic 
precursor is unsurprising without the acidic phenol acting as an internal catalyst. The 
methylated precursor exhibited increased stability over its predecessor, though the 
aldehyde was still base sensitive. Reactivity in the absence of the acidic phenol was 
attenuated accordingly and this attenuation was such that the rate of decomposition was 
always higher than the rate of rearrangement, preventing this compound being of any 
great synthetic use.  
2.6 Quinone Methide Methodology. 
2.6.1 Benzodioxins as Quinone Methide Precursors. 
While the generation of quinone methide intermediates was an unfortunate and 
unwelcome side reaction in many of our attempts to effect the Claisen rearrangement, it 
was not lost on us that there is a great deal of potential in developing new methods for 
the utilisation of those same reactive intermediates. Whilst there are a handful of 
examples of benzodioxin QM precursors noted in the literature, none of these have been 
utilised in as straightforward a manner as we had serendipitously achieved. 
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Chumachenko et al. demonstrated an acid catalysed means of generating the highly 
stabilised and isolable quinone methides (2.109a)-(2.109c) from the acetonides 
(2.108a)-(2.108c) using HCl in AcOH at elevated temperature (scheme 2.62).229 
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Scheme 2.62 : Reagents and Conditions: (a) HCl, AcOH, 110 °C, 20 mins (a = 88%, b = 86%, c = 66%). 
Lhomme et al.230 used even harsher acidic conditions to generate the unstabilised QM 
(2.111) from the methylene acetal (2.110) which underwent nucleophilic attack by 
AcOH and subsequent in situ acylation of the resulting phenol (scheme 2.63). 
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Scheme 2.63 : Reagents and Conditions: (a) Ac2O, AcOH, MsOH, 70 °C, 9 hrs (75%). 
Wang et al. demonstrated the use of acetals as photolabile protecting groups, photolysis 
of the general benzodioxin (2.113) was used to reveal the corresponding ketone (2.114) 
generating the QM (2.115) as a by-product (scheme 2.64).231 Extending this work to 
precursors where the phenyl groups at the benzyl position are absent the reaction 
proceeded more slowly and in the absence of the methoxy group on the ring the reaction 
failed entirely.232 
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Scheme 2.64 : Reagents and Conditions: (a) hν, MeCN, 40-80 mins (74-90% of (2.114)). 
The reactions we had observed thus far fell into two broad categories (scheme 2.65), 
those that were acid catalysed and occurred at relatively low temperature, such as the 
reactions with TFA and MAO and those that were initiated by a purely thermal process, 
without the need for further catalysis as observed with the additions of benzyl alcohol, 
mesitylene and N,N-diethylaniline. It was this latter class of reactions that were of 
particular interest, as no previous examples of the uncatalysed reaction have been noted 
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in the literature. The method of carrying these reactions out was straightforward and 
with the broad range of nucleophile compatibility associated with a thermal approach 
there was potential for the development of a synthetically useful method. 
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Scheme 2.65 : Reagents and Conditions: See table below. 
Reagent Conditions Result Yield (%) 
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MAO CH2Cl2, -30 °C to rt, overnight. O
OOH
O
Br (2.85)  
64 
 
2.6.2 Model Quinone Methide Addition Reactions. 
The simple model benzodioxin (2.120) was prepared from salicyl alcohol (1.491) by 
stirring with 2,2-dimethoxypropane in acetone with catalytic acid (scheme 2.66). This 
model would allow us to repeat the QM formations in isolation and expand upon the 
examples already discussed. It would also serve as a model for the introduction of a 
methoxy-substituted benzyl ether should that prove desirable in the synthesis of 
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lactonamycin (vide supra, scheme 2.55). This model was heated with an excess of 
various high-boiling, nucleophilic reactants, with that reactant also serving as the 
reaction solvent (0.65 mL of solvent was used per mmol of benzodioxin (2.120) as 
standard). Reactions were followed by crude NMR and considered complete when all 
the starting material has been consumed. 
OH OH
a
(1.491)
O O
b
OH
R
O
(2.120) (1.461) (2.121)  
Scheme 2.66 : Reagents and Conditions: (a) 2,2-Dimethoxypropane (5 eq.), pTSA (cat.), acetone, rt, 2 
days (83%); (b) See table below. 
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The results were very satisfying, with the analogous benzyl alcohol and aniline 
additions successfully repeated and a number of new nucleophilic adducts formed in 
good yield. Only the mesitylene reaction failed to provide the anticipated product. 
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Importantly the substituted benzyl alcohol (2.122) displayed the same reactivity as the 
unadorned version. The reactions were high yielding, though in the case of the 
nitrogenous solvents there was a small amount of decomposition noted (presumably 
base induced), which led to somewhat lower yields in those instances. 
There were noticeable variations in the rates of reactions between the different solvents. 
The reaction times would seem to suggest that addition of the nucleophile to the QM 
was not the rate determining step, if it were we would expect to see shorter reaction 
times associated with the more nucleophilic solvents such as methylpiperazine and 
morpholine especially compared to weak nucleophiles such as dimethylaniline. These 
results were consistent with the observations of Ohwada et al. who studied the 
formation of QM’s from benzoaxazines which also occurs via a retro-Diels-Alder 
mechanism (scheme 2.67).233 They noted that it was always the formation of the QM 
that was rate determining and that the primary factors in deciding this rate were the 
substitution pattern of the QM precursor and the polarity of the solvent. Both of these 
effects are explained if the formation of the QM goes through the highly polarised 
transition state (2.134), with more effective solvation of the transition state lowering the 
activation energy. We can envision a similar structure for the acetonide transition state 
(2.136).  
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Scheme 2.67 : A highly polarised transition state in the formation of QMs. 
When the reaction times of our reactions were compared with the polarity of the 
corresponding solvents (measured as the molecular dipole moment) in the case of 
additions to benzodioxin (2.120) (figure 2.2) the same trend was readily apparent, with 
the faster reaction times correlating with increased polarity. The main exception to this 
trend was thiophenol which exhibited a significantly faster rate than its polarity would 
suggest, however Ohwada’s results included only aprotic solvents therefore given the 
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acidity of the thiol proton of thiophenol (pKa = 6.51)234  we attributed this acceleration 
to acid catalysis of the QM formation step.  
Solvent Reaction time (mins) Dipole moment (D) 
 
Benzyl Alcohol 30 1.67c, [235] 
N,N-Dimethylaniline 240 1.59d, [236] 
Morpholine 720 1.48d, [237] 
Thiophenol  360 a 1.33c, [238] 
N-Methylpiperazine 600 1.14c, [239] 
Mesitylene --- b 0.10c, [240] 
a Extrapolated to 180 °C for comparison; b No conversion detected by crude NMR after 12 hrs at reflux;  
c Measured at 25 °C in benzene; d Measured at 20 °C in benzene.  
Figure 2.2 : Comparison of reaction time and solvent polarity in QM addition reactions. 
Substituent effects are also a pertinent point to consider in trying to explain the failure 
to repeat the formation of a mesityl adduct in the model system when the solvent system 
and temperature remained constant. Where the substituents in a system are such that 
they are able to stabilise the developing positive charge at the benzyl position in the 
transition state, as well as being able to stabilise the same positive charge in the 
zwitterionic resonance form of the QM (2.137) formation of the QM will be more rapid.  
The model system contains no substituents, but the Claisen precursor has three, the 
allyloxy residue which is strongly electron donating, the methylene of the lactone which 
is weakly electron donating and the carbonyl of the lactone which is strongly electron 
withdrawing. Rokita et al. have demonstrated that the presence of a methoxy substituent 
meta to the benzyl position can lead to a 10-fold increase in the rate of QM formation 
relative to the hydrogen bearing equivalent, the suppressive effect of a similarly 
positioned ester was much less substantial.241 The reactivity of the more complex 
benzodioxin (2.51) is therefore likely to be dominated by the alkyloxy residue resulting 
in a more reactive substrate than model (2.120). The mesitylene reaction was carried out 
at the lowest temperature due to the low boiling point of the solvent (165 °C) and its 
poor microwave absorption and as such represented a borderline case as far as 
temperature was concerned. 
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2.7 Development of Side-Chain Insertion Methodology. 
2.7.1 The Need for a New Propynoic Acid. 
In all previous cyclisations Board had utilised the trimethylsilylpropynoate residue to 
produce a cyclised product bearing a trimethylsilyl group, his unsuccessful attempts at 
trying to oxidise this silyl residue made it clear that this particular silane was unsuitable 
for a full synthesis of lactonamycin via the planned Fleming-Tamao chemistry (vide 
supra, scheme 1.90). The mechanism of both Fleming and Tamao oxidations requires 
the nucleophilic attack of a peroxide on silicon (scheme 2.68), for this to occur it is 
therefore necessary for there to be one or more suitable leaving groups on silicon. 
Tamao et al. utilised silyl chlorides, fluorides and hydrides as well as siloxy, alkoxy and 
silanamine derivatives to this end.103d Whilst all these activated silanes allowed for 
efficient and high-yielding conversion of the silyl residue to the corresponding alcohol 
they are more challenging to produce and more reactive than the corresponding all 
carbon silanes limiting their appeal as masked hydroxyl groups. 
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Scheme 2.68 : Mechanism of the Tamao oxidation. 
Fleming developed an alternate protocol (in parallel), utilising an aryl silane.104a The all 
carbon dimethylphenylsilane employed benefited from much decreased lability relative 
to the silanes employed by Tamao et al., increasing the utility of this group in more 
elaborate syntheses. Conversion of the silane to the alcohol could still be achieved by 
protodesilylation of the aromatic ring. When Fleming performed this transformation 
with fluoroboric acid, benzene and a silyl fluoride (2.144) resulted (scheme 2.69). This 
fluoride would then undergo oxidation with a peracid to give the alcohol (2.141). This 
concept was subsequently extended to include a number of one-pot procedures, where 
the activated silane is formed in situ.104e,242 A wide range of alternative all carbon 
silanes have subsequently been developed.103e,243 
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Scheme 2.69 : Fleming et al.’s conversion of DMPS to a reactive silyl fluoride.   
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As well as acting as a masked hydroxyl group, the silyl residue has been shown to play 
an important role in stabilising the intermediate radical formed at the α-carbon during 
Parsons, Board, Waters type cyclisations.83b This made it crucial that not only should it 
be possible to efficiently reveal the alcohol, but also that the silane should be 
electronically similar to the trimethylsilane that had already been proven efficacious. 
The substitution of trimethylsilane with dimethylphenylsilane was therefore proposed. 
2.7.2 Synthesis of Dimethylphenylpropynoic Acid (2.145). 
We had intended to synthesise the required DMPS propynoic acid (2.143) in a fashion 
analogous to Board’s synthesis of the TMS equivalent (vide supra, scheme 1.71). The 
acid would be prepared from the silane (2.146) by deprotonation followed by quenching 
with carbon dioxide (scheme 2.70). Unlike trimethylsilylacetylene the 
dimethylphenylsilane was not commercially available however so this would first need 
to be prepared. Fortunately both the intermediate silane and the acid were reported in 
the literature, but the procedure for formation of the silane was poorly described. As 
such work was carried out to establish the optimum conditions for its formation. 
(2.147)(2.145) (2.146)
Si
Me
Me
XSi
Me
Me
Si
Me
Me OH
O
  
Scheme 2.70 : Retrosynthesis of the modified propynoic acid. 
The silane was invariably prepared from silyl chloride (2.148) and methods were 
published by a number of authors.244 The majority of authors opted to form the lithiate 
or the Grignard of acetylene in situ, necessitating the careful measuring and handling of 
acetylene gas but Hasegawa et al.244a demonstrated the use of commercially available 
ethynylmagnesium bromide solution with some success. This approach was adopted for 
its convenience. Unfortunately Hasegawa et al. failed to report the number of 
equivalents of silyl chloride employed in their method. Investigation however revealed 
that 1.0 equivalent provided the optimum yield from this reaction (scheme 2.71). 
(2.148) (2.146)
a
Si
Me
Me
Cl Si
Me
Me
BrMg
(2.149)
 
Scheme 2.71 : Reagents and Conditions: (a) See table below. 
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Equivalents (2.146) Conditionsa Yield (2.144) (%)b 
0.9 0.5 M (2.149) in THF, THF, 0 °C to rt, 24 hrs. 71 
1.0 0.5 M (2.149) in THF, THF, 0 °C to rt, 24 hrs. 81 
1.1 0.5 M (2.149) in THF, THF, 0 °C to rt, 24 hrs. 75 
5.0 0.5 M (2.149) in THF, THF, 0 °C to rt, 24 hrs. 76 
a All aliquots of Grignard reagent were from the same bottle, the concentration was verified by titration with 
phenanthroline and sBuOH [245]; b Isolated Yield. 
Fleming et al.246 reported that the propynoic acid (2.143) was prepared by the formation 
of the alkynyl Grignard reagent with methylmagnesium chloride solution in THF 
followed by the addition of gaseous carbon dioxide. Following this procedure but using 
commercially available methylmagnesium bromide solution to form Grignard reagent 
(2.148) and then quenching the mixture over solid carbon dioxide provided the desired 
product in comparable yield (scheme 2.72). 
(2.150)(2.146)
Si
Me
Me
Si
Me
Me OH
Oa b
Si
Me
Me
MgBr
(2.145)  
Scheme 2.72 : Reagents and Conditions: (a) 3M MeMgBr in THF, 0 °C to rt, 2 hrs; (b) CO2(s), rt, 1 hr 
(79%). 
2.7.3 Synthesis of Triisopropyl-N-methyl-N-(prop-2-ynyl)silanamine 
(2.154). 
Throughout his studies Board had used the Boc-protected N-methylpropargylamine 
(1.388) prepared according to the method of Jacobson et al. (vide supra, scheme 
1.74).247 The lithiate of this amine would then be added to the chosen benzaldehyde  and 
the resulting Boc-protected adduct would require deprotection with HCl before the 
amine could be coupled with the propynoic acid residue (scheme 2.73).  
O
R
OH
R
Boc
N
Me
OH
R
H.HCl
N
Mea
b
Boc
N
Me
(2.151)
(1.388)
(2.152) (2.153)  
Scheme 2.73 : Reagents and Conditions: (a) (1.388), nBuLi then (2.151) then tBuBr, THF,  -100 °C; (b) 
HCl, Et2O.  
There was some suggestion in Board’s work that this deprotection could be problematic, 
leading at one point to an abandonment of such a route. Those difficulties were later 
resolved however and the Boc protection/deprotection sequence became the standard 
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method of introducing the amine side chain section. Upon expanding this method to a 
wider range of substrates however Faggiani found that the results of this sequence were 
rather unreliable, with the deprotection proving to be a recurring problem. The search 
for a more labile protecting group led to the preparation of the silyl protected amine 
(2.154). The TIPS-protected amine underwent addition to various benzaldehydes 
(2.151) in comparable yields to the Boc-protected variant (scheme 2.74), the relatively 
weak N-Si bond in the resulting alcohols (2.155) could then be reliably cleaved with 
aqueous hydrogen fluoride to give the free amine after treatment with basic resin during 
workup.82 
O
R
OH
R
TIPS
N
Me
OH
R
H
N
Mea
b
TIPS
N
Me
(2.151)
(2.154)
(2.155) (2.156)  
Scheme 2.74 : Reagents and Conditions: a) (2.154), 2.5M nBuLi in hexanes, THF, -78 °C to -20 °C, 30 
min then (2.151), THF, -78 °C to rt, 30 min; (b) HF (40% wt. in H2O), MeCN, rt, 10min. 
Given the apparent efficacy of this modified methodology the Boc-protected amine was 
abandoned in favour of the silylamine. Accordingly we prepared the N-methyl-N-
triisopropylpropargylamine (2.154) by the same method as Faggiani using the silyl 
triflate with triethylamine to give the protected amine in excellent yield (scheme 2.75).  
(1.372)
aH
N
Me
TIPS
N
Me
(2.154)  
Scheme 2.75 : Reagents and Conditions: (a) TIPSOTf (1.05 eq.), NEt3 (1.5 eq.), CH2Cl2, 0 °C to rt, 16 
hrs (88%).  
2.8 Post-Claisen Chemistry. 
2.8.1 A Postponement of the Claisen Rearrangement.  
Given the lack of a reliable supply of material from the Claisen rearrangement we were 
still very much open to alternate routes. Along this line we elected to pursue a 
somewhat more outlandish sequence, alongside that we had planned. This route would 
utilise what material remained of the methylated precursor (2.106) and would further 
delay work on the Claisen until a later point in the synthesis.  
It was proposed that we would form the Parsons, Board, Waters cyclisation precursor 
(2.160) in which the Claisen had yet to be carried out (scheme 2.76). Heating the 
enediyne at 180 °C would then hopefully effect both the Claisen rearrangement and 
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Parsons, Board, Waters cyclisations in sequence to give pentacyclic lactone (2.161), 
however any identified product from this reaction would be of interest in terms of the 
mechanism of the PBW reaction. 
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O
OH
Br (2.157)
O
OOMe
O
OH
Br (2.158)
b
O
OOMe
O
O
Br (2.106)
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Me
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d
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N
Me
(2.154)
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Me
Me Cl
O
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Scheme 2.76 : Reagents and Conditions: (a) Addition of lithiate of (2.154); (b) Silyl deprotection with HF; 
(c) Amide formation with acid chloride (2.159); (d) Tandem Claisen rearrangement / Parsons, Board, 
Waters cyclisation. 
This chemistry would also be a valuable opportunity to test side chain incorporation 
methodology developed by Faggiani. Due to the presence of the lactone there was some 
concern about the issue of selectivity of the nucleophilic lithiate insertion and it would 
be beneficial to establish whether this would necessitate a more cautious addition 
procedure. Upon following the method outlined below these fears proved to be 
needless, with the lactone surviving intact.  
It would still prove necessary to modify the original procedure (vide supra, scheme 
2.74) however. That protocol utilised an excess of the benzaldehyde to ensure all the 
amine was consumed. The residual aldehyde was then separated from the product by 
formation of the sodium bisulfite adduct. This way the silyl-protected addition product, 
which was not stable on silica, could be purified without the need for chromatography. 
A small scale test revealed that formation of the bisulfite adduct was particularly 
sluggish in the case of our more complex benzaldehyde (2.106) leaving us doubtful this 
procedure would prove effective. 
When the benzaldehyde was treated with the lithiate of amine (2.154) the reaction was 
found not to go to completion, leaving an excess of silylamine after workup (scheme 
2.77). Fortunately it proved possible to purify the adduct (2.157) from the unreacted 
starting materials by careful recrystallisation from diethyl ether/hexane though the 
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isolated yield of material was disappointing. The silyl protected adduct was then 
successfully desilylated by stirring in MeCN with an excess of hydrofluoric acid, with 
the deprotection proceeding in good yield to give amine (2.158). The free base was 
obtained exclusively by passing a solution of the crude product over the tertiary amine 
resin Amberlyst® A21. 
However it would prove significantly more efficient to resist the temptation to isolate 
the intermediate alcohol. Instead simply exposing the crude addition mixture to HF 
would result in global desilylation, allowing the resulting N-methylpropargyl amine 
(1.372) to be removed under reduced pressure, the product amine could then be purified 
effectively by chromatography. This gave a yield for comparison of some 47% against 
31% for the two step procedure. 
O
OOMe
O
O
Br
O
OOMe
O
OH
Br
(2.106) (2.157)
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b
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a
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N
Me
(2.154)
  
Scheme 2.77 : Reagents and Conditions: (a) (2.154) (1 eq.), 2.5M nBuLi in hexanes (1 eq.), THF, -78 °C 
to -20 °C, 30 min,  then (2.106) (1.05 eq.), THF, -78 °C to rt, 30 mins (45%); (b) HF (40% wt. in H2O) 
(excess), MeCN, rt, 10 mins (68%); (c) (2.154) (1 eq.), 2.5M nBuLi in hexanes (1 eq.), THF, -78 °C to -20 
°C, 30 min then (2.106) (1.05 eq.), THF, -78 °C to rt, 30 mins, solvent removed then HF (40% wt. in H2O) 
(excess), MeCN, rt, 10 mins (47%). 
The speculative nature of this chemistry meant it was never a top priority and it would 
be found that a lack of material prevented us from carrying this sequence on any further. 
2.8.2 Protection of Claisen Product (2.90). 
Proceeding with the original synthesis necessitated a protection of the two phenols in 
Claisen product (2.90) (scheme 2.78), this was necessary both to allow the use of 
organolithium reagents in the introduction of the side chain and because acid had been 
shown to have a detrimental effect on the results of the cyclisation. Methylation was the 
preferred means of protection as the methyl ether would be completely inert under the 
conditions required to furnish the pentacyclic lactone (2.161), there is also an abundance 
of examples of the oxidation of the para-dimethoxy unit to the desired quinone (2.162).  
The methylation of hydroquinone (2.90) would prove trying. This compound appeared 
to be even more unstable than the preceding benzaldehyde (2.89). As such efforts to 
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derive the dimethylated lactone (1.427) under fairly standard conditions were extremely 
poor yielding, with what little material resulted being challenging to separate from the 
detritus of decomposition. 
O
OOH
OH
O
(2.90)
O
OOMe
OMe
O
(1.427)
a
O
OOMe
OMe (2.161)
O
OO
O (2.162)Br Br  
Scheme 2.78 : Reagents and Conditions: (a) See table below. 
Reagent Equivalents Conditions Yield (%)a 
MeI 10 K2CO3, acetone, 50 °C, 5 hrs 11% 
MeI 4 Cs2CO3, DMF, 80 °C, 4 hrs 6% 
Me2SO4 10 K2CO3, acetone, 50 °C, 2 hrs decomp. 
a Isolated Yield. 
Having attributed the decomposition to the same lack of base stability observed in the 
case of the phenolic benzaldehyde (2.89) (vide supra, scheme 2.60), the prospect of a 
two-step methylation in which the reagents could be tailored to the two different 
phenolic environments seemed reasonable. TMS diazomethane would be used to 
methylate the more acidic phenol under neutral conditions and the resulting methyl ester 
(2.107) should then prove more resilient when the remaining phenol is protected under 
standard basic methylation conditions allowing for the formation of key intermediate 
(1.427) (scheme 2.79). Unfortunately the addition of a single equivalent of TMSCHN2 
to the hydroquinone still resulted in rapid decomposition of the starting material. 
O
OOH
OH
O
(2.90)
Br
O
OOMe
OH
O
(2.107)
Br
a
O
OOMe
OMe
O
(1.427)
Br
b
 
Scheme 2.79 : Reagents and Conditions: (a) TMSCN2 (1 eq.), toluene/MeOH (3:2), rt, 10 mins; (b) MeI, 
K2CO3, Acetone. 
With work toward the methylated compound faltering a different approach was devised, 
the phenols would instead be protected as their pivaloyl esters (scheme 2.80). The 
reaction with pivaloyl chloride would prove more facile than the alkylation and the 
steric bulk of the ester should make the ester robust enough to survive a careful addition 
of the lithiate to the aldehyde, this view was further reinforced by the fact the lactone 
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had survived that same addition as noted earlier. When benzaldehyde (2.90) was treated 
with pivaloyl chloride in pyridine at room temperature the reaction was both rapid and 
clean; the diester (2.160) was produced in good yield.248 
O
OOH
OH
O
(2.90)
Br
O
OOPiv
OPiv
O
(2.163)
Br
a
 
Scheme 2.80 : Reagents and Conditions: (a) PivCl (excess), pyridine, rt, 3 hrs (79%). 
We had sufficient remaining material to make a singular attempt at introducing the first 
side chain segment. Following the procedure for the methylated benzaldehyde (2.106) 
(vide supra, scheme 2.77) the pivaloyl ester (2.163) was dissolved in THF and added to 
a pre-prepared solution of the lithiate of amine (2.154) (scheme 2.81). This resulted in a 
complex multi-spot mixture by TLC presumably due to competitive nucleophilic attack 
on the Pivaloyl esters, none of the products were identifiable. This was an accepted 
consequence of this method given the presence of the more labile phenolic esters and a 
clear indication that greater care is required in its execution. This failure was therefore 
not unduly discouraging. 
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(2.154)
  
Scheme 2.81 : Reagents and Conditions: (a) (2.154) (0.95 eq.), 2.5M nBuLi in hexanes (0.95 eq.), THF, 
-78 °C to -20 °C, 30 min,  then (2.163), THF, -78 °C to rt, 30 mins. 
2.9 Future Work. 
2.9.2 Proposed Route Modifications. 
Whilst the route described above is generally reliable with respectable yields, up to the 
synthesis of the diol Claisen precursor (2.78), the author would strongly encourage 
anyone charged with the continuation of this work to invest a small amount of time 
investigating the oxidation of the hetero benzyl ethers (2.91a)-(2.91c) (vide supra, 
scheme 2.55). This would allow the circumvention of the most problematic chemistry of 
the route and the poor yield of the Claisen rearrangement. The rearrangement generating 
benzyl ether (2.91a) exhibited far superior yields and reliability and there is every 
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reason to believe a DDQ oxidation of this system would be successful. In addition the 
protection of the resulting hydroquinone system is likely to proceed with fewer 
complications in the absence of the electron withdrawing aldehyde, this should allow 
for a straightforward methylation allowing the use of the pivalate ester and its attendant 
complications to be avoided. 
2.9.2 Toward the Completion of the Achiral CDEF Ring System. 
With the hard fought battle to derive a fully substituted benzaldehyde now complete, 
progress towards lactonamycin should prove to be somewhat more rapid. The forward 
route (scheme 2.82) can be adapted to either the diester (2.163) resulting from the 
established work, or the methylated equivalent (1.427) that would result from the 
modification in route proposed above. 
The diester (2.163) should be apt to deliver the alcohol (2.164a) with a more careful 
approach involving a slow addition of the lithiate to the benzaldehyde. The diether 
(1.427) should prove less sensitive giving the equivalent alcohol (2.164b) by the 
previously established method. The immediate addition products will be desilylated 
using HF, either by the stepwise sequence preferred by Faggiani or a one-pot procedure 
from the benzaldehyde as demonstrated. Free amine (2.166a) or (2.166b) will be 
coupled with the dimethylsilylpropynoyl chloride, generated in situ from the 
corresponding carboxylic acid (2.145) with oxalyl chloride and catalytic DMF.  
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Scheme 2.82 : Reagents and Conditions: (a) (2.165); (b) HF; (c) (2.145), (COCl)2, DMF then (2.166a) or 
(2.166b); (d) Toluene, epoxyhexane, reflux; (e) Br2, AcOOH, AcOH; (f) BnBr, K2CO3. 
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With the second alkyne in place, both precursors (2.167a) and (2.167b) should undergo 
the well precedented radical cyclisation when heated in toluene with epoxyhexane 
acting as an acid trap. This would deliver either pentacyclic compound (2.168a) or 
(2.168b) respectively. The DMPS residue will allow for a Fleming oxidation of either 
silane by a one-pot procedure using bromine to effect a halodesilylation which in the 
presence of peracetic acid would result in the corresponding alcohol. This should be 
rapidly oxidised in air to the bisphenol. Protection of both phenols as their benzyl ethers 
would be achieved under standard conditions with benzyl bromide to give either lactone 
(2.169a) or (2.169b). 
2.9.3 Finishing the Chiral AB Ring System. 
Both of the protected hydroquinones will then be oxidised to the quinone (2.170) 
(scheme 2.83). In the case of the methylated substrate (2.169b) the 1,4-dimethoxy 
moiety will be readily oxidised to the quinone with argentic oxide249 or CAN.250 The 
pivalate (2.169a) may prove somewhat more resistant to oxidation but this too should 
be oxidised to the quinone with CAN as is observed with similar 1,4-diacetoxy 
systems.251 Should that fail saponification of the pivaloyl esters would reveal the 
hydroquinone which should be readily oxidised by heating in air.252 Any accompanying 
cleavage of the lactone should be easily reversed upon acidification. 
The formation of quinone (2.170) exposes a single non-aromatic double bond, 
dihydroxylation of this bond will install the cis-diol around which the AB ring system 
will be constructed. For an achiral synthesis a simple dihydroxylation with OsO4 or 
RuCl3 would suffice, delivering the racemic diol. However to incorporate the correct 
(7aS, 10aR) stereochemistry in diol (2.171) a more considered approach is required. The 
Sharpless asymmetric dihydroxylation is the method of choice for such 
transformations.253 Whilst the tetra-substituted alkene may prove a less than ideal 
substrate it is hoped that with increased catalyst loadings and the addition of the 
accelerating methanesulfonamide the desired enantiomer will be acquired in a viable 
e.e. using AD mix β.254 Should this fail an approach utilising stoichiometric quantities 
of OsO4 may be applied, though this is undesirable due to the expense and high toxicity 
of the reagent. With the diol introduced either in enantiomerically enriched form or as 
the racemate, heating the lactone (2.171) in methanol under acid conditions should 
transesterify the lactone to give the methyl ester (2.172) in equilibrium, with a large 
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excess of 2-methoxypropene the exposed 1,2-diol will be trapped as the dioxolane 
(2.173). The remaining free alcohol will be acetylated with acetic anhydride to give 
ester (2.174). Treatment of this ester with LDA will form enolate (2.175) which will 
spontaneously cyclise onto the methyl ester to give β-ketolactone (2.176). Exposure of 
the dioxolane to methanol under acidic conditions will result in deprotection, the 
revealed primary alcohol will then cyclise onto the adjacent ketone resulting in hemi-
acetal (2.178) which under the reaction conditions will be readily displaced by methanol 
to give the methyl ester (2.180), thus furnishing the main body of lactonamycinone in 
protected form.  
O
O
O
O
OBn
OMe
O
N
O
Me
BnO
O
(2.182)
O
O
O
O O
O
O
(S)
(R)
O
O
O
OOH
OH
O
O
O
OOR
OR
O
O
(2.171)(2.169a) R = Piv
(2.169b) R = Me
(2.170)
O
O
(2.172)
OH
OH
OMe
O
OH
O
O
(2.173)
OH
OMe
O
O
O
O
O
(2.174)
O
OMe
O
O
O
O
(2.176)
O
O
O
O
(2.177)
OH
O
OH
O
O
(2.175)
O
OMe
O
O
O
O
OH
O
O
O
OH
O
O
(2.178)
OH
O
O
O
OMe
O
O
(2.180)
OH
O
O
O
O
O
(2.179)
O
O
O
O
OH
OMe
O
N
O
Me
HO
O
(1.1)
a or b c d
e
g
OMe
OH
OMe
OH
f
h
i
O
O
(2.181)
 
Scheme 2.83 : Reagents and Conditions: (a) Ag2O.Ag2O3, HNO3; (b) CAN, H2O, MeCN; (c) AD Mix β; 
(d) 2-Methoxypropene, MeOH, CSA; (e) Ac2O, DMAP; (f) LDA; (g) MeOH, pTSA; (h) (2.181), Sc(OTf)3; (i) 
H2, Pd/C. 
We propose to add the required sugar residue via a Lewis acid mediated addition/ring 
opening cascade sequence (scheme 2.84). Exposure of the tertiary alcohol (2.180) to the 
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chiral epoxy aldehyde (2.181) in the presence of scandium (III) triflate will lead to 
nucleophilic attack on the aldehyde, the resulting alkoxide will then open the proximal 
epoxide, the configuration of this ring opening being controlled by coordination of both 
oxygen atoms to the Lewis acid.255 
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Scheme 2.84 : Proposed glycosylation procedure. 
The aldehyde (2.181) will be prepared by the careful hydrogenolytic debenzylation of 
known chiral epoxide (2.183),256 followed by oxidation of the resulting alcohol (2.184) 
(scheme 2.85). 
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Scheme 2.85 : Reagents and Conditions: (a) Hydrogenolysis; (b) Oxidation. 
Should this novel approach prove to be unsuccessful, it is possible that the α-rhodinose 
sugar might be added by the methodology of Tatsuta et al. by coupling the activated 
thiosaccharide (1.357a) with the exposed tertiary alcohol (2.180) (vide supra, scheme 
1.65). In the event that chirality was not introduced successfully at the osmylation stage, 
a resolution of the resulting diastereomeric glycosides should be possible by 
chromatography. Standard hydrogenolysis of the benzyl ethers will yield lactonamycin 
(1.1) as demonstrated on the analogous benzyl-protected lactonamycin (1.360) (vide 
supra, scheme 1.66). 
Modelling the chemistry detailed in schemes 2.82 & 2.83 is highly advised, fortunately 
Danishefky has already described the synthesis of two appropriate models for this work 
(figure 2.3) (vide supra, scheme 1.4). The tricyclic lactone (1.28) should serve as an apt 
model for methylated pentacycle (2.169b) whilst the demethylated precursor (1.27) 
should be readily Piv protected to serve as a model for the corresponding pentacycle 
(2.169a). 
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OMe(1.27) (1.28)  
Figure 2.3 : Models for developing the synthesis of the ABC ring system. 
2.9.4 An Additional Route to Key Intermediate (1.427). 
One further route to the hexacyclic intermediate was envisioned but never expanded 
upon (scheme 2.86). Starting from the known triol (1.258)69 this species would be 
selectively methylated on the phenolic oxygen with dimethylsulfate to give the diol 
(1.263).107 This diol would serve as the substrate for the formation of the symmetrical 
bislactone (2.185), which may be formed by an extension of the lithiate method 
employed previously (vide supra, scheme 2.9) or should the formation of the required 
tetra-lithiated species prove impossible an alternate lactone synthesis has been 
demonstrated by Larock and Fellows, an electrophilic thalliation/carbonylation 
sequence should be successful on the activated ring.257 A single equivalent of DIBAL 
would reduce one of the lactone rings to give the aldehyde (2.186). Conversion of the 
benzylic alcohol to an appropriate leaving group such as triflate (2.187) would allow the 
formation of the alkyne (2.188), introduced by a displacement with ethynylmagnesium 
bromide. Finally addition of the sterically hindered B-bromo-9-BBN across the 
acetylene would give the vinyl bromide (1.427) whilst avoiding the deprotection of the 
more hindered methyl ethers.258 
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Scheme 2.86 : Reagents and Conditions: (a) Hydroxymethylation, (b) Methylation with Me2SO4, (c) 
Lactone formation, (d) DIBAL reduction, (e) Leaving group formation with Tf2O, (f) Addition of 
ethynylmagnesium bromide, (g) B-bromo-9-BBN then acid workup. 
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3. Experimental 
 
 
“Now if by chance we are missing a flask 
We go to our neighbour, and timidly ask, 
“Can you give us the low down - who stole our glass?” 
With innocent surprise or utter dismay 
He tells us he has not seen it today 
So we give up our search, but the suspicion is strong 
       That our chemical neighbour has done us the wrong.” 259 
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3.1 General Procedure 
All reactions were carried out under an atmosphere of nitrogen unless otherwise stated, 
using oven dried glassware. Commercially available chemicals and reagents were used 
as supplied unless otherwise stated. 
Tetrahydrofuran and diethyl ether were distilled from sodium using benzophenone as an 
indicator. Dichloromethane and acetonitrile were distilled from calcium hydride.  Dry 
alcohol solvents were distilled from magnesium turnings and stored over 4 Å molecular 
sieves.  Nitrogenous solvents were distilled from calcium hydride and stored over 
potassium hydroxide. All solvents for high temperature reactions (>100 °C) were 
deoxygenated by sparging for at least 1 hour with nitrogen or argon gas.  
Microwave reactions were carried out using a CEM Discover-S 300W microwave 
system with a pressure tolerance of up to 18bar. 
Reactions were monitored either by crude NMR of the RM or by tlc using Merck glass 
backed tlc plates coated with a 0.25 mm layer of 60 F254 silica gel.  Visualisation was 
achieved using 254 nm UV radiation (where applicable) and potassium permanganate, 
phosphomolybdic acid or vanillin stains as deemed appropriate. Column 
chromatography was carried out using Merck Kieselgel 60. 
NMR spectroscopy was performed using either Varian NMR System-600 MHz (600 
MHz for 1H and 151 MHz for 13C), or Varian NMR System-500 MHz (500 MHz for 1H 
and 126 MHz for 13C). The solvent used for NMR samples was either perdeuterated 
chloroform or perdeuterated dimethylsulfoxide.  Chemical shifts were measured on the 
ppm scale and internally referenced to the shift of residual unlabelled chloroform (7.260 
ppm for 1H, 77.160 ppm for 13C) and dimethylsulfoxide (2.500 ppm for 1H, 39.520 ppm 
for 13C).260 All 13C NMR was performed with proton decoupling. 
Heteronuclear Single Quantum Coherence (HSQC), Heteronuclear Multiple Bond 
Coherence (HMBC), Correlation Spectroscopy (COSY) and Hydrogen-Deuterium 
exchange (H-D) experiments were also run where necessary to allow for the full 
elucidation of structures. 
Mass spectrometry was performed using a Fissons Instrument VG Autospec and a 
Bruker Daltonics Apex III.   
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Infrared spectra were recorded on a Perkin-Elmer 1710 Fourier transform instrument 
with ATR attachment. 
Melting points were recorded using a Gallenkamp melting point apparatus and are 
uncorrected. 
Whilst all compounds are named in accordance with IUPAC guidelines, atoms in the 
following section were numbered solely to aid in the assignment of NMR data and 
should be interpreted as such. 
3.2 Index of Compounds 
(1) (2,5-Dimethoxy-phenyl)-methanol 
(2) 4,7-Dimethoxy-2-benzofuran-1(3H)-one 
(3) 6-Bromo-4,7-dimethoxy-2-benzofuran-1(3H)-one  
(4) 2,5-Bis-(hydroxymethyl)-benzene-1,4-diol 
(5) 2,2,7,7-Tetramethyl-4,9-dihydro[1,3]dioxino[4,5-g][1,3] benzodioxine 
(6) (4-Hydroxymethyl-2,5-dimethoxy-phenyl)-methanol 
(7) 4,7-Dihydroxy-2-benzofuran-1(3H)-one 
(8) 4,7-Dihydroxy-6-(hydroxymethyl)-2-benzofuran-1(3H)-one 
(9) 4-Hydroxymethyl-2,5-dimethoxy-benzoic acid 
(10) 6-Hydroxy-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h][1,3] benzodioxin-9-one 
(11) 6-[(2-Bromo-2-propenyl)oxy]-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h] 
[1,3]benzodioxin-9-one 
(12) 4-[(2-Bromo-2-propenyl)oxy]-7-hydroxy-6-(mesitylmethyl)-2-benzofuran-1(3H)-
one  
(13) 4-[(2-Bromo-2-propenyl)oxy]-7-hydroxy-6-(hydroxymethyl)-2-benzofuran-1(3H)-
one 
(14) 4-[(2-Bromo-2-propenyl)oxy]-6-ethyl-7-hydroxy-2-benzofuran-1(3H)-one 
(15) {7-[(2-Bromo-2-propenyl)oxy]-4-hydroxy-3-oxo-1,3-dihydro-2-benzofuran-5-
yl}methyl trifluoroacetate 
(16) 5-(2-Bromo-2-propenyl)-6-[4-(diethylamino)benzyl]-4,7-dihydroxy-2-benzofuran-
1(3H)-one 
(17) 7-[(2-Bromo-2-propenyl)oxy]-4-hydroxy-3-oxo-1,3-dihydro-2-benzofuran-5-
carbaldehyde 
(18) 6-(2-Bromo-2-propenyl)-4,7-dihydroxy-3-oxo-1,3-dihydro-2-benzofuran-5-
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carbaldehyde 
(19) 6-[(Benzyloxy)methyl]-5-(2-bromo-2-propenyl)-4,7-dihydroxy-2-benzofuran-
1(3H)-one 
(20) 5-Hydroxy-2-methyl-6-oxo-6,8-dihydrofuro[2,3-e][2]benzofu-ran-4-carbaldehyde 
(21) 7-[(2-Bromo-2-propenyl)oxy]-4-methoxy-3-oxo-1,3-dihydro-2-benzofuran-5-
carbaldehyde 
(22) 4-[(2-Bromo-2-propenyl)oxy]-6-{1-hydroxy-4-[methyl(triisopropylsilyl)amino]-2-
butynyl}-7-methoxy-2-benzofuran-1(3H)-one 
(23) 4-[(2-Bromo-2-propenyl)oxy]-6-[1-hydroxy-4-(methylamino)-2-butynyl]-7-
methoxy-2-benzofuran-1(3H)-one 
(24) 6-(2-Bromo-2-propenyl)-4,7-dimethoxy-3-oxo-1,3-dihydro-2-benzofuran-5-
carbaldehyde 
(25) 5-(2-Bromo-2-propenyl)-7-[(2,2-dimethylpropanoyl)oxy]-6-formyl-1-oxo-1,3-
dihydro-2-benzofuran-4-yl pivalate 
(26) Ethynyl(dimethyl)phenylsilane 
(27) 3-[Dimethyl(phenyl)silyl]-2-propynoic acid 
(28) 2,2-Dimethyl-4H-1,3-benzodioxine 
(29) 2-[(Benzyloxy)methyl]phenol 
(30) 2-{[(4-Methoxybenzyl)oxy]methyl}phenol 
(31) 2-[(4-Methyl-1-piperazinyl)methyl]phenol 
(32) 2-(4-Morpholinylmethyl)phenol  
(33) 2-[(Phenylsulfanyl)methyl]phenol 
(34) 2-[4-(Dimethylamino)benzyl]phenol 
(35) 1,1,1-Triisopropyl-N-methyl-N-(prop-2-ynyl)silanamine 
(36) 2,3-Dibromopropene 
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(2.15) (2,5-Dimethoxyphenyl)methanol 
6
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Prepared by a modification of the method of Kumar et al.170 
2,5-Dimethoxybenzaldehyde (2.18) (25.00 g, 150 mmol) was dissolved in methanol 
(500 mL) and the solution cooled to -10 °C. Sodium borohydride (6.85 g, 165 mmol) 
was then added portionwise over 10 minutes. The RM was left to stir for three hours at 
rt after which the reaction was carefully quenched with water (500 mL) resulting in the 
evolution of a large quantity of hydrogen gas. The methanol was removed under 
reduced pressure to leave a white aqueous emulsion. This emulsion was extracted with 
diethyl ether (3 x 500 mL). The combined organic extracts were washed with water 
(500 mL) and aqueous sodium chloride solution (sat., 500 mL) before being dried over 
anhydrous sodium sulfate. The solvent was removed under reduced pressure and the 
resulting yellow oil was washed with hexane and then dried under vacuum to give the 
title compound as a yellow oil (24.44g, 97%). Spectra were consistent with those 
previously reported.170  
LRMS: (EI) m/z 168 (M+, 100%), 153 (23), 125 (62), 65 (41). 
IR: (neat, ν cm-1) 3401 (v. br), 2944, 2835, 1592. 
δH: (500 MHz, CDCl3): 6.90 (1H, d, J = 2.6 Hz, 3-H), 6.80 (2H, m, 5-H & 6-H), 4.66 
(2H, s, 1-H), 3.82 (3H, s, 8-H), 3.77 (3H, s, 9-H). 
δC: (126 MHz, CDCl3): 153.5 (C4), 151.0 (C7), 130.5 (C2), 114.0 (CH, C6), 112.6 (CH, 
C5), 111.1 (CH, C3), 60.2 (CH2, C1), 55.5 (CH3, C8 & C9). 
Rf: (5% MeOH in CH2Cl2) = 0.31 
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(2.14) 4,7-Dimethoxy-2-benzofuran-1(3H)-one  
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Prepared by a modification of the method of Magnus et al.171 
(2,5-Dimethoxyphenyl)methanol (2.15) (3.00 g, 17.8 mmol) was dissolved in dry 
tetrahydrofuran (50 mL), this solution was cooled to -78 °C and a solution of n-
butyllithium in hexanes (1.9M, 18.7 mL, 35.6 mmol) was added dropwise. The mixture 
was slowly warmed to 70 °C and allowed to stir for 2 hours. The RM was then cooled to 
-20 °C and solid carbon dioxide (large excess) added over 30 minutes. The reaction was 
quenched by the addition of aqueous hydrochloric acid (2M, 100 mL) resulting in the 
formation of a white precipitate. The precipitate was isolated by filtration, washed with 
hexanes and dried under vacuum to yield a white crystalline solid (0.98 g, 28%). The 
filtrate was extracted with chloroform (3 x 100 mL) and the combined organic extracts 
dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure 
and the resulting crude yellow solid was recrystallised from hot methanol to yield a 
further batch of white solid (0.85 g, 24%) giving an overall yield of 52%. Spectra were 
consistent with those previously reported. 171 
LRMS: (EI) m/z 194 (M+, 100%), 165 (81), 148 (76), 135 (29), 107 (23). 
HRMS: (ESI+) Calculated for C10H10O4Na, m/z 217.0471 found 217.0471 
IR: (neat, ν cm-1) 2843, 1756 (s), 1608, 1504, 1270. 
δH: (500 MHz, CDCl3): 7.05 (1H, d, J = 8.8 Hz, 6-H), 6.85 (1H, d, J = 8.7 Hz, 5-H), 
5.19 (2H, s, 1-H), 3.95 (3H, s, 8-H), 3.86 (3H, s, 9-H). 
δC: (126 MHz, CDCl3): 169.0 (C10), 152.2 (C4), 147.5 (C7), 136.9 (C2), 116.7 (CH, 
C6), 114.5 (C3), 111.6 (CH, C5), 67.1 (CH2, C1), 56.2 (CH3, C8), 55.8 (CH3, C9). 
Rf: (50% EtOAc in Hexane) = 0.30 
m.p.: 167-169 °C (Lit: 167-168 °C)261 
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(2.13) 6-Bromo-4,7-dimethoxy-2-benzofuran-1(3H)-one 
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4,7-Dimethoxy-2-benzofuran-1(3H)-one (2.14) (1.00 g, 5.15 mmol) and aluminium 
chloride (137 mg, 1.03 mmol) were dissolved in acetic acid (50 mL) and this solution 
was cooled in an ice bath while a solution of bromine (0.26 mL, 5.15 mmol) in acetic 
acid (25 mL) was carefully added over the course of 5 minutes. The RM was heated to 
70 °C and left to stir for 6 hours before being cooled to rt and left to stir overnight. The 
reaction was diluted with water (400 mL) resulting in the formation of a white 
precipitate which was separated by filtration and dried under vacuum to give a crude 
yellow solid. This solid was further purified by column chromatography eluting with a 
hexane: ethyl acetate gradient (1% to 20%). This produced the title compound as an off-
white crystalline solid (0.98 g, 69%). 
HRMS: (ESI+) Calculated for C10H9O481BrNa, m/z 296.9561 found 296.9552 
IR: (neat, ν cm-1) 2920, 1758, 1611, 1485, 1254. 
δH: (500 MHz, DMSO-d6): 7.53 (1H, s, 6-H), 5.22 (2H, s, 1-H), 3.85 (3H, s, 8-H), 3.84 
(3H, s, 9-H).  
δC: (126 MHz, CDCl3): 167.6 (C10), 149.8 (C7), 149.3 (C4), 136.0 (C2), 120.1 (CH, 
C6), 119.6 (C3), 117.7 (C5), 67.2 (CH2, C1), 62.6 (CH3, C8), 56.1 (CH3, C9). 
Rf: (30% Hexane in EtOAc) = 0.59 
m.p.: 177-180 °C 
Crystal Structure also determined. (Appendix  A) 
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(2.48) 2,5-Bis(hydroxymethyl)-1,4-benzenediol 
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Hydroquinone (2.47) (5.0 g, 45.4 mmol)) and sodium hydroxide (3.81 g, 95.3 mmol) 
were dissolved in water (35 mL) to give a clear brown solution and to this was added 
formalin solution (6.88 g, 37% wt. formaldehyde, 90.8 mmol). The RM was stirred in 
the dark for 5 days at rt. The reaction was quenched with acetic acid (5 mL) to give a 
solution of approximately pH 1, this solution was stirred for 10 minutes with 
decolourising charcoal before being filtered.  The filtrate was cooled in the fridge 
overnight developing off-white needle crystals. These crystals were further purified by 
recrystallisation from dimethylformamide by the addition of diethyl ether, this gave the 
title compound as an off-white crystalline solid (784 mg, 10%). Spectra were consistent 
with those previously reported.190 
HRMS: (ESI+) Calculated for C8H10O4Na, m/z 193.0471 found 193.0473 
IR: (neat, ν cm-1) 3395, 3138, 2949, 2901, 1413, 1197, 1003. 
δH: (500 MHz, DMSO-d6): 8.46 (2H, br s, 3-OH & 6-OH), 6.73 (2H, s, 4-H & 7-H), 
4.82 (2H, br s, 8-OH & 1-OH), 4.40 (4H, s, 1-H & 8-H). 
δC: (126 MHz, DMSO-d6): 146.3 (C3 & C6), 127.0 (C2 & C5), 113.7 (CH, C4 & C7), 
58.2 (CH2, C1 & C8). 
Rf: (10% MeOH in CH2Cl2) = 0.18 
m.p.: Decomposed above ~185 °C (Lit: Decomposed)190 
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(2.55) 2,2,7,7-Tetramethyl-4,9-dihydro[1,3]dioxino[4,5-g][1,3] 
benzodioxine 
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2,5-Bis-(hydroxymethyl)-1,4-benzenediol (2.48) (500 mg, 2.94 mmol) was dissolved in 
acetone (50 mL, excess) acidified with sulfuric acid (conc., 3 drops) to give a light 
brown solution that was stirred at rt for 48 hours. The RM was diluted with water (100 
mL) and then extracted with ethyl acetate (3 x 100 mL). The combined organic extracts 
were washed with water (100 mL) and aqueous sodium chloride solution (sat., 100 mL), 
before being dried over anhydrous magnesium sulfate. The solvent removed under 
reduced pressure, to give a crude brown solid. This solid was then further purified by 
recrystallisation from the minimum volume of boiling acetone. Cooling overnight 
produced the title compound as an off-white crystalline solid (258 mg, 35%). 
LRMS: (EI) m/z 250 (M+, 10%), 192 (100), 150 (34), 134 (51), 78 (96). 
HRMS: (ESI+) Calculated for C14H18O4Na, m/z 273.1097 found 273.1098 
IR: (neat, ν cm-1) 2989, 2938, 1742, 1508, 1441, 1129. 
δH: (500 MHz, CDCl3): 6.44 (2H, s, 4-H & 7-H), 4.79 (4H, s, 1-H & 8-H), 1.52 (12H, s, 
10-H, 11-H, 13-H & 14-H). 
δC: (126 MHz, CDCl3): 144.8 (C3 & C6), 119.4 (C2 & C5), 112.3 (CH, C4 & C7), 99.2 
(C9 & C12), 60.8 (CH2, C1 & C8), 24.7 (CH3, C10, C11, C13 & C14). 
Rf: (10% EtOAc in Hexane) = 0.35 
m.p.: 197-199 °C 
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(2.56) (4-Hydroxymethyl-2,5-dimethoxy-phenyl)-methanol 
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2,5-Bis-(hydroxymethyl)-benzene-1,4-diol (2.48) (200 mg, 1.18 mmol) and potassium 
carbonate (359 mg, 2.60 mmol) were dissolved in acetonitrile (5 mL) this mixture was 
warmed to 60 °C and methyl iodide (0.2 mL, 3.21 mmol) was added, the mixture was 
then heated at reflux for 8 hours with hourly additions of methyl iodide (0.2 mL, 3.21 
mmol). The RM was diluted with water (25 mL) before being extracted with 
dichloromethane (3 x 25 mL). The combined organics were dried over anhydrous 
magnesium sulfate before the solvent was removed under reduced pressure to give an 
off-white solid. This solid was further purified by recrystallisation from the minimum 
volume of hot ethyl acetate by the addition of hexane. Cooling overnight gave the title 
compound as a white solid (42 mg, 18%). Spectra were consistent with those previously 
reported.262 
HRMS: (ESI+) Calculated for C10H14O4Na, m/z 221.0784 found 221.0794 
IR: (neat, ν cm-1) 3267 (v br), 3006, 1504, 1403, 1203. 
δH: (500 MHz, CDCl3): 6.89 (2H, s, 4-H & 7-H), 4.68 (4H, d, J = 6.2 Hz, 1-H & 8-H), 
3.85 (6H, s, 9-H & 10-H), 2.23 (2H, t, J = 6.3 Hz, 8-OH & 1-OH). 
δC: (126 MHz, CDCl3): 151.2 (C3 & C6), 128.9 (C2 & C5), 111.4 (CH, C4 & C7), 61.9 
(CH2, C1 & C8), 55.9 (CH3, C9 & C10). 
Rf: (2% MeOH in CH2Cl2) = 0.18 
m.p.: 157-158 °C (Lit: 162-164 °C)262 
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(2.58) 4,7-Dihydroxy-2-benzofuran-1(3H)-one 
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4,7-Dimethoxy-2-benzofuran-1(3H)-one (2.14) (2.91 g, 15 mmol) was dissolved in 
dichloromethane (15 mL) to give a yellow solution. This solution was cooled to -78 °C. 
A solution of boron tribromide in dichloromethane (33 mL, 1M, 33 mmol) was added 
drop-wise over 10 minutes. The RM was stirred at -78 °C for 4 hours before being 
allowed to warm slowly to rt overnight. The RM was cooled in an ice bath and 
quenched by the careful addition of water (50 mL) and then this mixture was extracted 
with ethyl acetate (5 x 100 mL). The combined organic extracts were washed with water 
(100 mL) and aqueous sodium chloride solution (sat., 100 mL) before being dried over 
anhydrous sodium sulfate. The solvent was removed under reduced pressure, to give a 
crude brown solid, this was further purified by column chromatography eluting with 5% 
methanol in dichloromethane to give the title compound as a tan solid (2.34 g, 94%). 
Spectra were consistent with those previously reported.194 
LRMS: (EI) m/z 166 (M+, 90%), 137 (100), 109 (21), 81 (25). 
HRMS: (ESI+) Calculated for C8H6O4Na, m/z 189.0158 found 189.0159 
IR: (neat, ν cm-1) 3310 (br), 3072 (br), 2855, 1717, 1502, 1403, 1288. 
δH: (500 MHz, DMSO-d6): 9.80 (1H, s, 4-OH), 9.48 (1H, s, 7-OH), 6.94 (1H, d, J = 8.6 
Hz, 6-H), 6.73 (1H, d, J = 8.6 Hz, 5-H), 5.14 (2H, s, 1-H). 
δC: (126 MHz, DMSO-d6): 169.4 (C8), 149.9 (C4), 144.1 (C7), 133.8 (C2), 122.9 (CH, 
C6), 117.0 (CH, C5), 111.9 (C3), 67.4 (CH2, C1). 
Rf: (10% MeOH in CH2Cl2) = 0.52  
m.p.: Decomposed ~225 °C 
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(2.59) 4,7-Dihydroxy-6-(hydroxymethyl)-2-benzofuran-1(3H)-one 
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4,7-Dihydroxy-2-benzofuran-1(3H)-one (2.58) (5.0 g, 30 mmol) and NaOH (2.4 g, 60 
mmol) were dissolved in water (30 mL) to give a  dark brown solution and to this 
solution was added a formalin solution (3.24 g, 37% wt. formaldehyde, 36 mmol), the 
RM was stirred in the dark at rt for 6 days. Acetic acid (15 mL) was added, resulting in 
the formation of a white precipitate which was isolated by filtration. The filtrate was 
then extracted with n-butanol (3 x 100 mL), the combined organic extracts were then 
washed with water (350 mL) and aqueous sodium chloride solution (sat., 350 mL) 
before being dried over anhydrous sodium sulfate. The solvent was removed under 
reduced pressure to give an off-white solid. Residual solvent was removed by 
azeotroping with toluene. The solids were then combined and further purified by 
recrystallisation from boiling ethyl acetate. This gave the title compound as a white 
solid (4.07 g, 69%). 
LRMS: (EI) m/z 196 (M+, 39%), 178 (100), 149 (30), 121 (18). 
HRMS: (ESI+) Ion not found. 
IR: (neat, ν cm-1) 3367 (br), 3048 (v br), 1717, 1443, 1098. 
δH: (500 MHz, DMSO-d6): 9.50 (1H, s, 4-OH), 8.81 (1H, s, 7-OH), 7.13 (1H, s, 6-H) 
5.22 (1H, t, J = 5.5 Hz, 9-OH), 5.16 (2H, s, 1-H), 4.48 (2H, d, J = 5.3 Hz, 9-H). 
δC: (126 MHz, DMSO-d6): 170.4 (C8), 145.7 (C4), 144.4 (C7), 131.9 (C2), 130.9 (C5), 
121.4 (CH, C6), 112.3 (C3), 67.7 (CH2, C1), 58.1 (CH2, C9). 
Rf: (10% MeOH in CH2Cl2) = 0.22 
m.p.: 200-203 °C 
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(2.21) 4-Hydroxymethyl-2,5-dimethoxy-benzoic acid 
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(2,5-Dimethoxyphenyl)methanol (2.15) (32.3 g, 192 mmol) was dissolved in 
tetrahydrofuran (200 mL) this solution was cooled to -78 °C and a solution of n-
butyllithium in hexane (240 mL, 1.6M, 384 mmol) was slowly added. The mixture was 
slowly warmed to 70 °C and allowed to stir for 3 hours. The RM was then allowed to 
cool to rt and solid carbon dioxide added continuously over 60 minutes. Aqueous 
hydrochloric acid (700 mL, 2M) was added, developing a white precipitate of (2.58) 
(10.2 g), this was isolated by filtration. The filtrate was then extracted with chloroform 
(3 x 500 mL) and the combined organic extracts washed with water (1000 mL) and 
aqueous sodium chloride solution (sat., 1000 mL) before being dried over anhydrous 
sodium sulfate. The solvent was removed under reduced pressure to give an off-white 
solid which was further purified by recrystallisation from boiling ethyl acetate giving 
the title compound as a crystalline white solid (5.81 g, 14%). 
LRMS: (EI) m/z 212 (M+, 100%), 194 (81), 165 (62), 148 (44). 
HRMS: (ESI+) Calculated for C10H12O5Na, m/z 235.0577 found 235.0576 
IR: (neat, ν cm-1) 3451, 3195, 2928, 1703, 1406, 1205. 
δH: (500 MHz, DMSO-d6): 12.44 (1H, s, 10-OH), 7.19 (1H, s, 6-H), 7.17 (1H, s, 3-H), 
5.19 (1H, t, J = 4.8 Hz, 1-OH), 4.50 (2H, d, J = 4.2 Hz, 1-H), 3.77 (3H, s, 9-H), 3.74 
(3H, s, 8-H). 
δC: (126 MHz, DMSO-d6): 167.4 (C10), 153.2 (C7), 149.5 (C4), 136.6 (C2), 119.2 (C5), 
112.6 (CH, C6), 112.3 (CH, C3), 58.2 (CH2, C1), 56.9 (CH3, C9), 56.1 (CH3, C8). 
Rf: (10% MeOH in CH2Cl2) = 0.45 
m.p.: 158-159 °C 
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(2.50) 6-Hydroxy-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h][1,3] 
benzodioxin-9-one 
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4,7-Dihydroxy-6-(hydroxymethyl)-2-benzofuran-1(3H)-one (2.59) (23.0 g, 117 mmol) 
was suspended in acetone (490 mL), to this suspension was added 2,2-
dimethoxypropane (72 mL, 579 mmol). A crystal of para-toluenesulfonic acid was 
added and the RM was then heated to 60 °C and stirred for 3 hours after which the solid 
had dissolved to give an orange solution. This solution was diluted with water (2000 
mL) and then extracted with ethyl acetate (3 x 1000 mL), the combined organics were 
washed with water (1500 mL) and aqueous sodium chloride solution (sat., 1500 mL) 
before being dried over anhydrous sodium sulfate. The solvent was removed under 
reduced pressure, to give a solid. This solid was further purified by column 
chromatography eluting with 5% methanol in dichloromethane to give the title 
compound as an off-white solid (24.1 g, 87%). 
HRMS: (ESI+) Calculated for C12H12O5Na, m/z 259.0577 found 259.0577 
IR: (neat, ν cm-1) 3375, 3090, 1717, 1443, 1094. 
δH: (500 MHz, DMSO-d6): 9.78 (1H, s, 7-OH), 6.83 (1H, s, 6-H), 5.19 (2H, s, 1-H), 
4.84 (2H, s, 9-H), 1.50 (6H, s, 11-H & 12-H). 
δC: (126 MHz, DMSO-d6): 168.3 (C8), 144.7 (C4), 142.7 (C7), 134.1 (C2), 121.2 (CH, 
C6), 117.8 (C5), 113.3 (C3), 100.3 (C10), 67.4 (CH2, C1), 60.5 (CH2, C9), 25.0 (CH3, 
C11 & C12). 
Rf: (10% MeOH in CH2Cl2) = 0.41 
m.p.: 200-203 °C  
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(2.51) 6-[(2-Bromo-2-propenyl)oxy]-2,2-dimethyl-4,7-dihydro-9H-
furo[3,4-h][1,3]benzodioxin-9-one 
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6-Hydroxy-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h][1,3]benzodioxin-9-one (2.50) 
(15.3 g, 64.8 mmol) and potassium hydroxide (3.64 g, 64.8 mmol) were dissolved in 
ethanol (225 mL) and heated to 80 °C giving a dark brown solution. 2,3-
dibromopropene (1.370) (7.3 mL, 15.5 g, 77.8 mmol)  was added and the RM stirred at 
80 °C for 2.5 hours. The reaction was quenched with water (1500 mL) resulting in the 
formation of an off-white precipitate, this precipitate was isolated by filtration before 
being redissolved in dichloromethane. This solution was washed with aqueous sodium 
hydroxide solution (0.2M, 1000 mL), water (1000 mL) and aqueous sodium chloride 
solution (sat., 1000 mL) the solvent was removed under reduced pressure to give a 
crude solid which was further purified by column chromatography eluting with 2% 
methanol in dichloromethane. This gave the title compound as an off-white solid (14.0 
g, 61%). Unreacted starting material was recovered by neutralisation of the basic extract 
with an equal volume of aqueous hydrochloric acid (0.2M, 1000 mL) followed by 
extraction with ethyl acetate (3 x 500 mL). Removal of the solvent under reduced 
pressure gave a crude red oil, this was recrystallised from dichloromethane by the 
addition of hexane to produce 6-hydroxy-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-
h][1,3]benzodioxin-9-one as an off white solid (3.1 g, 20%) giving a combined yield of 
81%.  
HRMS: (ESI+) Calculated for C15H15O579BrNa, m/z 376.9995 found 376.9990 
IR: (neat, ν cm-1) 2991, 1760 (s), 1499, 1301, 1012. 
δH: (500 MHz, DMSO-d6): 7.19 (1H, s, 6-H), 6.15 (1H, d, J = 2.1 Hz, 15-HA), 5.76 (1H, 
d, J = 2.2 Hz, 15-HB), 5.27 (2H, s, 1-H), 4.86 (2H, s, 9-H), 4.80 (2H, s, 13-H), 1.51 (6H, 
s, 11-H & 12-H). 
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δC: (126 MHz, DMSO-d6): 167.4 (C8), 144.3 (C7), 143.7 (C4), 136.1 (C2), 127.0 (C14), 
120.6 (C5), 120.4 (CH2, C15), 116.1 (CH, C6), 113.2 (C3), 100.3 (C10), 72.0 (CH2, 
C13), 66.7 (CH2, C1), 60.1 (CH2, C9), 24.5 (CH3, C11 & C12). 
Rf: (25% Ethyl Acetate in Hexane) = 0.20 
m.p.: 129-132 °C  
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(2.70) 4-[(2-Bromo-2-propenyl)oxy]-7-hydroxy-6-(mesitylmethyl) 
-2-benzofuran-1(3H)-one 
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6-[(2-Bromo-2-propenyl)oxy]-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h][1,3]benzodiox- 
in-9-one (2.51) (100 mg, 0.28 mmol) was dissolved in mesitylene (6 mL), this solution 
was then heated to reflux for 24 hours. The solvent was then removed under reduced 
pressure and the residue was further purified by column chromatography eluting with 
dichloromethane to give the title compound as a white solid (92 mg, 78%).  
HRMS: (ESI+) Calculated for C21H21O479BrNa, m/z 439.0515 found 439.0497 
IR: (neat, ν cm-1) 3448, 2918, 1746, 1429, 1312. 
δH: (500 MHz, CDCl3): 7.66 (1H, s, 4-OH), 6.91 (2H, s, 15-H & 17-H), 6.31 (1H, s, 6-
H), 5.59 (1H, d, J = 1.8 Hz, 11-HB), 5.53 (d, J = 2.3 Hz, 11-HA), 5.28 (2H, s, 1-H), 4.38 
(2H, s, 9-H), 3.97 (2H, s, 12-H)), 2.30 (3H, s, 21-H), 2.16 (6H, s, 19-H & 20-H). 
δC: (126 MHz, CDCl3): 172.8 (C8), 148.8 (C4), 144.7 (C7), 137.1 (C14 & C18), 136.3 
(C16), 132.4 (C13), 131.5 (C2), 129.2 (CH, C15 & C17), 128.8 (C5), 127.3 (C10), 
120.3 (CH, C6), 119.7 (CH2, C11), 111.6 (C3), 72.9 (CH2,C9), 69.1 (CH2, C1), 27.6 
(CH2 ,C12), 21.1 (CH3, C21), 20.0 (CH3, C19 & C20). 
Rf: (CH2Cl2) = 0.57 
m.p.: 157-159 °C  
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(2.78) 4-[(2-Bromo-2-propenyl)oxy]-7-hydroxy-6-(hydroxy 
methyl)-2-benzofuran-1(3H)-one 
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6-[(2-Bromo-2-propenyl)oxy]-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h][1,3]benzodiox- 
in-9-one (2.51) (40 mg, 0.11 mmol) was suspended in a solution of acetic acid in water 
(50% v/v, 10 mL), and heated to 60 °C for 2.5 hours. The solvent was then removed 
under reduced pressure and residual acetic acid removed by azeotroping with toluene to 
give the title compound as a white solid (35 mg, quant.). 
LRMS: (EI) m/z 316 (M+(81Br), 26%), 314 (M+(79Br), 27%), 217 (68), 195 (98), 149 
(90). 
HRMS: (ESI+) Ion not found. 
IR: (neat, ν cm-1) 3415, 3287 (br), 3006, 1748, 1630. 
δH: (500 MHz, CDCl3): 7.58 (1H, s, 4-OH), 7.17 (1H, s, 6-H), 5.96 (1H, d, J = 1.0 Hz, 
12-HA), 5.71 (1H, d, J = 1.1 Hz, 12-HB), 5.33 (2H, s, 1-H), 4.78 (2H, s, 9-H), 4.69 (2H, 
s, 10-H). 
δC: (126 MHz, CDCl3): 172.1 (C8), 148.0 (C4), 145.0 (C7), 133.2 (C2), 129.1 (C11), 
126.7 (C5), 120.0 (CH, C6), 119.0 (CH2, C12), 112.1 (C3), 73.0 (CH2, C10), 68.9 (CH2, 
C1), 59.9 (CH2, C9). 
Rf: (5% MeOH in CH2Cl2) = 0.43 
m.p.: 125-126 °C  
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(2.85) 4-[(2-Bromo-2-propenyl)oxy]-6-ethyl-7-hydroxy-2-
benzofuran-1(3H)-one 
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Trimethylaluminium (0.24 mL, 2.52 mmol) was dissolved in dry dichloromethane (3 
mL) and cooled to -30 °C and to this mixture was added water (9 μL, 0.56 mmol). The 
colourless RM was then stirred for 10 minutes before a solution of 6-[(2-bromo-2-
propenyl)oxy]-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h][1,3]benzodioxin-9-one (2.51) 
(200 mg, 0.56 mmol) in dichloromethane (2 mL) was added. This mixture was stirred at 
-30 °C for 1 hour. The RM was then allowed to warm slowly to rt overnight. The 
reaction was quenched by bubbling oxygen gas through the RM until all volatiles had 
been evaporated to give a gummy orange solid. This solid was redissolved in 
dichloromethane (10 mL) which was then extracted with aqueous sodium hydroxide 
solution (2M, 3 x 10 mL) the combined aqueous extracts were combined and 
neutralised with an equal volume of aqueous hydrochloric acid (2M, 30 mL). The 
neutralised aqueous extract was then extracted with dichloromethane (3 x 10 mL), the 
combined organics were then dried over anhydrous magnesium sulfate and the solvent 
removed under reduced pressure to give the title compound as a white solid (113 mg, 
64%). 
HRMS: (ESI+) Calculated for C13H13O479BrNa, m/z 334.9889 found 334.9896 
IR: (neat, ν cm-1) 3425, 2975, 2944, 1751, 1630, 1319, 1007. 
δH: (500 MHz, CDCl3): 7.52 (1H, s, 4-OH), 6.93 (1H, s, 6-H), 5.96 (1H, d, J = 1.8 Hz, 
13-HA), 5.71 (1H, d, J = 2.0 Hz, 13-HB), 5.30 (2H, s, 1-H), 4.66 (2H, s, 11-H), 2.70 (2H, 
q, J = 7.3 Hz, 9-H), 1.23 (3H, t, J = 7.6 Hz, 10-H). 
δC: (126 MHz, CDCl3): 172.6 (C8), 148.6 (C4), 144.7 (C7), 132.6 (C5), 131.2 (C2), 
126.9 (C12), 121.4 (CH2, C13), 118.7 (CH, C6), 111.5 (C3), 73.1 (CH2, C11), 68.8 
(CH2, C1), 22.4 (CH2, C9), 14.1 (CH3, C10). 
Rf: (CH2Cl2) = 0.54 
m.p.: 108-110 °C  
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(2.83) (7-[(2-Bromo-2-propenyl)oxy]-4-hydroxy-3-oxo-1,3-
dihydro-2-benzofuran-5-yl)methyl trifluoroacetate 
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From (2.78) 
4-[(2-Bromo-2-propenyl)oxy]-7-hydroxy-6-(hydroxymethyl)-2-benzofuran-1(3H)-one 
(2.78) (100 mg, 0.63 mmol) was dissolved in trifluoroacetic acid (5 mL), this  solution 
was stirred at rt for 2 hours. The solvent was removed under reduced pressure to give 
the title compound as a white solid. (126 mg, 96%). 
From (2.51) 
6-[(2-Bromo-2-propenyl)oxy]-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h][1,3]benzodiox- 
in-9-one (2.51) (100 mg, 0.28 mmol) was dissolved in trifluoroacetic acid (2 mL), this  
solution was stirred at rt for 3 hours. The solvent was removed under reduced pressure 
to give the title compound as a white solid. (111 mg, 97%). 
LRMS: (EI) m/z 412 (M+(81Br), 5.2%), 410 (M+(79Br), 5.4%), 316 (81Br, 8), 314 (79Br, 
8), 291 (18), 217 (69). 
HRMS: (ESI+) Ion not found. 
IR: (neat, ν cm-1) 3421, 1774, 1747, 1433, 1138. 
δH: (500 MHz, CDCl3): 7.65 (1H, s, 4-OH), 7.12 (1H, s, 6-H), 5.96 (1H, d, J = 2.1 Hz, 
14- HA), 5.74 (1H, d, J = 2.2 Hz, 14- HB), 5.45 (2H, s, 9-H), 5.36 (2H, s, 1-H), 4.69 (3H, 
s, 12-H). 
δC: (126 MHz, CDCl3): 171.9 (C8), 157.5 (q, J = 42.6 Hz, C10), 149.2 (C4), 145.2 (C7), 
136.0 (C2), 126.6 (C13), 121.7 (CH, C6), 121.4 (C5), 119.7 (CH2, C14), 114.6 (CF3, q, 
J = 285.7 Hz, C11), 112.9 (C3), 73.23 (CH2, C12), 69.1 (CH2, C1), 63.3 (CH2, C9). 
Rf: (CH2Cl2) = 0.20 
m.p.: 112-114 °C  
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(2.87) 5-(2-Bromo-2-propenyl)-6-[4-(diethylamino)benzyl]-4,7-
dihydroxy-2-benzofuran-1(3H)-one 
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4-[(2-Bromo-2-propenyl)oxy]-7-hydroxy-6-(hydroxymethyl)-2-benzofuran-1(3H)-one 
(2.51) (100 mg, 0.32 mmol) was suspended in N,N-diethylaniline (2 mL), this red 
solution was heated in the microwave at 200 °C for 30 minutes. The resulting brown 
solution was subjected to column chromatography eluting with a 10% ethyl acetate in 
hexanes. This gave the title compound as a red oil (72 mg, 50%). 
HRMS: (ESI+) Calculated for C22H25O481BrNH, m/z 448.0947 found 448.0944 
IR: (neat, ν cm-1) 3435 (v br), 2968, 2927, 1728, 1517. 
δH: (500 MHz, CDCl3): 7.58 (1H, br s, OH), 6.98 (2H, d, J = 8.2 Hz, 14-H & 18-H), 
6.59 (2H, d, J = 8.4 Hz, 15-H & 17-H), 5.52 (1H, d, J = 1.9 Hz, 11-HB), 5.43 (1H, d, J = 
1.9 Hz, 11-HA), 5.32 (2H, s, 1-H), 4.00 (2H, s, 12-H), 3.86 (2H, s, 9-H), 3.30 (4H, q, J = 
7.0 Hz, 19-H & 21-H), 1.13 (6H, t, J = 7.0 Hz, 20-H & 22-H). 
δC: (126 MHz, CDCl3): 172.9 (C8), 149.1 (C4), 146.5 (C16), 141.7 (C7), 133.0 (C5), 
130.8 (C2), 129.6 (C10), 129.4 (C6), 129.1 (CH, C14 & C18), 125.9 (C13), 118.3 (CH2, 
C11), 112.5 (CH, C15 & C17), 110.6 (C3), 69.1 (CH2, C1), 44.6 (CH2, C19 & C21), 
39.0 (CH2, C9), 30.1 (CH2, C12), 12.7 (CH3, C20 & C22). 
Rf: (2% MeOH in CH2Cl2) = 0.22 
 
 
 
 
 
 
Studies Toward a Total Synthesis of Lactonamycin                                                              Experimental 
180 
(2.89) 7-[(2-Bromo-2-propenyl)oxy]-4-hydroxy-3-oxo-1,3-
dihydro-2-benzofuran-5-carbaldehyde 
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4-[(2-Bromo-2-propenyl)oxy]-7-hydroxy-6-(hydroxymethyl)-2-benzofuran-1(3H)-one  
(2.78) (200 mg, 0.64 mmol) was dissolved in acetone (5 mL) to give a yellow solution, 
to which was added manganese dioxide (556 mg, 6.4 mmol), this mixture was stirred 
under nitrogen for 3 hours at rt. The mixture was then filtered through celite, and the 
solid residue rinsed with further acetone. The solvent was removed under reduced 
pressure before the residue was redissolved in a solution of formic acid in 
dichloromethane (1% v/v, 20 mL) activated carbon powder was added and the mixture 
stirred for 10 minutes. This solution was filtered through celite, which was flushed with 
further dichloromethane. The combined organics were dried over anhydrous magnesium 
sulfate and then the solvent removed under reduced pressure. This gave a pale yellow 
solid that was further purified by column chromatography eluting with 40% ethyl 
acetate in hexane. This gave the title compound as a white solid (107 mg, 54%). 
HRMS: (ESI+) Calculated for C12H9O581BrNa, m/z 336.9511 found 336.9498 
IR: (neat, ν cm-1) 3449, 2917, 1748, 1311, 997. 
δH: (500 MHz, CDCl3): 10.66 (1H, s, 4-OH), 10.08 (1H, s, 9-H), 7.32 (1H, s,6-H), 6.00 
(1H, d, J = 1.7 Hz, 12-HA), 5.77 (1H, d, J = 2.1 Hz, 12-HB), 5.34 (2H, s, 1-H), 4.75 (2H, 
s, 10-H). 
δC: (126 MHz, CDCl3): 193.3 (CH, C9), 168.2 (C8), 155.1 (C4), 145.1 (C2), 144.9 (C7), 
126.1 (C11), 121.9 (C5), 120.1 (CH, C6), 119.7 (CH2, C12), 115.3 (C3), 73.0 (CH2, 
C10), 67.9 (CH2, C1). 
Rf: (2% MeOH in CH2Cl2) = 0.25 
m.p.: 152-154 °C  
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(2.90) 6-(2-Bromo-2-propenyl)-4,7-dihydroxy-3-oxo-1,3-dihydro-
2-benzofuran-5-carbaldehyde 
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7-[(2-Bromo-2-propenyl)oxy]-4-hydroxy-3-oxo-1,3-dihydro-2-benzofuran-5-
carbaldehyde (2.89) (110 mg, 0.35 mmol) was in benzyl alcohol (6 mL) and stirred 
under nitrogen for 15 minutes. The RM was heated in the microwave at 180 °C for 2 
hours. When complete the RM was diluted with methanol (20 mL) to this was added 
Amberlyst® A21 resin (10 g). The mixture was stirred for 10 minutes at rt before the 
resin was isolated by filtration. The resin was washed with methanol (3 x 100 mL) 
before being added to a solution of formic acid in methanol (5% v/v, 50 mL), this was 
stirred for 10 minutes before the resin was filtered off. This was repeated twice more 
before the filtrates were combined and the solvent removed under reduced pressure. The 
resulting solid was further purified by column chromatography, eluting with 0.5% 
methanol in dichloromethane. This gave the title compound as a yellow solid (23 mg, 
21%). 
HRMS: (ESI+) Calculated for C12H9O579BrNa, m/z 334.9526 found 334.9533 
IR: (neat, ν cm-1) 3176 (v br), 1728, 1646, 1630, 1253. 
δH: (500 MHz, DMSO-d6): 11.92 (1H, s, 4-OH), 10.28 (1H, s, 9-H), 9.76 (1H, s, 7-OH), 
5.52 (1H, d, J = 2.1 Hz, 12-HA), 5.50 (1H, d, J = 2.1 Hz, 12-HB), 5.32 (2H, s, 1-H), 4.26 
(2H, s, 10-H). 
δC: (126 MHz, DMSO-d6): 195.8 (CH, C9), 167.4 (C8), 154.2 (C4), 143.8 (C2), 141.8 
(C7), 133.3 (C6), 130.6 (C11), 119.4 (C5), 118.4 (CH2, C12), 112.3 (C3), 67.7 (CH2, 
C1), 35.4 (CH2, C10). 
Rf: (5% MeOH in CH2Cl2) = 0.31 
m.p.: Decomposed ~140 °C 
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(2.91a) 6-[(Benzyloxy)methyl]-5-(2-bromo-2-propenyl)-4,7-
dihydroxy-2-benzofuran-1(3H)-one 
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6-[(2-Bromo-2-propenyl)oxy]-2,2-dimethyl-4,7-dihydro-9H-furo[3,4-h][1,3]benzodiox- 
in-9-one (2.51) (100 mg, 0.28 mmol) was dissolved in benzyl alcohol (6 mL) and stirred 
under nitrogen for 15 minutes. The RM was heated in the microwave at 180 °C for 15 
minutes. The solvent was removed under reduced pressure to give a yellow oil. The 
addition of hexanes produced an off-white precipitate and this solid was further purified 
by column chromatography eluting with 20% ethyl acetate in hexane, to give the title 
compound as a white solid (73 mg, 64%). 
HRMS: (ESI+) Calculated for C19H17O581BrNa, m/z 429.0137 found 429.0142 
IR: (neat, ν cm-1) 3248 (v br), 1732, 1637, 1107. 
δH: (500 MHz, CDCl3 7.66 (1H, s, 4-OH), 7.38 (4H, app d, J = 4.7 Hz, 15-H, 16-H, 17-
H & 18-H), 7.35 - 7.30 (1H, m, 19-H), 5.49 (1H, d, J = 1.9 Hz, 12-HA), 5.35 (1H, d, J = 
1.8 Hz, 12-HB), 5.24 (2H, s, 1-H), 5.20 (1H, br s, 7-OH), 4.65 (2H, s, 9-H), 4.62 (2H, s, 
13-H), 3.95 (2H, s, 10-H). 
δC: (126 MHz, CDCl3): 172.2 (C8), 149.5 (C4), 141.7 (C7), 137.6 (C14), 134.2 (C6), 
133.8 (C2), 129.7 (C11), 128.7 (CH, C17 & C18), 128.4 (CH, C15 & C16), 128.2 (CH, 
C19), 124.6 (C5), 118.6 (CH2, C12), 110.9 (C3), 73.3 (CH2, C13), 68.9 (CH2, C1), 62.2 
(CH2, C9), 38.6 (CH2, C10). 
Rf: (2% MeOH in CH2Cl2) = 0.44 
m.p.: 165-166 °C 
NMR Data appended (Appendix B). 
 
 
Studies Toward a Total Synthesis of Lactonamycin                                                              Experimental 
183 
(2.102) 5-Hydroxy-2-methyl-6-oxo-6,8-dihydrofuro[2,3-e][2] 
benzofuran-4-carbaldehyde 
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This compound was isolated during the preparation of (2.90). 
The title compound was isolated as an orange solid in variable yield (0-20%) 
HRMS: (ESI+) Calculated for C12H8O5Na, m/z 255.0264 found 255.0260 
IR: (neat, ν cm-1) 3145, 1750, 1637, 1276, 1272, 1051. 
δH: (500 MHz, CDCl3): 10.51 (1H, br s, 4-OH), 10.45 (1H, s, 9-H), 7.08 (1H, s, 10-H), 
5.49 (2H, s, 1-H), 2.56 (3H, s, 12-H). 
δC: (126 MHz, CDCl3): 190.5 (CH, C9), 169.7 (C8), 164.0 (C11), 157.8 (C4), 141.4 
(C7), 136.9 (C6), 136.1 (C2), 112.1 (C5), 108.1 (C3), 103.2 (CH, C10), 67.0 (CH2, C1), 
14.7 (CH3, C12).  
Rf: (5% MeOH in CH2Cl2) = 0.55 
m.p.: Decomposed above 265 °C  
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(2.106) 7-[(2-Bromo-2-propenyl)oxy]-4-methoxy-3-oxo-1,3-
dihydro-2-benzofuran-5-carbaldehyde 
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7-[(2-Bromo-2-propenyl)oxy]-4-hydroxy-3-oxo-1,3-dihydro-2-benzofuran-5-
carbaldehyde (2.89) (500 mg, 1.6 mmol) was suspended in a mixture of methanol (6.4 
mL) and toluene (9.6 mL). To which was added a solution of 
trimethylsilyldiazomethane in hexane (2M, 0.85 mL, 1.9 mmol) dropwise. The RM was 
allowed to stir for 10 minutes at rt. The RM was then quenched with acetic acid (3 
drops) before the solvent was removed under reduced pressure. This material was then 
purified by column chromatography eluting with 0.5% methanol in dichloromethane. 
This gave the title compound as a white solid (289 mg, 55%) and recovered starting 
material (210 mg, 42%) to give a combined yield of 97%. 
HRMS: (ESI+) Calculated for C13H11O579BrNa, m/z 348.9682 found 348.9691 
IR: (neat, ν cm-1) 2875, 1764, 1686, 1013. 
δH: (500 MHz, CDCl3): 10.44 (1H, s, 9-H), 7.53 (1H, s, 6-H), 6.00 (1H, d, J = 2.0 Hz, 
12-HA), 5.75 (1H, d, J = 2.2 Hz, 12-HB), 5.32 (2H, s, 1-H), 4.76 (2H, s, 10-H), 4.24 (3H, 
s, 13-H). 
δC: (126 MHz, CDCl3): 188.2 (CH, C9), 167.4 (C8), 156.7 (C4), 147.8 (C7), 144.4 (C2), 
130.3 (C5), 126.0 (C11), 120.0 (C3), 119.9 (CH2, C12), 115.2 (CH, C6), 72.6 (CH2, 
C10), 67.7 (CH2, C1), 64.6 (CH3, C13). 
Rf: (2% MeOH in CH2Cl2) = 0.51 
m.p.: 174-175 °C  
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(2.157) 4-[(2-Bromo-2-propenyl)oxy]-6-{1-hydroxy-4-
[methyl(triisopropylsilyl)amino]-2-butynyl}-7-methoxy-2-
benzofuran-1(3H)-one 
 
O
O
8
O
1
O
5
6
7
2
3
49
OH
10
11
Br
12
HA
HB
13
14
15
16
N
Si
17
18
20
19
22 21
23
24
25
26
 
1,1,1-Triisopropyl-N-methyl-N-(prop-2-ynyl)silanamine (2.154) (131 mg, 0.58 mmol) 
was dissolved in tetrahydrofuran (2 mL) and cooled to -78 °C, to this mixture was 
added a solution of n-butyllithium in hexane (2.5M, 0.24 mL, 0.58 mmol). The RM was 
stirred at -78 °C for 10 minutes before being allowed to warm to -20 °C, after stirring 
for 15 minutes the mixture was cooled to -78 °C and stirred for a further 30 minutes. 7-
[(2-Bromo-2-propenyl)oxy]-4-methoxy-3-oxo-1,3-dihydro-2-benzofuran-5-carbalde-
hyde (2.106)  (200 mg, 0.61 mmol) was dissolved in tetrahydrofuran (4 mL) and then 
the resulting solution transferred into the cold lithiate solution in one portion. This 
resulted in an immediate colour change from pale yellow to bright orange. The mixture 
was stirred at -78 °C for 30 minutes before being allowed to warm to rt. The reaction 
was quenched by the addition of aqueous ammonium chloride solution (sat., 2 mL) and 
water (10 mL). Ethyl acetate (20 mL) was added and the layers separated. The organic 
layer was washed with water (20 mL) and aqueous sodium chloride solution (sat., 20 
mL) before being dried over anhydrous sodium sulfate. The solvent was removed under 
reduced pressure to give an oily residue comprised of the desired product and 1,1,1-
triisopropyl-N-methyl-N-(prop-2-ynyl)silanamine. This residue could be recrystallised 
from diethyl ether and hexane by cooling overnight to give the title compound as a 
white solid (151 mg, 45%). 
HRMS: (ESI+) Calculated for C26H38O5N81BrSiH, m/z 554.1760 found 554.1778 
IR: (neat, ν cm-1) 3349 (v br), 2941, 2864 1741, 1494, 1007. 
δH: (500 MHz, CDCl3): 7.37 (1H, s, 6-H), 5.97 (1H, d, J = 1.7 Hz, 12-HA), 5.81 (1H, s, 
9-H), 5.72 (1H, d, J = 2.0 Hz, 12-HB), 5.24 (2H, s, 1-H), 4.71 (2H, s, 10-H), 4.10 (3H, s, 
13-H), 3.63 (2H, s, 16-H), 2.82 (1H, br s, 9-OH), 2.58 (3H, s, 17-H), 1.16 - 1.08 (3H, m, 
18-H, 19-H & 20-H), 1.02 (18H, d, J = 7.2 Hz, 21-H, 22-H, 23-H, 24-H, 25-H & 26-H). 
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δC: (126 MHz, CDCl3): 168.3 (C8), 150.3 (C4), 147.7 (C7), 137.1 (C2), 136.5 (C5), 
126.4 (C11), 119.2 (CH2, C12), 118.9 (C3), 117.1 (CH, C6), 86.6 (C14), 81.7 (C15), 
72.6 (CH2, C10), 67.4 (CH2, C1), 63.5 (CH3, C13), 59.9 (CH, C9), 41.1 (CH2, C16), 
36.6 (CH3, C17), 18.5 (CH3, C21, C22, C23, C24, C25 & C26), 12.2 (CH, C18, C19 & 
C20). 
Rf: Decomposes on silica. 
m.p.: 130-132 °C  
 
Studies Toward a Total Synthesis of Lactonamycin                                                              Experimental 
187 
(2.158) 4-[(2-Bromo-2-propenyl)oxy]-6-[1-hydroxy-4-
(methylamino)-2-butynyl]-7-methoxy-2-benzofuran-1(3H)-one 
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4-[(2-Bromo-2-propenyl)oxy]-6-{1-hydroxy-4-[methyl(triisopropylsilyl)amino]-2-
butynyl}-7-methoxy-2-benzofuran-1(3H)-one (2.157) (80 mg, 0.14 mmol) was 
dissolved in acetonitrile (5 mL) and to this was added hydrofluoric acid (40% wt. in 
water, 1 mL) in one portion, the RM was allowed to stir for 10 minutes at rt. The 
reaction was then quenched by pouring the RM into stirred aqueous potassium 
carbonate solution (10% w/w, 20 mL). The aqueous phase was saturated with sodium 
chloride and subsequently extracted with ethyl acetate (3 x 10 mL). The combined 
organic fractions were dried over anhydrous sodium sulfate and the solvent removed 
under reduced pressure. The residue was redissolved in dichloromethane (100 ml) and 
Amberlyst® A21 resin (2 g) added, this mixture was stirred for 10 minutes before being 
filtered. Evaporation of the solvent under reduced pressure gave an oily residue which 
was further purified by column chromatography eluting with 2% methanol in 
dichloromethane. This gave the title compound as a viscous yellow oil (39 mg, 68%). 
HRMS: (ESI+) Calculated for C17H18O5N79BrNaH, m/z 396.0441 found 396.0446 
IR: (neat, ν cm-1) 3500-2800 (v br), 2939, 1756, 1489, 1015. 
δH: (500 MHz, CDCl3): 7.39 (1H, s, 6-H), 5.99 (1H, d, J = 2.2 Hz, 12-HA), 5.81 (1H, t, J 
= 1.8 Hz, 9-H), 5.74 (1H, d, J = 2.2 Hz, 12-HB), 5.27 (2H, s, 1-H), 4.75 (2H, s, 10-H), 
4.14 (3H, s, 13-H), 3.50 (2H, d, J = 1.7 Hz, 16-H), 2.50 (3H, s, 17-H), 2.46 (2H, v.br s, 
9-OH & 16/17-NH). 
δC: (126 MHz, CDCl3): 168.2 (C8), 150.4 (C4), 147.7 (C7), 137.2 (C2), 136.1 (C5), 
126.4 (C11), 119.2 (CH2, C12), 119.0 (C3), 117.1 (CH, C6), 84.4 (C15), 83.5 (C14), 
72.6 (CH2, C10), 67.5 (CH2, C1), 63.5 (CH3, C13), 59.9 (CH, C9), 40.4 (CH2, C16), 
35.5 (CH3, C17). 
Rf: (5% MeOH in CH2Cl2) = 0.16 
NMR Data appended (Appendix B). 
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(1.427) 6-(2-Bromo-2-propenyl)-4,7-dimethoxy-3-oxo-1,3-
dihydro-2-benzofuran-5-carbaldehyde 
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6-(2-Bromo-2-propenyl)-4,7-dihydroxy-3-oxo-1,3-dihydro-2-benzofuran-5-
carbaldehyde (2.90) (50 mg, 0.16 mmol) was dissolved in acetone (5 mL) and to this 
was added potassium carbonate (221 mg, 1.6 mmol) to give a yellow solution. The RM 
was allowed to stir at rt for 10 minutes before being heated to 50 °C, methyl iodide (0.2 
mL, 3.2 mmol) was added and the RM stirred at 50 °C for 5 hours. The RM was then 
allowed to cool and was subsequently filtered before the solvent was removed under 
reduced pressure to give a yellow solid. This solid was further purified by column 
chromatography eluting with 10% ethyl acetate in hexane to give the title compound as 
a white solid (6 mg, 11%). 
HRMS: (ESI+) Calculated for C14H13O579BrNa, m/z 362.9839 found 362.9853 
IR: (neat, ν cm-1) 2940, 1767, 1686, 1601, 1392, 1021. 
δH: (500 MHz, CDCl3): 10.52 (1H, s, 9-H), 5.44 (1H, d, J = 1.7 Hz, 12-HA), 5.40 (2H, s, 
1-H), 5.26 (1H, d, J = 1.8 Hz, 12-HB), 4.28 (2H, s, 10-H), 4.21 (3H, s, 13-H), 3.88 (3H, 
s, 14-H). 
δC: (126 MHz, CDCl3): 190.8 (CH, C9), 167.0 (C8), 158.9 (C4), 148.9 (C7), 143.7 (C2), 
138.5 (C5), 130.5 (C11), 129.6 (C6), 118.3 (C8), 117.4 (CH2, C12), 67.5 (CH2, C1), 
64.6 (CH3, C13), 60.9 (CH3, C14), 37.1 (CH2, C10). 
Rf: (CH2Cl2) = 0.56 
m.p.: 90-92 °C 
NMR Data appended (Appendix B). 
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(2.163) 5-(2-Bromo-2-propenyl)-7-[(2,2-dimethylpropanoyl)oxy]-
6-formyl-1-oxo-1,3-dihydro-2-benzofuran-4-yl pivalate 
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6-(2-Bromo-2-propenyl)-4,7-dihydroxy-3-oxo-1,3-dihydro-2-benzofuran-5-carbalde-
hyde (2.90) (65 mg, 0.21 mmol) was dissolved in pyridine (3 mL), to this solution 
pivaloyl chloride (1 mL, excess) was added dropwise over 5 minutes. The RM was 
allowed to stir at rt for 3 hours before the solvent was removed under reduced pressure 
to leave an oily residue. This residue was redissolved in dichloromethane (10 mL) 
before being washed with water (10 mL), aqueous sodium bicarbonate solution (sat., 10 
mL) and a further portion of water (10 mL). The solution was dried over anhydrous 
sodium sulfate before the solvent was removed under reduced pressure to give an off 
white solid. This solid was further purified by column chromatography eluting with 
20% diethyl ether in hexane to give the title compound as a white solid (79 mg, 79%).  
HRMS: (ESI+) Calculated for C22H25O779BrNa, m/z 503.0676 found 503.0711 
IR: (neat, ν cm-1) 2984, 1782, 1757, 1701, 1625, 1075. 
δH: (500 MHz, CDCl3): 10.34 (1H, s, 9-H), 5.45 (1H, d, J = 2.1 Hz, 12-HA), 5.18 (1H, d, 
J = 2.0 Hz, 12-HB), 5.12 (2H, s, 1-H), 4.19 (2H, s, 10-H), 1.46 (9H, s, 15-H, 16-H & 17-
H), 1.40 (9H, s, 20-H, 21-H & 22-H). 
δC: (126 MHz, CDCl3): 187.7 (CH, C9), 175.9 (C18), 175.3 (C13), 166.0 (C8), 150.2 
(C4), 145.4 (C2), 142.1 (C7), 138.4 (C6), 129.2 (C5), 128.2 (C11), 119.9 (C3), 118.3 
(CH2, C12),  67.4 (CH2, C1), 39.8 (C19), 39.7 (C14), 37.5 (CH2, C10), 27.3 (CH3, C15, 
C16, C17, C18, C19 & C20). 
Rf: (CH2Cl2) = 0.45 
m.p.: 106-109 °C 
NMR Data appended (Appendix B). 
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(2.146) Ethynyl(dimethyl)phenylsilane 
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Prepared by a modification of the method of Hasegawa et al.244a 
Chlorodimethylphenylsilane (2.148) (4.50 g, 26.6 mmol) was added to a stirred solution 
of ethynylmagnesium bromide in tetrahydrofuran (0.5M, 53.3 mL, 26.6 mmol) at 0 °C. 
The mixture was stirred for 1 hr before being allowed to warm to rt and then stirred for 
a further 24 hours. The reaction was quenched with water (100 mL) and then extracted 
with diethyl ether (3 x 75 mL). The combined organic extracts were washed with water 
(100 mL) and aqueous sodium chloride solution (sat., 100 mL) before being dried over 
anhydrous magnesium sulfate. The solvent was removed under reduced pressure to give 
a crude yellow oil which was further purified by column chromatography eluting with 
1% diethyl ether in hexane. This gave the title compound as a colourless oil (3.42 g, 
81%). Spectra were consistent with those previously reported.244a 
HRMS: (ESI+) Ion not found. 
IR: (neat, ν cm-1) 3275, 2963, 2035, 1429, 1250, 1117. 
δH: (500 MHz, CDCl3): 7.70 - 7.62 (2H, m, 7-H &  9-H), 7.43 - 7.37 (3H, m, 6-H, 8-H 
& 10-H), 2.53 (1H, s, 1-H), 0.47 (6H, s, 3-H & 4-H). 
δC: (126 MHz, CDCl3): 136.4 (C5), 133.8 (CH, C7 & C9), 129.8 (CH, C8), 128.1 (CH, 
C6 & C10), 94.9 (CH, C1), 88.3 (C2), -1.0 (CH3, C3 & C4). 
Rf: (5% Diethyl Ether in Hexane) = 0.89 
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(2.145) 3-[Dimethyl(phenyl)silyl]-2-propynoic acid 
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Prepared by a modification of the method of Fleming et al.246 
Ethynyl(dimethyl)phenylsilane (2.146) (2.20 g, 13.7 mmol) was dissolved in 
tetrahydrofuran (5 mL) and this was added in one portion to a solution of 
methylmagnesium bromide in diethyl ether (3M, 9.1 mL, 27.4 mmol)  at 0 °C. This 
mixture was allowed to warm to rt and stirred for a further 2 hours, developing a thick 
white precipitate. The precipitate was redissolved by the addition of further 
tetrahydrofuran (10 mL) and then solid carbon dioxide (large excess) added over 1 hour. 
The reaction was quenched with aqueous ammonium chloride solution (sat., 20 mL) 
before being extracted with ethyl acetate (3 x 25 mL). The combined organics were 
washed with water (25 mL) and aqueous sodium chloride solution (sat., 25 mL) before 
being dried over anhydrous sodium sulfate. The solvent was removed under reduced 
pressure to leave a crude yellow oil which was further purified by column 
chromatography eluting with dichloromethane, this gave a pale yellow oil that solidified 
in the freezer to give the title compound as an off-white solid (2.20 g, 79%). Spectra 
were consistent with those previously reported.246 
HRMS: (ESI+) Calculated for C11H12O2SiNa, m/z 227.0499 found 227.0498 
IR: (neat, ν cm-1) 3250-2500 (v br), 2964, 2632, 2167, 1674, 1406, 1253. 
δH: (500 MHz, CDCl3): 9.40 (1H, v.br s, 11-OH), 7.62 (2H, d, J = 7.4 Hz, 6-H & 10-H), 
7.47 - 7.38 (3H, m, 7-H, 8-H & 9-H), 0.53 (6H, s, 3-H & 4-H). 
δC: (126 MHz, CDCl3): 157.0 (C11), 134.3 (C5), 133.9 (CH, C6 & C10), 130.3 (CH, 
C8), 128.3 (CH, C7 & C9), 95.5 (C2), 95.13 (C1), -1.7 (CH3, C3 & C4). 
Rf: (CH2Cl2) = 0.45 
m.p.: 30-35 °C  
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(2.120) 2,2-Dimethyl-4H-1,3-benzodioxine 
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2-(Hydroxymethyl)phenol (1.491) (25.0 g, 200 mmol) was dissolved in acetone (500 
mL)  and to this solution was added 2,2-dimethoxypropane (123 mL, 1000 mmol) and 
one crystal of para-toluenesulfonic acid. The RM was stirred for 2 days at rt. The 
solvent was then removed under reduced pressure to give a dark orange oil. This oil was 
redissolved in diethyl ether (200 mL) and then washed with aqueous sodium hydroxide 
solution (2M, 3 x 200 mL), water (200 mL) and aqueous sodium chloride solution (sat., 
200 mL). The organics were dried over anhydrous sodium sulfate before the solvent 
was removed under reduced pressure to give the title compound as a pale yellow oil 
(27.1 g, 83%). Spectra were consistent with those previously reported.263 
HRMS: (ESI+) Ion not found. 
IR: (neat, ν cm-1) 2994, 2857, 1590, 1490, 1459, 1268. 
δH: (500 MHz, CDCl3): 7.17 (1H, app t, J = 7.7 Hz, 3-H), 6.97 (1H, app d, J = 7.4 Hz, 
5-H), 6.90 (1H, app t, J = 7.4 Hz, 4-H), 6.84 (1H, app d, J = 8.2 Hz, 2-H), 4.86 (2H, s, 
7-H), 1.56 (6H, s, 9-H & 10-H). 
δC: (126 MHz, CDCl3): 151.3 (C1), 128.2 (CH, C3), 124.7 (CH, C5), 120.4 (CH, C4), 
119.6 (C6), 117.2 (CH, C2), 99.6 (C8), 61.0 (CH2, C7), 24.9 (CH3, C9 & C10). 
Rf: (20% Diethyl Ether in Hexane) = 0.80 
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(2.127) 2-[(Benzyloxy)methyl]phenol 
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2,2-Dimethyl-4H-1,3-benzodioxine (2.120) (2.48 g, 15.1 mmol) was dissolved in benzyl 
alcohol (2.117) (10 mL), the RM was then heated in the microwave to 180 °C for 30 
minutes. When complete the solvent was removed under reduced pressure to give a 
yellow oil. This oil was further purified by column chromatography eluting with 1% 
formic acid in dichloromethane, to give the title compound as a pale yellow solid (2.82 
g, 87%). Spectra were consistent with those previously reported.264 
HRMS: (ESI+) Calculated for C14H14O2Na, m/z 237.0886 found 237.0882 
IR: (neat, ν cm-1) 3249 (br), 2945, 2887, 1612, 1596, 1499, 1081. 
δH: (500 MHz, CDCl3): 7.47 (1H, s, 1-OH), 7.41 - 7.31 (5H, m, 10-H, 11-H, 12-H, 13-H 
& 14-H), 7.23 (1H, td, J = 8.0 & 1.6 Hz, 3-H), 7.01 (1H, dd, J = 7.5 & 1.4 Hz, 5-H), 
6.91 (1H, dd, J = 8.1 & 0.9 Hz, 2-H), 6.85 (1H, td, J = 7.4 & 1.1 Hz, 4-H), 4.75 (2H, s, 
7-H), 4.60 (2H, s, 8-H). 
δC: (126 MHz, CDCl3): 156.4 (C1), 137.0 (C9), 129.7 (CH, C3), 128.8 (CH, C11 & 
C13), 128.5 (CH, C12), 128.4 (CH, C5), 128.3 (CH, C10 & C14), 122.2 (C6), 120.1 
(CH, C4), 116.7 (CH, C2), 72.6 (CH2, C8) 71.6 (CH2, C7). 
Rf: (CH2Cl2) = 0.71 
m.p.: 53-54 °C (Lit: 55-56 °C)264 
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(2.128) 2-{[(4-Methoxybenzyl)oxy]methyl}phenol 
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2,2-Dimethyl-4H-1,3-benzodioxine (2.120) (2.48 g, 15.1 mmol) was dissolved in 
molten para-methoxybenzyl alcohol (2.122) (10 mL), the RM was then heated in the 
microwave to 180 °C for 30 minutes. When complete the RM was diluted with 
methanol (20 mL) and to this solution was added Amberlyst® A21 resin (10 g). The 
mixture was stirred for 10 minutes at rt before the resin was isolated by filtration. The 
resin was washed with methanol (3 x 100 mL) before being added to a solution of 
formic acid in methanol (5% v/v, 50 mL), this was stirred for 10 minutes before the 
resin was filtered off. This was repeated twice more before the filtrates were combined 
and the solvent removed under reduced pressure. The resulting solid was further 
purified by column chromatography, eluting with 1% formic acid in dichloromethane. 
This gave the title compound as a white solid (3.13 g, 85%). Spectra were consistent 
with those previously reported.265 
HRMS: (ESI+) Calculated for C15H16O3Na, m/z 267.0992 found 267.0988 
IR: (neat, ν cm-1) 3293 (br), 2924, 2866, 1610, 1513. 
δH: (500 MHz, CDCl3): 7.53 (s, 1H), 7.27 (2H, d, J = 8.7 Hz, 10-H & 14-H), 7.22 (1H, 
td, J = 7.9 & 1.7 Hz, 3-H), 7.00 (1H, dd, J = 7.5 & 1.6 Hz, 5-H), 6.92 - 6.89 (3H, m, 11-
H, 13-H & 2-H), 6.85 (1H, td, J = 7.4 & 1.2 Hz, 4-H), 4.72 (2H, s, 7-H), 4.53 (2H, s, 8-
H), 3.82 (3H, s, 15-H). 
δC: (126 MHz, CDCl3): 159.7 (C12), 156.3 (C1), 129.8 (CH, C10 & C14), 129.5 (CH, 
C3), 128.8 (C9), 128.2 (CH, C5), 122.1 (C6), 119.8 (CH, C4), 116.5 (CH, C2), 114.0 
(CH, C11 & C13), 72.1(CH2, C8), 71.2 (CH2, C7), 55.3 (CH3, C15). 
Rf: (CH2Cl2) = 0.75 
m.p.: 40-42 °C  
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(2.129) 2-[(4-Methyl-1-piperazinyl)methyl]phenol 
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2,2-Dimethyl-4H-1,3-benzodioxine (2.120) (2.48 g, 15.1 mmol) was dissolved in N-
methylpiperazine (2.123) (10 mL), the RM was then heated in the microwave to 180 °C 
for 10 hours. When complete the RM was diluted with methanol (20 mL) to this was 
added Amberlyst® A21 resin (10 g). The mixture was stirred for 10 minutes at rt before 
the resin was isolated by filtration. The resin was washed with methanol (3 x 100 mL) 
before being added to a solution of formic acid in methanol (5% v/v, 50 mL), this was 
stirred for 10 minutes before the resin was filtered off. This was repeated twice more 
before the filtrates were combined and the solvent removed under reduced pressure. The 
resulting solid was further purified by column chromatography, eluting with 2% 
methanol in dichloromethane. This gave the title compound as a red solid (2.36 g, 76%). 
Spectra were consistent with those previously reported.266 
HRMS: (ESI+) Calculated for C12H18ON2Na, m/z 229.1311 found 229.1317 
IR: (neat, ν cm-1) 2944, 2803, 2550 (v br), 1593, 1457. 
δH: (500 MHz, CDCl3): 7.17 (1H, td, J = 8.0 & 1.5 Hz, 3-H), 6.98 (1H, d, J = 7.4 Hz, 5-
H), 6.82 (1H, d, J = 8.1 Hz, 2-H), 6.78 (1H, td, J = 7.4 & 1.1 Hz, 4-H), 3.71 (2H, s, 7-
H), 2.58 (8H, br s, 8-H, 9-H, 10-H & 11-H), 2.32 (3H, s, 12-H). 
δC: (126 MHz, CDCl3): 157.9 (C1), 129.0 (CH, C3), 128.8 (CH, C5), 121.3 (C6), 119.3 
(CH, C4), 116.2 (CH, C2), 61.5 (CH2, C7), 55.0 (CH2, C9 & C10), 52.5 (CH2, C8 & 
C11), 45.9 (CH3, C12). 
Rf: (5% MeOH in CH2Cl2) = 0.24 
m.p.: 41-43 °C (Lit: 42-45 °C)266 
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(2.130) 2-(4-Morpholinylmethyl)phenol 
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2,2-Dimethyl-4H-1,3-benzodioxine (2.120) (2.48 g, 15.1 mmol) was dissolved in 
morpholine (2.124) (10 mL), the RM was then heated in the microwave to 180 °C for 
12 hours. The resulting mixture was separated by column chromatography, eluting with 
0.5% methanol in dichloromethane. This gave the title compound as a yellow solid 
(2.29 g, 79%). Spectra were consistent with those previously reported.267 
HRMS: (ESI+) Calculated for C11H15O2NH, m/z 194.1176 found 194.1173 
IR: (neat, ν cm-1) 2823, 2800 (v br), 1585, 1455. 
δH: (500 MHz, CDCl3): 10.62 (1H, s, 1-OH), 7.18 (1H, t, J = 7.7 Hz, 3-H), 6.98 (1H, d, 
J = 7.4 Hz, 5-H), 6.83 (1H, d, J = 8.1 Hz, 2-H), 6.79 (1H, t, J = 7.4 Hz, 4-H), 3.75 (4H, 
s, 9-H & 10-H), 3.71 (2H, s, 7-H), 2.57 (4H, s, 8-H & 11-H). 
δC: (126 MHz, CDCl3): 157.7 (C1), 129.2 (CH, C3), 129.0 (CH, C5), 120.8 (C6), 119.5 
(CH, C4), 116.3 (CH, C2), 67.0 (CH2, C9 & C10), 62.0 (CH2, C7), 53.1 (CH2, C8 & 
C11). 
Rf: (5% MeOH in CH2Cl2) = 0.41 
m.p.: 92-94 °C (Lit: 91-92 °C)268 
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 (2.132) 2-[(Phenylsulfanyl)methyl]phenol 
OH
6
5
4
3
2
17
S8
13
12
11
10
9
 
2,2-Dimethyl-4H-1,3-benzodioxine (2.120) (2.48 g, 15.1 mmol) was dissolved in 
thiophenol (2.126) (10 mL), the RM was then heated to 170 °C for 12 hours. When 
complete the solvent was removed under reduced pressure to give a yellow oil. This oil 
was further purified by column chromatography eluting with 0.5% methanol in 
dichloromethane, to give the title compound as a colourless oil (2.77 g, 85%). Spectra 
were consistent with those previously reported.122b 
HRMS: (ESI+) Calculated for C13H12OSNa, m/z 239.0501 found 239.0500 
IR: (neat, ν cm-1) 3390 (v br), 3056, 1582, 1455, 736. 
δH: (500 MHz, CDCl3): 7.38 (m, 2H), 7.29 (m, 3H), 7.18 (1H, app t, J = 7.6 Hz, 3-H), 
7.09 (1H, m, 5-H), 6.88 (2H, m, 2-H & 4-H), 6.05 (1H, s, 1-OH), 4.20 (2H, s, 7-H). 
δC: (126 MHz, CDCl3): 154.6 (C1), 134.9 (C8), 130.8 (CH, C10 & C12), 130.7 (CH, 
C5), 129.2 (CH, C3), 129.0 (CH, C9 & C13), 127.1 (CH, C11), 122.9 (C6), 120.9 (CH, 
C4), 116.7 (CH, C2), 35.4 (CH2, C7). 
Rf: (CH2Cl2) = 0.64 
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(2.131) 2-[4-(Dimethylamino)benzyl]phenol 
OH
6
5
4
3
2
17
8
13
12
11
10
9
N
15
14  
2,2-Dimethyl-4H-1,3-benzodioxine (2.120) (2.48 g, 15.1 mmol) was dissolved in N,N-
dimethylaniline (2.125) (10 mL), the RM was then heated in the microwave to 180 °C 
for 2 hours. When complete the remaining N,N-dimethylaniline was removed under 
reduced pressure to give a red oil. This oil was further purified by column 
chromatography eluting with dichloromethane, to give the title compound as a pale 
orange oil (2.33 g, 68%). Spectra were consistent with those previously reported.269 
HRMS: (ESI+) Calculated for C15H17ONNa, m/z 250.1202 found 250.1209 
IR: (neat, ν cm-1) 3336 (v br), 2888, 1499, 1614, 1516, 1454. 
δH: (500 MHz, CDCl3): 7.17-7.10 (4H, m, 3-H, 5-H, 9-H & 13-H), 6.90 (1H, t, J = 7.4 
Hz, 4-H), 6.79 (1H, d, J = 8.3 Hz, 2-H), 6.72 (2H, d, J = 8.5 Hz, 10-H & 12-H), 4.79 
(1H, v.br s, 1-OH), 3.93 (2H, s, 7-H), 2.93 (6H, s, 14-H & 15-H). 
δC: (126 MHz, CDCl3): 154.2 (C1), 149.6 (C2), 130.9 (CH, C5), 129.4 (CH, C9 & C13), 
127.8 (CH, C3) 127.7 (C6), 127.4 (C8), 120.9 (CH, C4), 116.0 (CH, C2) 113.4 (CH, 
C10 & C12), 40.9 (CH3, C14 & C15), 35.9 (CH2, C7). 
Rf: (CH2Cl2) = 0.35 
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(2.154) 1,1,1-Triisopropyl-N-methyl-N-(prop-2-ynyl)silanamine 
1
2
3
N
Si
4
5
7
6
9 8
10
11
12
13
 
Prepared according to the method of Faggiani.82 
N-Methylpropargylamine (1.380) (5.0 g, 72.4 mmol) was dissolved in dichloromethane 
(50 mL) and this solution was cooled to 0 °C and to this was added triethylamine (15.1 
mL, 108.5 mmol) followed by the dropwise addition of triisopropylsilyl triflate (23.3 g, 
76.0 mmol). The RM was allowed to stir for 30 minutes before being allowed to warm 
to rt. The RM was stirred for a further 16 hours before being quenched with aqueous 
potassium carbonate solution (10% w/w, 50 mL), separated and then washed with 
further potassium carbonate solution (50 mL). The organics were dried over anhydrous 
sodium sulfate before removal of the solvent under reduced pressure gave a crude 
yellow oil. This oil was further purified by distillation under reduced pressure (85 °C at 
2.1 mbar) to give the title compound as a colourless oil (14.4 g, 88%). Spectra were 
consistent with those previously reported.82 
HRMS: (ESI+) Calculated for C13H27NH, m/z 226.1986 found 226.1982 
IR: (neat, ν cm-1) 3311, 2944, 2865, 1463, 1142. 
δH: (500 MHz, CDCl3): 3.56 (2H, d, J = 2.3 Hz, 3-H), 2.60 (3H, s, 4-H), 2.13 (1H, t, J = 
2.3 Hz, 1-H), 1.21 - 1.08 (3H, m, 5-H, 6-H & 7-H), 1.06 (18H, d, J = 8.2 Hz, 8-H, 9-H, 
10-H, 11-H, 12-H & 13-H). 
δC: (126 MHz, CDCl3): 83.4 (C2), 70.2 (CH, C1), 40.8 (CH2, C3), 36.3 (CH3, C4), 18.5 
(CH3, C8, C9, C10, C11, C12 & C13), 12.3 (CH, C5, C6 & C7). 
Rf: Decomposes on silica. 
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(1.370) 2,3-Dibromopropene 
Br
2
3
Br
1
HB
HA  
Prepared by a modification of the method of Chin-Hsien.199 
1,2,3-Tribromopropane (2.63) (80.0 g, 284.8 mmol) and hexadecylpyridinium chloride 
monohydrate (4.0 g, 5% wt.) were added to a solution of potassium hydroxide (19.2 g, 
341.8 mmol) in water (100 mL) the RM was heated at reflux for 2 hours before being 
allowed to cool to rt. The organic layer was separated and washed with water (3 x 100 
mL) before being dried over anhydrous magnesium sulfate. This crude oil was then 
distilled under reduced pressure (89 °C at 5.3 mbar) to give the title compound as a 
colourless oil (38.0 g, 66%). Spectra were consistent with those previously reported.270 
IR: (neat, ν cm-1) 1620, 1189, 900. 
δH: (500 MHz, CDCl3): 6.01 (1H, d, J = 2.0 Hz, 1-HA), 5.62 (1H, d, J = 2.2 Hz, 15-HB), 
4.15 (2H, s, 1-H). 
δC: (126 MHz, CDCl3): 127.5 (C2), 121.1 (CH2, C1), 36.8 (CH2, C3). 
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“I think that I shall never see 
A study as muddled as chemistry 
A study hidden in pondrous books, 
      Where only a chemist ever looks!” 271 
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Table 1.  Crystal data and structure refinement . 
Identification code  Compound (2.13) 
Empirical formula  C10H9BrO4 
Formula weight  273.08 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  Pn  (No.7) 
Unit cell dimensions a = 10.5872(8) Å = 90°. 
 b = 3.9457(3) Å = 94.092(5)°. 
 c = 11.8125(8) Å  = 90°. 
Volume 492.20(6) Å3 
Z 2 
Density (calculated) 1.84 Mg/m3 
Absorption coefficient 4.17 mm-1 
F(000) 272 
Crystal size 0.35 x 0.35 x 0.20 mm3 
Theta range for data collection 3.46 to 25.95°. 
Index ranges -13<=h<=13, -4<=k<=4, -14<=l<=14 
Reflections collected 4146 
Independent reflections 1748 [R(int) = 0.052] 
Reflections with I>2sigma(I) 1704 
Completeness to theta = 25.95° 99.6 %  
Tmax. and Tmin.  0.3865 and 0.2003 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1748 / 2 / 138 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.045, wR2 = 0.107 
R indices (all data) R1 = 0.046, wR2 = 0.109 
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Absolute structure parameter 0.009(15) 
Largest diff. peak and hole 1.16 and -1.27 e.Å-3  (near Br) 
 
Data collection KappaCCD , Program package WinGX , Abs correction MULTISCAN  
Refinement using SHELXL-97, Drawing using ORTEP-3 for Windows  
 
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for dec1007. U (eq) is defined as one third of the trace of the orthogonalized 
Uij tensor. 
______________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________ 
Br 6140 4439(1) 2152 27(1) 
O(1) 7441(4) 857(10) 4193(4) 28(1) 
O(2) 2592(5) 5064(11) 5043(4) 26(1) 
O(3) 5295(4) -415(10) 7229(4) 27(1) 
O(4) 7209(4) -1824(13) 6694(4) 34(1) 
C(1) 5493(5) 3555(14) 3573(4) 22(1) 
C(2) 4269(6) 4622(13) 3742(6) 22(1) 
C(3) 3761(5) 4113(12) 4777(5) 23(1) 
C(4) 4504(5) 2444(12) 5611(4) 21(1) 
C(5) 5708(4) 1403(14) 5427(4) 20(1) 
C(6) 6256(4) 1948(13) 4407(4) 20(1) 
C(7) 6213(6) -419(13) 6469(5) 24(1) 
C(8) 4182(5) 1402(15) 6781(5) 25(1) 
C(9) 8471(5) 2568(16) 4798(6) 36(1) 
C(10) 1796(5) 6773(17) 4182(4) 26(1) 
______________________________________________________________________ 
 
 
 
Table 3.   Bond lengths [Å] and angles [°] for dec1007. 
_____________________________________________________ 
Br-C(1)  1.890(5) 
O(1)-C(6)  1.367(6) 
O(1)-C(9)  1.430(7) 
O(2)-C(3)  1.351(7) 
O(2)-C(10)  1.441(7) 
O(3)-C(7)  1.369(8) 
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O(3)-C(8)  1.446(7) 
O(4)-C(7)  1.204(7) 
C(1)-C(6)  1.383(7) 
C(1)-C(2)  1.389(8) 
C(2)-C(3)  1.385(9) 
C(3)-C(4)  1.383(7) 
C(4)-C(5)  1.372(7) 
C(4)-C(8)  1.504(7) 
C(5)-C(6)  1.391(7) 
C(5)-C(7)  1.491(8) 
 
C(6)-O(1)-C(9) 115.9(4) 
C(3)-O(2)-C(10) 117.7(5) 
C(7)-O(3)-C(8) 111.0(5) 
C(6)-C(1)-C(2) 122.7(5) 
C(6)-C(1)-Br 119.1(4) 
C(2)-C(1)-Br 118.2(4) 
C(3)-C(2)-C(1) 120.5(6) 
O(2)-C(3)-C(4) 116.8(5) 
O(2)-C(3)-C(2) 125.8(5) 
C(4)-C(3)-C(2) 117.4(5) 
C(5)-C(4)-C(3) 121.2(5) 
C(5)-C(4)-C(8) 109.7(4) 
C(3)-C(4)-C(8) 129.1(5) 
C(4)-C(5)-C(6) 122.7(5) 
C(4)-C(5)-C(7) 107.2(5) 
C(6)-C(5)-C(7) 130.0(5) 
O(1)-C(6)-C(1) 120.7(5) 
O(1)-C(6)-C(5) 123.8(5) 
C(1)-C(6)-C(5) 115.4(4) 
O(4)-C(7)-O(3) 120.5(5) 
O(4)-C(7)-C(5) 131.3(5) 
O(3)-C(7)-C(5) 108.2(5) 
O(3)-C(8)-C(4) 103.9(4) 
_____________________________________________________________ 
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Appendix B: NMR Spectra 
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